ý
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Large Accelerated Filer
|
|
¨
|
|
Accelerated Filer
|
|
x
|
|
|
|
|
|||
Non-accelerated Filer
|
|
¨
(Do not check if smaller reporting company)
|
|
Smaller Reporting Company
|
|
¨
|
|
|
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
x
|
|
|
Page
|
PART I
|
||
Item 1.
|
||
Item 1A.
|
||
Item 1B.
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
PART II
|
||
Item 5.
|
||
Item 6.
|
||
Item 7.
|
||
Item 7A.
|
||
Item 8.
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
Item 9.
|
||
Item 9A.
|
||
Item 9B.
|
||
PART III
|
||
Item 10.
|
||
Item 11.
|
||
Item 12.
|
||
Item 13.
|
||
Item 14.
|
||
PART IV
|
||
Item 15.
|
||
|
||
|
•
|
deterioration in the financial condition of borrowers resulting in significant increases in the Company’s loan and lease losses and provisions for those losses and other adverse impacts to results of operations and financial condition;
|
•
|
changes in Small Business Administration ("SBA") rules, regulations and loan products, including specifically the Section 7(a) program, changes in SBA standard operating procedures or changes to the status of Live Oak Banking Company (the "Bank") as an SBA Preferred Lender;
|
•
|
changes in rules, regulations or procedures for other government loan programs, including those of the United States Department of Agriculture;
|
•
|
changes in interest rates that affect the level and composition of deposits, loan demand and the values of loan collateral, securities, and interest sensitive assets and liabilities;
|
•
|
the failure of assumptions underlying the establishment of reserves for possible loan and lease losses;
|
•
|
changes in loan underwriting, credit review or loss reserve policies associated with economic conditions, examination conclusions, or regulatory developments;
|
•
|
a reduction in or the termination of the Company’s ability to use the technology-based platform that is critical to the success of the Company’s business model, including a failure in or a breach of the Company’s operational or security systems or those of its third party service providers;
|
•
|
changes in financial market conditions, either internationally, nationally or locally in areas in which the Company conducts operations, including reductions in rates of business formation and growth, demand for the Company’s products and services, commercial and residential real estate development and prices, premiums paid in the secondary market for the sale of loans, and valuation of servicing rights;
|
•
|
changes in accounting principles, policies, and guidelines applicable to bank holding companies and banking;
|
•
|
fluctuations in markets for equity, fixed-income, commercial paper and other securities, which could affect availability, market liquidity levels, and pricing;
|
•
|
the effects of competition from other commercial banks, non-bank lenders, consumer finance companies, credit unions, securities brokerage firms, insurance companies, money market and mutual funds, and other financial institutions operating in the Company’s market area and elsewhere, including institutions operating regionally, nationally and internationally, together with such competitors offering banking products and services by mail, telephone and the Internet;
|
•
|
the Company's ability to attract and retain key personnel;
|
•
|
changes in governmental monetary and fiscal policies as well as other legislative and regulatory changes, including with respect to SBA lending programs and investment tax credits;
|
•
|
changes in political and economic conditions;
|
•
|
the impact of heightened regulatory scrutiny of financial products and services, primarily led by the Consumer Financial Protection Bureau;
|
•
|
the Company's ability to comply with any requirements imposed on it by regulators, and the potential negative consequences that may result;
|
•
|
operational, compliance and other factors, including conditions in local areas in which the Company conducts business such as inclement weather or a reduction in the availability of services or products for which loan proceeds will be used, that could prevent or delay closing and funding loans before they can be sold in the secondary market;
|
•
|
the effect of any mergers, acquisitions or other transactions, to which the Company or the Bank may from time to time be a party, including management’s ability to successfully integrate any businesses acquired;
|
•
|
other risk factors listed from time to time in reports that the Company files with the SEC, including those described under “Risk Factors” in this Report; and
|
•
|
the success at managing the risks involved in the foregoing.
|
Item 1.
|
BUSINESS
|
•
|
Reltco, Inc. and National Assurance Title, Inc. (collectively referred to as “Reltco”), two companies under common control acquired on February 1, 2017, that provide nationwide title agency and settlement services;
|
•
|
Live Oak Clean Energy Financing LLC, formed in November 2016 for the purpose of providing financing to entities for renewable energy applications;
|
•
|
Canapi, Inc (formerly Live Oak Ventures, Inc.), formed in August 2016 for the purpose of investing in businesses that align with the Company's strategic initiative to be a leader in financial technology;
|
•
|
Live Oak Grove, LLC, opened in September 2015 for the purpose of providing Company employees and business visitors an on-site restaurant location;
|
•
|
Government Loan Solutions, Inc. (“GLS”), a management and technology consulting firm that specializes in the settlement, accounting, and securitization processes for government guaranteed loans, including loans originated under the SBA 7(a) loan program and USDA-guaranteed loans; and
|
•
|
504 Fund Advisors, LLC (“504FA”), formed to serve as the investment advisor to the 504 Fund, a closed-end mutual fund organized to invest in SBA section 504 loans.
|
•
|
it may acquire direct or indirect ownership or control of any voting shares of any bank if, after the acquisition, the bank holding company will directly or indirectly own or control more than 5% of the voting shares of the bank;
|
•
|
it or any of its subsidiaries, other than a bank, may acquire all or substantially all of the assets of any bank; or
|
•
|
it may merge or consolidate with any other bank holding company.
|
•
|
the bank holding company has registered securities under Section 12 of the Securities Exchange Act of 1934, as amended, or the Exchange Act; or
|
•
|
no other person owns a greater percentage of that class of voting securities immediately after the transaction.
|
•
|
“well capitalized” if it has a Total Risk-Based Capital ratio of 10% or greater, a Tier 1 Risk-Based Capital ratio of 8% or greater, a Common Equity Tier 1 Capital ratio of 6.5% or greater and a leverage ratio of 5% or greater and is not subject to any order or written directive by the appropriate regulatory authority to meet and maintain a specific capital level for any capital measure;
|
•
|
“adequately capitalized” if it has a Total Risk-Based Capital ratio of 8% or greater, a Tier 1 Risk-Based Capital ratio of 6% or greater, a Common Equity Tier 1 Capital ratio of 4.5% or greater and a leverage ratio of 4% or greater and is not “well capitalized”;
|
•
|
“undercapitalized” if it has a Total Risk-Based Capital ratio of less than 8%, a Tier 1 Risk-Based Capital ratio of less than 6%, a Common Equity Tier 1 Capital ratio of less than 4% or a leverage ratio of less than 4%;
|
•
|
“significantly undercapitalized” if it has a Total Risk-Based Capital ratio of less than 6%, a Tier 1 Risk-Based Capital ratio of less than 4%, a Common Equity Tier 1 Capital ratio of less than 3% or a leverage ratio of less than 3%; and
|
•
|
“critically undercapitalized” if its tangible equity is equal to or less than 2% of average quarterly tangible assets.
|
•
|
The rule implements higher minimum capital requirements, includes a new common equity Tier1 capital requirement, and establishes criteria that instruments must meet in order to be considered Common Equity Tier 1 capital, additional Tier 1 capital, or Tier 2 capital. These enhancements are intended to both improve the quality and increase the quantity of capital required to be held by banking organizations. The minimum capital to risk-weighted assets (“RWA”) requirements under the rule are a common equity Tier 1 capital ratio of 4.5% and a Tier 1 capital ratio of 6.0%, which is an increase from 4.0%, and a total capital ratio of 8.0%. The minimum leverage ratio (Tier 1 capital to total assets) is 4.0%. The rule maintained the general structure of the current prompt corrective action, or PCA, framework while incorporating these increased minimum requirements.
|
•
|
The rule implements changes to the definition of capital. Among the most important changes are stricter eligibility criteria for regulatory capital instruments that disallow the inclusion of instruments such as trust preferred securities in Tier 1 capital going forward, and constraints on the inclusion of minority interests, mortgage-servicing assets (“MSAs”), deferred tax assets (“DTAs”), and certain investments in the capital of unconsolidated financial institutions. In addition, the rule requires that certain regulatory capital deductions be made from common equity Tier 1 capital.
|
•
|
Under the rule, in order to avoid limitations on capital distributions, including dividend payments and certain discretionary bonus payments to executive officers, a banking organization must hold a capital conservation buffer composed of common equity Tier 1 capital above its minimum risk-based capital requirements. The buffer is measured relative to RWA. A three-year phase-in of the capital conservation buffer requirements began on January 1, 2016. A banking organization with a buffer greater than 2.5% would not be subject to limits on capital distributions or discretionary bonus payments; however, a banking organization with a buffer of less than 2.5% would be subject to increasingly stringent limitations as the buffer approaches zero. The rule also prohibits a banking organization from making distributions or discretionary bonus payments during any quarter if its eligible retained income is negative in that quarter and its capital conservation buffer ratio was less than 2.5% at the beginning of the quarter. When the rule is fully phased in, the minimum capital requirements plus the capital conservation buffer will exceed the PCA well-capitalized thresholds.
|
•
|
The rule also increases the risk weights for past-due loans, certain commercial real estate loans, and some equity exposures, and makes selected other changes in risk weights and credit conversion factors.
|
•
|
total reported loans for construction, land development and other land, or C&D, represent 100% or more of the institution’s total capital; or
|
•
|
total CRE loans represent 300% or more of the institution’s total capital, and the outstanding balance of the institution’s CRE loan portfolio has increased over 50% or more during the prior 36 months.
|
Item 1A.
|
RISK FACTORS
|
•
|
the market price for new equipment of a like kind;
|
•
|
the age of the equipment at the time it is sold, as well as wear and tear on the equipment relative to its age;
|
•
|
the supply of used equipment on the market;
|
•
|
technological advances relating to the equipment;
|
•
|
demand for the used equipment; and
|
•
|
general economic conditions.
|
•
|
our ability to build and maintain long-term customer relationships while ensuring high ethical standards and safe and sound banking practices;
|
•
|
the scope, relevance and pricing of products and services that we offer;
|
•
|
customer satisfaction with our products and services;
|
•
|
industry and general economic trends; and
|
•
|
our ability to keep pace with technological advances and to invest in new technology.
|
•
|
The rule implements higher minimum capital requirements, includes a new common equity Tier1 capital requirement, and establishes criteria that instruments must meet in order to be considered Common Equity Tier 1 capital, additional Tier 1 capital, or Tier 2 capital. These enhancements are intended to both improve the quality and increase the quantity of capital required to be held by banking organizations. The minimum capital to risk-weighted assets (“RWA”) requirements under the rule are a common equity Tier 1 capital ratio of 4.5% and a Tier 1 capital ratio of 6.0%, which is an increase from 4.0%, and a total capital ratio that remains at 8.0%. The minimum leverage ratio (Tier 1 capital to total assets) is 4.0%. The rule maintains the general structure of the current prompt corrective action, or PCA, framework while incorporating these increased minimum requirements.
|
•
|
The rule implements changes to the definition of capital. Among the most important changes are stricter eligibility criteria for regulatory capital instruments that would disallow the inclusion of instruments such as trust preferred securities in Tier 1 capital going forward, and new constraints on the inclusion of minority interests, mortgage-servicing assets (“MSAs”), deferred tax assets (“DTAs”), and certain investments in the capital of unconsolidated financial institutions. In addition, the rule requires that certain regulatory capital deductions be made from common equity Tier 1 capital.
|
•
|
Under the rule, in order to avoid limitations on capital distributions, including dividend payments and certain discretionary bonus payments to executive officers, a banking organization must hold a capital conservation buffer composed of common equity Tier 1 capital above its minimum risk-based capital requirements. The buffer is measured relative to RWA. A three-year phase-in of the capital conservation buffer requirements began on January 1, 2016. A banking organization with a buffer greater than 2.5% would not be subject to limits on capital distributions or discretionary bonus payments; however, a banking organization with a buffer of less than 2.5% would be subject to increasingly stringent limitations as the buffer approaches zero. The rule also prohibits a banking organization from making distributions or discretionary bonus payments during any quarter if its eligible retained income is negative in that quarter and its capital conservation buffer ratio was less than 2.5% at the beginning of the quarter. When the rule is fully phased in, the minimum capital requirements plus the capital conservation buffer will exceed the PCA well-capitalized thresholds.
|
•
|
The rule also increases the risk weights for past-due loans, certain commercial real estate loans, and some equity exposures, and makes selected other changes in risk weights and credit conversion factors.
|
Item 1B.
|
UNRESOLVED STAFF COMMENTS
|
Item 2.
|
PROPERTIES
|
Office
|
|
Address
|
|
Year Opened
|
|
Approximate Square Footage
|
|
Owned or Leased
|
Main Offices
|
|
1741 Tiburon Dr
1757 Tiburon Dr
|
|
2013
2015
|
|
36,000
55,000
|
|
Owned
|
Satellite Wilmington Office
|
|
2605 Irongate Dr
Ste. 100
|
|
2016
|
|
10,632
|
|
Leased
|
Atlanta Loan Production Office
|
|
3060 Peachtree Rd
Ste. 1220
|
|
2010
|
|
4,455
|
|
Leased
|
Santa Rosa, CA Office
|
|
100 B Street
Ste. 100
|
|
2015
|
|
2,386
|
|
Leased
|
Houston, TX Relationship Office
|
|
16801 Greenspoint Park Dr Ste. 395
|
|
2015
|
|
3,514
|
|
Leased
|
Roseville, CA Office
|
|
1223 Pleasant Grove Blvd
Ste. 120
|
|
2016
|
|
1,186
|
|
Leased
|
Tampa, FL Office
|
|
13401 McCormick Dr
|
|
2017
|
|
10,846
|
|
Leased
|
Wilmington Flight Operations
|
|
1890 Trask Drive
|
|
2017
|
|
25,500
|
|
Owned
|
Washington, DC Office
|
|
2099 Pennsylvania Ave, NW
|
|
2017
|
|
3,698
|
|
Leased
|
Item 3.
|
LEGAL PROCEEDINGS
|
Item 4.
|
MINE SAFETY DISCLOSURES
|
Item 5.
|
MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
|
|
|
Closing Price
|
|
Cash
Dividends
Declared
|
||||||||
Quarter ended
|
|
High
|
|
Low
|
|
|||||||
March 31, 2016
|
|
$
|
15.29
|
|
|
$
|
12.14
|
|
|
$
|
0.02
|
|
June 30, 2016
|
|
16.50
|
|
|
13.70
|
|
|
0.01
|
|
|||
September 30, 2016
|
|
14.96
|
|
|
13.01
|
|
|
0.02
|
|
|||
December 31, 2016
|
|
19.85
|
|
|
14.10
|
|
|
0.02
|
|
|||
March 31, 2017
|
|
24.59
|
|
|
18.00
|
|
|
0.02
|
|
|||
June 30, 2017
|
|
26.05
|
|
|
20.95
|
|
|
0.02
|
|
|||
September 30, 2017
|
|
25.80
|
|
|
20.75
|
|
|
0.03
|
|
|||
December 31, 2017
|
|
26.35
|
|
|
22.00
|
|
|
0.03
|
|
Item 6.
|
SELECTED FINANCIAL DATA
|
(dollars in thousands, except per share data)
|
As of and for the Year Ended December 31,
|
||||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Income Statement Data
|
|
|
|
|
|
|
|
|
|
||||||||||
Net interest income
|
$
|
78,034
|
|
|
$
|
42,649
|
|
|
$
|
25,589
|
|
|
$
|
14,713
|
|
|
$
|
10,779
|
|
Provision for (recovery of) loan and lease loss
|
9,536
|
|
|
12,536
|
|
|
3,806
|
|
|
2,793
|
|
|
(858
|
)
|
|||||
Noninterest income
|
172,921
|
|
|
93,539
|
|
|
84,328
|
|
|
60,042
|
|
|
56,477
|
|
|||||
Noninterest expense
|
143,165
|
|
|
106,445
|
|
|
71,715
|
|
|
54,526
|
|
|
40,172
|
|
|||||
Income, before income taxes
|
98,254
|
|
|
17,207
|
|
|
34,396
|
|
|
17,436
|
|
|
27,942
|
|
|||||
Income tax (benefit) expense
|
(2,245
|
)
|
|
3,443
|
|
|
13,795
|
|
|
7,388
|
|
|
—
|
|
|||||
Net income
|
100,499
|
|
|
13,764
|
|
|
20,601
|
|
|
10,048
|
|
|
27,942
|
|
|||||
Net income attributable to noncontrolling interest
|
—
|
|
|
9
|
|
|
24
|
|
|
—
|
|
|
120
|
|
|||||
Net income to common shareholders
|
100,499
|
|
|
13,773
|
|
|
20,625
|
|
|
10,048
|
|
|
28,062
|
|
|||||
Net income (net of tax effect) (1)
|
100,499
|
|
|
13,773
|
|
|
20,625
|
|
|
10,723
|
|
|
17,258
|
|
|||||
Period End Balances
|
|
|
|
|
|
|
|
|
|
||||||||||
Assets
|
2,758,474
|
|
|
1,755,261
|
|
|
1,052,622
|
|
|
673,315
|
|
|
430,355
|
|
|||||
Loans held for sale
|
680,454
|
|
|
394,278
|
|
|
480,619
|
|
|
295,180
|
|
|
159,438
|
|
|||||
Loans and leases held for investment
|
1,343,973
|
|
|
907,566
|
|
|
279,969
|
|
|
203,936
|
|
|
141,349
|
|
|||||
Allowance for loan and lease losses
|
24,190
|
|
|
18,209
|
|
|
7,415
|
|
|
4,407
|
|
|
2,723
|
|
|||||
Deposits
|
2,260,263
|
|
|
1,485,076
|
|
|
804,788
|
|
|
522,080
|
|
|
356,620
|
|
|||||
Borrowings
|
26,564
|
|
|
27,843
|
|
|
28,375
|
|
|
47,949
|
|
|
12,325
|
|
|||||
Shareholders' equity
|
436,933
|
|
|
222,847
|
|
|
199,488
|
|
|
91,814
|
|
|
48,390
|
|
|||||
Per Common Share Data
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income per share - basic
|
2.75
|
|
|
0.40
|
|
|
0.66
|
|
|
0.42
|
|
|
1.38
|
|
|||||
Net income per share - diluted
|
2.65
|
|
|
0.39
|
|
|
0.65
|
|
|
0.41
|
|
|
1.37
|
|
|||||
Net income per share (net of tax effect) - basic (1)
|
2.75
|
|
|
0.40
|
|
|
0.66
|
|
|
0.45
|
|
|
0.85
|
|
|||||
Net income per share (net of tax effect) - diluted (1)
|
2.65
|
|
|
0.39
|
|
|
0.65
|
|
|
0.44
|
|
|
0.84
|
|
|||||
Operating net income per share (Non-GAAP) - basic (2)
|
1.29
|
|
|
0.59
|
|
|
0.54
|
|
|
0.57
|
|
|
0.48
|
|
|||||
Operating net income per share (Non-GAAP) - diluted (2)
|
1.25
|
|
|
0.57
|
|
|
0.53
|
|
|
0.56
|
|
|
0.48
|
|
|||||
Dividends declared
|
0.10
|
|
|
0.07
|
|
|
0.10
|
|
|
2.18
|
|
|
0.48
|
|
|||||
Book value
|
10.95
|
|
|
6.51
|
|
|
5.84
|
|
|
3.21
|
|
|
2.38
|
|
|||||
Tangible book value (2)
|
10.85
|
|
|
6.51
|
|
|
5.84
|
|
|
3.20
|
|
|
2.36
|
|
|
As of and for the Year Ended December 31,
|
||||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Performance Ratios
|
|
|
|
|
|
|
|
|
|
||||||||||
Return on average assets
|
4.55
|
%
|
|
0.96
|
%
|
|
2.26
|
%
|
|
1.77
|
%
|
|
6.53
|
%
|
|||||
Return on average equity
|
33.80
|
|
|
6.55
|
|
|
14.52
|
|
|
14.11
|
|
|
62.82
|
|
|||||
Return on average assets (net of tax effect) (1)
|
4.55
|
|
|
0.96
|
|
|
2.26
|
|
|
1.89
|
|
|
4.02
|
|
|||||
Return on average equity (net of tax effect) (1)
|
33.80
|
|
|
6.55
|
|
|
14.52
|
|
|
15.05
|
|
|
38.63
|
|
|||||
Net interest margin
|
3.92
|
|
|
3.28
|
|
|
3.26
|
|
|
3.04
|
|
|
2.95
|
|
|||||
Efficiency ratio (2)
|
57.05
|
|
|
78.16
|
|
|
65.25
|
|
|
72.87
|
|
|
59.74
|
|
|||||
Noninterest income to total revenue
|
68.91
|
|
|
68.68
|
|
|
76.72
|
|
|
80.34
|
|
|
83.97
|
|
|||||
Average equity to average assets
|
13.46
|
|
|
14.63
|
|
|
15.53
|
|
|
12.56
|
|
|
10.40
|
|
|||||
Dividend payout ratio (inclusive of tax distributions)
|
3.64
|
|
|
17.50
|
|
|
15.15
|
|
|
447.33
|
|
|
10.65
|
|
|||||
Dividend payout ratio (net of tax effect) (1)
|
3.64
|
|
|
17.50
|
|
|
15.15
|
|
|
419.17
|
|
|
17.32
|
|
|||||
Selected Loan Metrics
|
|
|
|
|
|
|
|
|
|
||||||||||
Loans and leases originated
|
$
|
1,934,238
|
|
|
$
|
1,537,010
|
|
|
$
|
1,158,640
|
|
|
$
|
848,090
|
|
|
$
|
498,752
|
|
Guaranteed loans sold
|
787,926
|
|
|
761,933
|
|
|
640,886
|
|
|
433,912
|
|
|
339,342
|
|
|||||
Average net gain on sale of guaranteed loans
|
100.38
|
|
|
98.86
|
|
|
105.14
|
|
|
115.18
|
|
|
112.64
|
|
|||||
Held for sale guaranteed loans (note amount) (3)
|
1,087,636
|
|
|
754,834
|
|
|
497,875
|
|
|
326,723
|
|
|
144,228
|
|
|||||
Annual increase in held for sale guaranteed loans (note amount)
|
332,802
|
|
|
256,959
|
|
|
171,152
|
|
|
182,495
|
|
|
22,562
|
|
|||||
Estimated net gain to be recognized on annual increase in guaranteed loans held for sale (4)
|
33,407
|
|
|
25,403
|
|
|
17,995
|
|
|
21,020
|
|
|
2,541
|
|
|||||
Asset Quality Ratios
|
|
|
|
|
|
|
|
|
|
||||||||||
Allowance for loan and lease losses to loans and leases held for investment
|
1.80
|
%
|
|
2.01
|
%
|
|
2.65
|
%
|
|
2.16
|
%
|
|
1.93
|
%
|
|||||
Net charge-offs
|
$
|
3,555
|
|
|
$
|
1,742
|
|
|
$
|
798
|
|
|
$
|
1,109
|
|
|
$
|
1,888
|
|
Net charge-offs to average loans and leases held for investment
|
0.32
|
%
|
|
0.29
|
%
|
|
0.37
|
%
|
|
1.21
|
%
|
|
3.47
|
%
|
|||||
Nonperforming loans
|
$
|
23,480
|
|
|
$
|
23,781
|
|
|
$
|
12,367
|
|
|
$
|
18,692
|
|
|
$
|
8,697
|
|
Foreclosed assets
|
1,281
|
|
|
1,648
|
|
|
2,666
|
|
|
1,084
|
|
|
773
|
|
|||||
Nonperforming loans (unguaranteed exposure)
|
3,610
|
|
|
4,784
|
|
|
2,037
|
|
|
3,137
|
|
|
1,714
|
|
|||||
Foreclosed assets (unguaranteed exposure)
|
90
|
|
|
246
|
|
|
373
|
|
|
371
|
|
|
341
|
|
|||||
Nonperforming loans not guaranteed by the SBA and foreclosed assets
|
3,700
|
|
|
5,030
|
|
|
2,410
|
|
|
3,508
|
|
|
2,055
|
|
|||||
Nonperforming loans not guaranteed by the SBA and foreclosed assets to total assets
|
0.13
|
%
|
|
0.29
|
%
|
|
0.23
|
%
|
|
0.52
|
%
|
|
0.48
|
%
|
|||||
Capital and Liquidity Ratios
|
|
|
|
|
|
|
|
|
|
||||||||||
Common equity tier 1 capital (to risk-weighted assets)
|
17.81
|
%
|
|
15.31
|
%
|
|
23.22
|
%
|
|
N/A
|
|
|
N/A
|
|
|||||
Total capital (to risk-weighted assets)
|
18.91
|
|
|
16.56
|
|
|
24.12
|
|
|
19.63
|
%
|
|
15.95
|
%
|
|||||
Tier 1 risk-based capital (to risk-weighted assets)
|
17.81
|
|
|
15.31
|
|
|
23.22
|
|
|
17.41
|
|
|
15.09
|
|
|||||
Tier 1 leverage capital (to average assets)
|
15.50
|
|
|
12.00
|
|
|
18.36
|
|
|
13.38
|
|
|
10.39
|
|
(1)
|
Net income (net of tax effect), earnings per share (net of tax effect) on a basic and diluted basis, return on average assets (net of tax effect), and return on average equity (net of tax effect) for each year shown was determined by calculating a provision for income taxes using an assumed annual effective income tax rate of 38.5% for the years ended December 31, 2014 and 2013, and adjusting our historical net income for each period presented to give effect to the pro forma provision for federal and state income taxes for such year. For the year ended December 31, 2014 the Company also excluded the initial deferred tax liability recorded as a result of the change in tax status on August 3, 2014 due to the conversion from an S corporation to a C corporation.
|
(2)
|
See "Non-GAAP Measures" in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Report for more information and a reconciliation to the most closely related GAAP measure.
|
(3)
|
Includes the entire note amount, including undisbursed funds for multi-advance loans.
|
(4)
|
The estimated revenue from the sale of the annual increase in guaranteed loans is based on the average net gain on sale of loans for that year. This is an estimate based on the respective year activity and does not reflect actual gains to be recognized.
|
Item 7.
|
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
•
|
The Company entered seven new verticals bringing the total number of vertical business units at year-end to twenty.
|
•
|
Apiture, a digital banking joint venture formed with First Data Corporation, was established in the fourth quarter of 2017 generating a one-time gain for the Bank of $68.0 million. Apiture combines First Data’s and Live Oak Bank’s digital banking platforms, products, and services, delivering innovative technology solutions tailored for financial institutions. Both the Bank and First Data Corporation hold 50% voting control of Apiture.
|
•
|
Net interest income and loan servicing revenue increased by $38.6 million, or 60.2%, to $102.6 million in 2017.
|
•
|
Loan and lease production increased to $1.93 billion for 2017, a 25.8% increase over 2016.
|
•
|
$24.9 million in investment tax credits were generated by the Company's investment of $90.6 million in renewable energy assets which are leased under operating lease arrangements.
|
•
|
During the third quarter, the Company completed a successful secondary public offering which generated an additional $113.1 million in capital.
|
•
|
Guaranteed loan sales were relatively flat at $787.9 million in 2017, a 3.4% increase over 2016, as the Company focused on guaranteed loan retention to increase recurring revenue.
|
•
|
Loans held for investment increased by $436.4 million, or 48.1%, to $1.34 billion at the end of 2017 as a result of robust 2017 loan originations.
|
•
|
Total nonperforming unguaranteed loans and leases as a percentage of total loans and leases held for investment declined from 0.53% at the end of 2016 to 0.27% at the end of 2017.
|
•
|
Net charge-offs as a percentage of average held for investment loans and leases, for the years ended December 31, 2017 and 2016, were 0.32% and 0.29%, respectively
|
•
|
Core revenues consisting of net interest income, servicing revenue and gains on sale of loans increased to $181.2 million, a 30.0% increase over 2016.
|
•
|
Total deposits rose by 52.2% to $2.26 billion at the end of 2017 following successful deposit gathering campaigns.
|
•
|
As a result of the December 22, 2017 Tax Cut and Jobs Act, the Company recorded a one-time reduction in tax expense of $18.9 million arising from the revaluation of its net deferred tax liability.
|
•
|
Reported net income increased by 630.2% over 2016 to $100.5 million. Non-GAAP net income, which excludes non-routine income and expenses, improved $27.0 million over 2016, or 134.2%, to $47.2 million. See "Non-GAAP Financial Measures" below for more information about Non-GAAP net income. The reconciliation of non-GAAP measures is presented at the conclusion of this Item 7.
|
•
|
Increased net interest income of $35.4 million, or 83%, predominately driven by significant growth in the loans and leases held for sale and held for investment portfolios combined with a significantly higher net interest margin;
|
•
|
A $68.0 million one-time gain arising from the Company's fourth quarter equity method investment in Apiture; and
|
•
|
A decrease in income tax expense of $5.7 million, or 165.2%, due to the generation of investment tax credits by the Company's renewable energy leasing business combined with the positive impact of the enactment of the Tax Cuts and Jobs Act on December 22, 2017, as further discussed below.
|
•
|
Decreased provision for loan and lease losses of $3.0 million principally driven by the one-time transfer of $318.8 million in unguaranteed loans from held for sale to held for investment classification during the second quarter of 2016;
|
•
|
Increased loan servicing revenue of $3.2 million, or 14.9%, as a result of continued growth in the servicing portfolio due to ongoing loan sales;
|
•
|
Increased net gains on sales of loans of $3.3 million, or 4.3%, due to higher sale volumes combined with an increase in the average net gain per loan sold.
|
•
|
An increase in the provision for loan and lease losses of $8.7 million, or 229.4%, arising primarily from significantly higher levels of loans held for investment, which included the transfer of $318.8 million in unguaranteed loans from being classified as held for sale to held for investment in the second quarter of 2016. This increase in the loan loss provision resulted in significant growth to the allowance for loan losses of $4.0 million. The higher provision also reflected the increase of $944 thousand in net charge-offs during 2016 as compared to 2015.
|
•
|
Decreased noninterest income from a one-time gain of $3.8 million in the first quarter of 2015 related to the sale of an investment in nCino, Inc., a former subsidiary of the Company (“nCino”) combined with a higher negative loan servicing revaluation adjustment of $2.2 million; and
|
•
|
Increased noninterest expense of $34.7 million, or 48.4%, attributable to the rapid growth of the business franchise. The increase in noninterest expense was predominantly driven by higher salaries and employee benefits of $22.7 million, or 56.2%, occupancy expense of $1.1 million, or 31.6%, data processing expense of $1.7 million, or 47.9%, and other expense of $3.3 million, or 56.9%. Factors driving these higher non-interest expense levels were increased investments in human capital, infrastructure and regulatory costs to support growing loan production from new and existing verticals as well as development of a new small business loan and deposit platform. Also contributing significantly to the increase in noninterest expense was a renewable energy tax credit investment impairment of $3.2 million related to a $4.6 million renewable energy tax credit investment in the fourth quarter. As reflected in lower income tax expense, this investment generated tax savings of $5.5 million for 2016.
|
|
|
2017
|
|
2016
|
|
2015
|
|||||||||||||||||||||||||||
|
|
Average Balance
|
|
Interest
|
|
Average Yield/Rate
|
|
Average Balance
|
|
Interest
|
|
Average Yield/Rate
|
|
Average Balance
|
|
Interest
|
|
Average Yield/Rate
|
|||||||||||||||
Interest earning assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Interest earning balances in other banks
|
|
$
|
232,398
|
|
|
$
|
2,407
|
|
|
1.04
|
%
|
|
$
|
222,704
|
|
|
$
|
1,033
|
|
|
0.46
|
%
|
|
$
|
84,782
|
|
|
$
|
300
|
|
|
0.35
|
%
|
Investment securities
|
|
76,250
|
|
|
1,432
|
|
|
1.88
|
|
|
62,746
|
|
|
1,132
|
|
|
1.80
|
|
|
50,431
|
|
|
811
|
|
|
1.61
|
|
||||||
Loans held for sale
|
|
582,245
|
|
|
34,567
|
|
|
5.94
|
|
|
413,468
|
|
|
22,645
|
|
|
5.48
|
|
|
435,508
|
|
|
22,590
|
|
|
5.19
|
|
||||||
Loans and leases held for investment
|
|
1,097,510
|
|
|
65,066
|
|
|
5.93
|
|
|
602,875
|
|
|
32,462
|
|
|
5.38
|
|
|
213,974
|
|
|
10,750
|
|
|
5.02
|
|
||||||
Total interest earning assets
|
|
1,988,403
|
|
|
103,472
|
|
|
5.20
|
|
|
1,301,793
|
|
|
57,272
|
|
|
4.40
|
|
|
784,695
|
|
|
34,451
|
|
|
4.39
|
|
||||||
Less: Allowance for loan ad lease losses
|
|
(19,230
|
)
|
|
|
|
|
|
(10,899
|
)
|
|
|
|
|
|
(5,254
|
)
|
|
|
|
|
||||||||||||
Non-interest earning assets
|
|
239,797
|
|
|
|
|
|
|
146,169
|
|
|
|
|
|
|
135,151
|
|
|
|
|
|
||||||||||||
Total assets
|
|
$
|
2,208,970
|
|
|
|
|
|
|
$
|
1,437,063
|
|
|
|
|
|
|
$
|
914,592
|
|
|
|
|
|
|||||||||
Interest bearing liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Interest bearing checking
|
|
$
|
39,213
|
|
|
$
|
256
|
|
|
0.65
|
%
|
|
$
|
20,410
|
|
|
$
|
116
|
|
|
0.57
|
%
|
|
$
|
6,604
|
|
|
$
|
39
|
|
|
0.59
|
%
|
Savings
|
|
193,083
|
|
|
2,685
|
|
|
1.39
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Money market accounts
|
|
413,648
|
|
|
4,060
|
|
|
0.98
|
|
|
423,035
|
|
|
3,197
|
|
|
0.76
|
|
|
347,429
|
|
|
2,562
|
|
|
0.74
|
|
||||||
Certificates of deposit
|
|
1,161,651
|
|
|
17,222
|
|
|
1.48
|
|
|
712,327
|
|
|
10,346
|
|
|
1.45
|
|
|
343,625
|
|
|
4,778
|
|
|
1.39
|
|
||||||
Total deposits
|
|
1,807,595
|
|
|
24,223
|
|
|
1.34
|
|
|
1,155,772
|
|
|
13,659
|
|
|
1.18
|
|
|
697,658
|
|
|
7,379
|
|
|
1.06
|
|
||||||
Small business lending fund
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,222
|
|
|
94
|
|
|
1.51
|
|
||||||
Other borrowings
|
|
34,968
|
|
|
1,215
|
|
|
3.47
|
|
|
28,250
|
|
|
964
|
|
|
3.41
|
|
|
39,515
|
|
|
1,389
|
|
|
3.52
|
|
||||||
Total interest bearing liabilities
|
|
1,842,563
|
|
|
25,438
|
|
|
1.38
|
|
|
1,184,022
|
|
|
14,623
|
|
|
1.24
|
|
|
743,395
|
|
|
8,862
|
|
|
1.19
|
|
||||||
Non-interest bearing deposits
|
|
40,831
|
|
|
|
|
|
|
21,665
|
|
|
|
|
|
|
15,131
|
|
|
|
|
|
||||||||||||
Non-interest bearing liabilities
|
|
28,248
|
|
|
|
|
|
|
21,046
|
|
|
|
|
|
|
14,004
|
|
|
|
|
|
||||||||||||
Shareholders' equity
|
|
297,328
|
|
|
|
|
|
|
210,311
|
|
|
|
|
|
|
142,044
|
|
|
|
|
|
||||||||||||
Noncontrolling interest
|
|
|
|
|
|
|
|
19
|
|
|
|
|
|
|
18
|
|
|
|
|
|
|||||||||||||
Total liabilities and shareholders' equity
|
|
$
|
2,208,970
|
|
|
|
|
|
|
$
|
1,437,063
|
|
|
|
|
|
|
$
|
914,592
|
|
|
|
|
|
|||||||||
Net interest income and interest rate spread
|
|
|
|
$
|
78,034
|
|
|
3.82
|
%
|
|
|
|
$
|
42,649
|
|
|
3.16
|
%
|
|
|
|
$
|
25,589
|
|
|
3.20
|
%
|
||||||
Net interest margin
|
|
|
|
|
|
3.92
|
|
|
|
|
|
|
3.28
|
|
|
|
|
|
|
3.26
|
|
||||||||||||
Ratio of average interest-earning assets to average interest-bearing liabilities
|
|
|
|
|
|
107.92
|
%
|
|
|
|
|
|
109.95
|
%
|
|
|
|
|
|
105.56
|
%
|
|
|
2017 vs. 2016
|
|
2016 vs. 2015
|
||||||||||||||||||||
|
|
Increase (Decrease) Due to
|
|
Increase (Decrease) Due to
|
||||||||||||||||||||
|
|
Rate
|
|
Volume
|
|
Total
|
|
Rate
|
|
Volume
|
|
Total
|
||||||||||||
Interest income:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest earning balances in other banks
|
|
$
|
1,301
|
|
|
$
|
73
|
|
|
$
|
1,374
|
|
|
$
|
169
|
|
|
$
|
564
|
|
|
$
|
733
|
|
Investment securities
|
|
51
|
|
|
249
|
|
|
300
|
|
|
111
|
|
|
210
|
|
|
321
|
|
||||||
Loans held for sale
|
|
2,290
|
|
|
9,632
|
|
|
11,922
|
|
|
1,230
|
|
|
(1,175
|
)
|
|
55
|
|
||||||
Loans and leases held for investment
|
|
4,625
|
|
|
27,979
|
|
|
32,604
|
|
|
1,473
|
|
|
20,239
|
|
|
21,712
|
|
||||||
Total interest income
|
|
8,267
|
|
|
37,933
|
|
|
46,200
|
|
|
2,983
|
|
|
19,838
|
|
|
22,821
|
|
||||||
Interest expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest bearing checking
|
|
25
|
|
|
115
|
|
|
140
|
|
|
(3
|
)
|
|
80
|
|
|
77
|
|
||||||
Savings
|
|
—
|
|
|
2,685
|
|
|
2,685
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Money market accounts
|
|
945
|
|
|
(82
|
)
|
|
863
|
|
|
71
|
|
|
564
|
|
|
635
|
|
||||||
Certificates of deposit
|
|
282
|
|
|
6,594
|
|
|
6,876
|
|
|
327
|
|
|
5,241
|
|
|
5,568
|
|
||||||
Small business lending fund
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(94
|
)
|
|
(94
|
)
|
||||||
Other borrowings
|
|
20
|
|
|
231
|
|
|
251
|
|
|
(35
|
)
|
|
(390
|
)
|
|
(425
|
)
|
||||||
Total interest expense
|
|
1,272
|
|
|
9,543
|
|
|
10,815
|
|
|
360
|
|
|
5,401
|
|
|
5,761
|
|
||||||
Net interest income
|
|
$
|
6,995
|
|
|
$
|
28,390
|
|
|
$
|
35,385
|
|
|
$
|
2,623
|
|
|
$
|
14,437
|
|
|
$
|
17,060
|
|
|
|
Years Ended December 31,
|
|
2016/2017 Increase (Decrease)
|
|
2015/2016 Increase (Decrease)
|
||||||||||||||||||||
|
|
2017
|
|
2016
|
|
2015
|
|
Amount
|
|
Percent
|
|
Amount
|
|
Percent
|
||||||||||||
Noninterest income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Loan servicing revenue
|
|
$
|
24,588
|
|
|
$
|
21,393
|
|
|
$
|
16,081
|
|
|
$
|
3,195
|
|
|
14.93
|
%
|
|
$
|
5,312
|
|
|
33.03
|
%
|
Loan servicing revaluation
|
|
(13,171
|
)
|
|
(8,391
|
)
|
|
(6,229
|
)
|
|
(4,780
|
)
|
|
(56.97
|
)
|
|
(2,162
|
)
|
|
(34.71
|
)
|
|||||
Net gains on sales of loans
|
|
78,590
|
|
|
75,326
|
|
|
67,385
|
|
|
3,264
|
|
|
4.33
|
|
|
7,941
|
|
|
11.78
|
|
|||||
Equity in loss of non-consolidated affiliates
|
|
—
|
|
|
—
|
|
|
(26
|
)
|
|
—
|
|
|
—
|
|
|
26
|
|
|
100.00
|
|
|||||
Gain of sale of investment in non-consolidated affiliate
|
|
—
|
|
|
—
|
|
|
3,782
|
|
|
—
|
|
|
—
|
|
|
(3,782
|
)
|
|
(100.00
|
)
|
|||||
Gain on contribution to equity method investment
|
|
68,000
|
|
|
—
|
|
|
—
|
|
|
68,000
|
|
|
100.00
|
|
|
—
|
|
|
—
|
|
|||||
Gain (loss) on sale of securities available-for-sale
|
|
—
|
|
|
1
|
|
|
13
|
|
|
(1
|
)
|
|
(100.00
|
)
|
|
(12
|
)
|
|
(92.31
|
)
|
|||||
Construction supervision fee income
|
|
1,776
|
|
|
2,667
|
|
|
1,623
|
|
|
(891
|
)
|
|
(33.41
|
)
|
|
1,044
|
|
|
64.33
|
|
|||||
Title insurance income
|
|
7,565
|
|
|
—
|
|
|
—
|
|
|
7,565
|
|
|
100.00
|
|
|
—
|
|
|
—
|
|
|||||
Other noninterest income
|
|
5,573
|
|
|
2,543
|
|
|
1,699
|
|
|
3,030
|
|
|
119.15
|
|
|
844
|
|
|
49.68
|
|
|||||
Total noninterest income
|
|
$
|
172,921
|
|
|
$
|
93,539
|
|
|
$
|
84,328
|
|
|
$
|
79,382
|
|
|
84.87
|
%
|
|
$
|
9,211
|
|
|
10.92
|
%
|
|
Three months ended December 31,
|
|
Three months ended September 30,
|
|
Three months ended June 30,
|
|
Three months ended March 31,
|
||||||||||||||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||||||||||
Amount of loans and leases originated
|
$
|
483,422
|
|
|
$
|
514,565
|
|
|
$
|
395,682
|
|
|
$
|
381,050
|
|
|
$
|
586,471
|
|
|
$
|
356,865
|
|
|
$
|
468,663
|
|
|
$
|
284,530
|
|
Guaranteed portions of loans sold
|
211,654
|
|
|
260,125
|
|
|
163,843
|
|
|
210,610
|
|
|
203,714
|
|
|
135,555
|
|
|
208,715
|
|
|
155,643
|
|
||||||||
Outstanding balance of guaranteed loans sold
(1)
|
2,680,641
|
|
|
2,278,618
|
|
|
2,584,163
|
|
|
2,102,468
|
|
|
2,521,506
|
|
|
1,970,908
|
|
|
2,410,791
|
|
|
1,894,428
|
|
|
|
Years ended December 31,
|
||||||||||||||||||
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Amount of loans and leases originated
|
|
$
|
1,934,238
|
|
|
$
|
1,537,010
|
|
|
$
|
1,158,640
|
|
|
$
|
848,090
|
|
|
$
|
498,752
|
|
Guaranteed portions of loans sold
|
|
787,926
|
|
|
761,933
|
|
|
640,886
|
|
|
433,912
|
|
|
339,342
|
|
|||||
Outstanding balance of guaranteed loans sold
(1)
|
|
2,680,641
|
|
|
2,278,618
|
|
|
1,779,989
|
|
|
1,302,828
|
|
|
1,005,764
|
|
(1)
|
This represents the outstanding principal balance of guaranteed loans serviced, as of the last day of the applicable period, which have been sold into the secondary market.
|
Change in Yield Curve Assumption
|
|
Increase (Decrease) in Value
|
+300 basis point
|
|
$(5,235)
|
+200 basis point
|
|
(3,613)
|
+100 basis point
|
|
(1,872)
|
- 100 basis point
|
|
2,020
|
Change in Yield Curve Assumption
|
|
Increase (Decrease) in Value
|
+300 basis point
|
|
$(5,027)
|
+200 basis point
|
|
(3,461)
|
+100 basis point
|
|
(1,789)
|
- 100 basis point
|
|
1,918
|
|
Years Ended December 31,
|
|
2016/2017 Increase (Decrease)
|
|
2015/2016 Increase (Decrease)
|
||||||||||||||||||||
|
2017
|
|
2016
|
|
2015
|
|
Amount
|
|
Percent
|
|
Amount
|
|
Percent
|
||||||||||||
Noninterest expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Salaries and employee benefits
|
$
|
74,669
|
|
|
$
|
62,996
|
|
|
$
|
40,323
|
|
|
$
|
11,673
|
|
|
18.53
|
%
|
|
$
|
22,673
|
|
|
56.23
|
%
|
Non-staff expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Travel expense
|
8,124
|
|
|
8,205
|
|
|
7,379
|
|
|
(81
|
)
|
|
(0.99
|
)
|
|
826
|
|
|
11.19
|
|
|||||
Professional services expense
|
4,937
|
|
|
3,482
|
|
|
2,643
|
|
|
1,455
|
|
|
41.79
|
|
|
839
|
|
|
31.74
|
|
|||||
Advertising and marketing expense
|
6,363
|
|
|
4,534
|
|
|
4,333
|
|
|
1,829
|
|
|
40.34
|
|
|
201
|
|
|
4.64
|
|
|||||
Occupancy expense
|
6,195
|
|
|
4,573
|
|
|
3,475
|
|
|
1,622
|
|
|
35.47
|
|
|
1,098
|
|
|
31.60
|
|
|||||
Data processing expense
|
8,449
|
|
|
5,299
|
|
|
3,583
|
|
|
3,150
|
|
|
59.45
|
|
|
1,716
|
|
|
47.89
|
|
|||||
Equipment expense
|
7,479
|
|
|
2,246
|
|
|
2,119
|
|
|
5,233
|
|
|
232.99
|
|
|
127
|
|
|
5.99
|
|
|||||
Other loan origination and maintenance expense
|
4,970
|
|
|
2,825
|
|
|
2,069
|
|
|
2,145
|
|
|
75.93
|
|
|
756
|
|
|
36.54
|
|
|||||
Renewable energy tax credit investment impairment
|
690
|
|
|
3,197
|
|
|
—
|
|
|
(2,507
|
)
|
|
(78.42
|
)
|
|
3,197
|
|
|
100.00
|
|
|||||
FDIC insurance
|
3,206
|
|
|
1,417
|
|
|
514
|
|
|
1,789
|
|
|
126.25
|
|
|
903
|
|
|
175.68
|
|
|||||
Title insurance closing services expense
|
2,418
|
|
|
—
|
|
|
—
|
|
|
2,418
|
|
|
100.00
|
|
|
—
|
|
|
—
|
|
|||||
Impairment expense on goodwill and other intangibles
|
3,648
|
|
|
—
|
|
|
—
|
|
|
3,648
|
|
|
100.00
|
|
|
—
|
|
|
—
|
|
|||||
Other expense
|
12,017
|
|
|
7,671
|
|
|
5,277
|
|
|
4,346
|
|
|
56.65
|
|
|
2,394
|
|
|
45.37
|
|
|||||
Total non-staff expenses
|
68,496
|
|
|
43,449
|
|
|
31,392
|
|
|
25,047
|
|
|
57.65
|
|
|
12,057
|
|
|
38.41
|
|
|||||
Total noninterest expense
|
$
|
143,165
|
|
|
$
|
106,445
|
|
|
$
|
71,715
|
|
|
$
|
36,720
|
|
|
34.50
|
%
|
|
$
|
34,730
|
|
|
48.43
|
%
|
•
|
Growth in cash and investments, largely a product of the secondary offering in August of 2017 of $113.1 million combined with successful deposit gathering campaigns generating $247.4 million in new deposits;
|
•
|
Growth in loan and lease originations combined with longer retention times of loans held for sale, comprised largely of loans in newer verticals which require a period of loan advances to become fully funded prior to being sold;
|
•
|
Growth in premises and equipment related primarily to construction of a new aircraft hangar, the addition of two new aircraft in replacement of two older ones and the addition of solar panels to meet leasing commitments;
|
•
|
Increased other assets largely related to:
|
◦
|
$68.0 million one-time gain recognized as a result of the fourth quarter equity method investment in Apiture, see Note 3. Unconsolidated Joint Venture for further discussion;
|
◦
|
income taxes receivable arising from investment tax credits generated by investment in solar panels classified in premises and equipment in which the Company is the lessor; and
|
◦
|
intangibles of $4.3 million generated by the first quarter acquisition of Reltco.
|
•
|
Growth in loan and lease originations combined with longer retention times of loans held for sale, comprised largely of loans in newer verticals which require a period of loan advances to become fully funded prior to being sold; and
|
•
|
Increased levels of deposits arising from successful deposit gathering efforts.
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|||||||||||||||||||||||||
|
Total Loans and Leases
|
|
% of Loans in Category of Total Loans and Leases
|
|
Total Loans and Leases
|
|
% of Loans in Category of Total Loans and Leases
|
|
Total Loans and Leases
|
|
% of Loans in Category of Total Loans and Leases
|
|
Total Loans and Leases
|
|
% of Loans in Category of Total Loans and Leases
|
|
Total Loans and Leases
|
|
% of Loans in Category of Total Loans and Leases
|
|||||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Agriculture
|
$
|
3,274
|
|
|
0.24
|
%
|
|
$
|
1,714
|
|
|
0.19
|
%
|
|
$
|
30
|
|
|
0.01
|
%
|
|
$
|
—
|
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
%
|
Death Care Management
|
13,495
|
|
|
1.00
|
|
|
9,684
|
|
|
1.06
|
|
|
4,832
|
|
|
1.73
|
|
|
3,603
|
|
|
1.77
|
|
|
1,782
|
|
|
1.25
|
|
|||||
Healthcare
|
43,301
|
|
|
3.21
|
|
|
37,270
|
|
|
4.10
|
|
|
15,240
|
|
|
5.44
|
|
|
12,319
|
|
|
6.06
|
|
|
8,739
|
|
|
6.15
|
|
|||||
Independent Pharmacies
|
99,920
|
|
|
7.42
|
|
|
83,677
|
|
|
9.21
|
|
|
41,588
|
|
|
14.86
|
|
|
34,079
|
|
|
16.75
|
|
|
24,026
|
|
|
16.91
|
|
|||||
Registered Investment Advisors
|
93,770
|
|
|
6.96
|
|
|
68,335
|
|
|
7.52
|
|
|
18,358
|
|
|
6.56
|
|
|
9,660
|
|
|
4.75
|
|
|
2,817
|
|
|
1.98
|
|
|||||
Veterinary Industry
|
46,387
|
|
|
3.45
|
|
|
38,930
|
|
|
4.29
|
|
|
21,579
|
|
|
7.71
|
|
|
20,902
|
|
|
10.27
|
|
|
19,978
|
|
|
14.06
|
|
|||||
Other Industries
|
184,903
|
|
|
13.73
|
|
|
94,836
|
|
|
10.44
|
|
|
3,230
|
|
|
1.15
|
|
|
494
|
|
|
0.24
|
|
|
17
|
|
|
0.01
|
|
|||||
Total
|
485,050
|
|
|
36.01
|
|
|
334,446
|
|
|
36.81
|
|
|
104,857
|
|
|
37.46
|
|
|
81,057
|
|
|
39.84
|
|
|
57,359
|
|
|
40.36
|
|
|||||
Construction & Development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Agriculture
|
34,188
|
|
|
2.54
|
|
|
32,372
|
|
|
3.56
|
|
|
11,351
|
|
|
4.05
|
|
|
3,910
|
|
|
1.92
|
|
|
—
|
|
|
—
|
|
|||||
Death Care Management
|
6,119
|
|
|
0.45
|
|
|
3,956
|
|
|
0.44
|
|
|
769
|
|
|
0.27
|
|
|
92
|
|
|
0.05
|
|
|
989
|
|
|
0.70
|
|
|||||
Healthcare
|
49,770
|
|
|
3.70
|
|
|
30,467
|
|
|
3.35
|
|
|
7,231
|
|
|
2.58
|
|
|
2,957
|
|
|
1.45
|
|
|
4,997
|
|
|
3.52
|
|
|||||
Independent Pharmacies
|
1,496
|
|
|
0.11
|
|
|
2,013
|
|
|
0.22
|
|
|
101
|
|
|
0.04
|
|
|
215
|
|
|
0.11
|
|
|
101
|
|
|
0.07
|
|
|||||
Registered Investment Advisors
|
376
|
|
|
0.03
|
|
|
294
|
|
|
0.03
|
|
|
378
|
|
|
0.13
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Veterinary Industry
|
13,184
|
|
|
0.98
|
|
|
11,514
|
|
|
1.27
|
|
|
3,834
|
|
|
1.37
|
|
|
2,207
|
|
|
1.08
|
|
|
4,199
|
|
|
2.95
|
|
|||||
Other Industries
|
58,120
|
|
|
4.32
|
|
|
31,715
|
|
|
3.49
|
|
|
658
|
|
|
0.24
|
|
|
145
|
|
|
0.07
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
163,253
|
|
|
12.13
|
|
|
112,331
|
|
|
12.36
|
|
|
24,322
|
|
|
8.68
|
|
|
9,526
|
|
|
4.68
|
|
|
10,286
|
|
|
7.24
|
|
|||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Agriculture
|
46,717
|
|
|
3.47
|
|
|
5,591
|
|
|
0.62
|
|
|
1,863
|
|
|
0.67
|
|
|
259
|
|
|
0.13
|
|
|
—
|
|
|
—
|
|
|||||
Death Care Management
|
67,381
|
|
|
5.00
|
|
|
52,510
|
|
|
5.78
|
|
|
20,327
|
|
|
7.26
|
|
|
18,879
|
|
|
9.28
|
|
|
11,668
|
|
|
8.21
|
|
|||||
Healthcare
|
126,631
|
|
|
9.40
|
|
|
114,281
|
|
|
12.58
|
|
|
37,684
|
|
|
13.46
|
|
|
26,173
|
|
|
12.86
|
|
|
11,129
|
|
|
7.83
|
|
|||||
Independent Pharmacies
|
19,028
|
|
|
1.41
|
|
|
15,151
|
|
|
1.67
|
|
|
7,298
|
|
|
2.61
|
|
|
4,750
|
|
|
2.33
|
|
|
3,490
|
|
|
2.46
|
|
|||||
Registered Investment Advisors
|
11,789
|
|
|
0.88
|
|
|
11,462
|
|
|
1.26
|
|
|
2,808
|
|
|
1.00
|
|
|
2,161
|
|
|
1.06
|
|
|
171
|
|
|
0.12
|
|
|||||
Veterinary Industry
|
113,932
|
|
|
8.46
|
|
|
102,906
|
|
|
11.33
|
|
|
59,999
|
|
|
21.43
|
|
|
57,934
|
|
|
28.48
|
|
|
47,896
|
|
|
33.70
|
|
|||||
Other Industries
|
134,172
|
|
|
9.96
|
|
|
46,245
|
|
|
5.09
|
|
|
4,752
|
|
|
1.70
|
|
|
1,464
|
|
|
0.72
|
|
|
107
|
|
|
0.08
|
|
|||||
Total
|
519,650
|
|
|
38.58
|
|
|
348,146
|
|
|
38.33
|
|
|
134,731
|
|
|
48.13
|
|
|
111,620
|
|
|
54.86
|
|
|
74,461
|
|
|
52.40
|
|
|||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Agriculture
|
178,897
|
|
|
13.28
|
|
|
113,569
|
|
|
12.50
|
|
|
16,036
|
|
|
5.73
|
|
|
1,248
|
|
|
0.62
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
178,897
|
|
|
13.28
|
|
|
113,569
|
|
|
12.50
|
|
|
16,036
|
|
|
5.73
|
|
|
1,248
|
|
|
0.62
|
|
|
—
|
|
|
—
|
|
|||||
Total Loans and Leases
|
$
|
1,346,850
|
|
|
100.00
|
%
|
|
$
|
908,492
|
|
|
100.00
|
%
|
|
$
|
279,946
|
|
|
100.00
|
%
|
|
$
|
203,451
|
|
|
100.00
|
%
|
|
$
|
142,106
|
|
|
100.00
|
%
|
|
At December 31, 2017
|
|
At December 31, 2016
|
|
At December 31, 2015
|
|
At December 31, 2014
|
|
At December 31, 2013
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
Concentration Risk
|
|
Concentration Risk
|
|
Concentration Risk
|
|
Concentration Risk
|
|
Concentration Risk
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
Unguaranteed
|
|
Guaranteed
|
|
Total
|
|
Unguaranteed
|
|
Guaranteed
|
|
Total
|
|
Unguaranteed
|
|
Guaranteed
|
|
Total
|
|
Unguaranteed
|
|
Guaranteed
|
|
Total
|
|
Unguaranteed
|
|
Guaranteed
|
|
Total
|
||||||||||||||||||||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Agriculture
|
$
|
—
|
|
|
$
|
2,276
|
|
|
$
|
2,276
|
|
|
$
|
—
|
|
|
$
|
1,248
|
|
|
$
|
1,248
|
|
|
$
|
171
|
|
|
$
|
51
|
|
|
$
|
222
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Death Care Management
|
—
|
|
|
4,619
|
|
|
4,619
|
|
|
—
|
|
|
841
|
|
|
841
|
|
|
3,483
|
|
|
556
|
|
|
4,039
|
|
|
2,312
|
|
|
2,855
|
|
|
5,167
|
|
|
1,166
|
|
|
2,740
|
|
|
3,906
|
|
|||||||||||||||
Healthcare
|
—
|
|
|
22,540
|
|
|
22,540
|
|
|
—
|
|
|
5,061
|
|
|
5,061
|
|
|
13,728
|
|
|
2,046
|
|
|
15,774
|
|
|
5,250
|
|
|
4,979
|
|
|
10,229
|
|
|
3,404
|
|
|
2,866
|
|
|
6,270
|
|
|||||||||||||||
Independent Pharmacies
|
—
|
|
|
2,357
|
|
|
2,357
|
|
|
—
|
|
|
2,930
|
|
|
2,930
|
|
|
29,903
|
|
|
2,833
|
|
|
32,736
|
|
|
24,513
|
|
|
6,696
|
|
|
31,209
|
|
|
13,272
|
|
|
8,058
|
|
|
21,330
|
|
|||||||||||||||
Registered Investment Advisors
|
—
|
|
|
12,201
|
|
|
12,201
|
|
|
—
|
|
|
10,360
|
|
|
10,360
|
|
|
17,537
|
|
|
5,087
|
|
|
22,624
|
|
|
9,471
|
|
|
5,667
|
|
|
15,138
|
|
|
3,355
|
|
|
2,719
|
|
|
6,074
|
|
|||||||||||||||
Veterinary Industry
|
—
|
|
|
17,820
|
|
|
17,820
|
|
|
—
|
|
|
5,639
|
|
|
5,639
|
|
|
12,894
|
|
|
2,838
|
|
|
15,732
|
|
|
9,301
|
|
|
5,744
|
|
|
15,045
|
|
|
9,800
|
|
|
3,202
|
|
|
13,002
|
|
|||||||||||||||
Other Industries
|
—
|
|
|
67,719
|
|
|
67,719
|
|
|
—
|
|
|
32,121
|
|
|
32,121
|
|
|
8,774
|
|
|
6,624
|
|
|
15,398
|
|
|
1,500
|
|
|
963
|
|
|
2,463
|
|
|
1,026
|
|
|
131
|
|
|
1,157
|
|
|||||||||||||||
Total
|
—
|
|
|
129,532
|
|
|
129,532
|
|
|
—
|
|
|
58,200
|
|
|
58,200
|
|
|
86,490
|
|
|
20,035
|
|
|
106,525
|
|
|
52,347
|
|
|
26,904
|
|
|
79,251
|
|
|
32,023
|
|
|
19,716
|
|
|
51,739
|
|
|||||||||||||||
Construction & Development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Agriculture
|
—
|
|
|
81,902
|
|
|
81,902
|
|
|
—
|
|
|
96,028
|
|
|
96,028
|
|
|
17,005
|
|
|
83,949
|
|
|
100,954
|
|
|
2,246
|
|
|
11,230
|
|
|
13,476
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Death Care Management
|
—
|
|
|
12,278
|
|
|
12,278
|
|
|
—
|
|
|
10,299
|
|
|
10,299
|
|
|
1,698
|
|
|
5,778
|
|
|
7,476
|
|
|
36
|
|
|
179
|
|
|
215
|
|
|
1,374
|
|
|
5,235
|
|
|
6,609
|
|
|||||||||||||||
Healthcare
|
—
|
|
|
130,154
|
|
|
130,154
|
|
|
—
|
|
|
73,596
|
|
|
73,596
|
|
|
11,469
|
|
|
54,374
|
|
|
65,843
|
|
|
1,764
|
|
|
8,695
|
|
|
10,459
|
|
|
6,493
|
|
|
26,427
|
|
|
32,920
|
|
|||||||||||||||
Independent Pharmacies
|
—
|
|
|
4,489
|
|
|
4,489
|
|
|
—
|
|
|
6,041
|
|
|
6,041
|
|
|
152
|
|
|
760
|
|
|
912
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
151
|
|
|
158
|
|
|
309
|
|
|||||||||||||||
Registered Investment Advisors
|
—
|
|
|
1,128
|
|
|
1,128
|
|
|
—
|
|
|
881
|
|
|
881
|
|
|
567
|
|
|
2,835
|
|
|
3,402
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Veterinary Industry
|
—
|
|
|
31,038
|
|
|
31,038
|
|
|
—
|
|
|
21,377
|
|
|
21,377
|
|
|
3,900
|
|
|
19,360
|
|
|
23,260
|
|
|
1,677
|
|
|
8,385
|
|
|
10,062
|
|
|
4,177
|
|
|
13,110
|
|
|
17,287
|
|
|||||||||||||||
Other Industries
|
—
|
|
|
120,990
|
|
|
120,990
|
|
|
—
|
|
|
38,698
|
|
|
38,698
|
|
|
1,590
|
|
|
4,934
|
|
|
6,524
|
|
|
16
|
|
|
79
|
|
|
95
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Total
|
—
|
|
|
381,979
|
|
|
381,979
|
|
|
—
|
|
|
246,920
|
|
|
246,920
|
|
|
36,381
|
|
|
171,990
|
|
|
208,371
|
|
|
5,739
|
|
|
28,568
|
|
|
34,307
|
|
|
12,195
|
|
|
44,930
|
|
|
57,125
|
|
|||||||||||||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Agriculture
|
—
|
|
|
47,001
|
|
|
47,001
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,794
|
|
|
6,455
|
|
|
9,249
|
|
|
1,809
|
|
|
9,043
|
|
|
10,852
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Death Care Management
|
—
|
|
|
10,487
|
|
|
10,487
|
|
|
—
|
|
|
3,336
|
|
|
3,336
|
|
|
17,808
|
|
|
1,971
|
|
|
19,779
|
|
|
15,572
|
|
|
4,744
|
|
|
20,316
|
|
|
12,015
|
|
|
3,528
|
|
|
15,543
|
|
|||||||||||||||
Healthcare
|
—
|
|
|
25,255
|
|
|
25,255
|
|
|
—
|
|
|
12,224
|
|
|
12,224
|
|
|
34,749
|
|
|
10,974
|
|
|
45,723
|
|
|
24,668
|
|
|
33,787
|
|
|
58,455
|
|
|
6,173
|
|
|
1,822
|
|
|
7,995
|
|
|||||||||||||||
Independent Pharmacies
|
—
|
|
|
975
|
|
|
975
|
|
|
—
|
|
|
1,996
|
|
|
1,996
|
|
|
5,661
|
|
|
2,325
|
|
|
7,986
|
|
|
5,082
|
|
|
3,155
|
|
|
8,237
|
|
|
3,528
|
|
|
—
|
|
|
3,528
|
|
|||||||||||||||
Registered Investment Advisors
|
—
|
|
|
222
|
|
|
222
|
|
|
—
|
|
|
1,186
|
|
|
1,186
|
|
|
2,205
|
|
|
—
|
|
|
2,205
|
|
|
2,731
|
|
|
2,464
|
|
|
5,195
|
|
|
220
|
|
|
109
|
|
|
329
|
|
|||||||||||||||
Veterinary Industry
|
—
|
|
|
15,145
|
|
|
15,145
|
|
|
—
|
|
|
8,039
|
|
|
8,039
|
|
|
32,025
|
|
|
1,690
|
|
|
33,715
|
|
|
26,237
|
|
|
22,932
|
|
|
49,169
|
|
|
18,088
|
|
|
3,932
|
|
|
22,020
|
|
|||||||||||||||
Other Industries
|
—
|
|
|
34,021
|
|
|
34,021
|
|
|
—
|
|
|
8,333
|
|
|
8,333
|
|
|
9,880
|
|
|
1,104
|
|
|
10,984
|
|
|
2,865
|
|
|
1,818
|
|
|
4,683
|
|
|
684
|
|
|
—
|
|
|
684
|
|
|||||||||||||||
Total
|
—
|
|
|
133,106
|
|
|
133,106
|
|
|
—
|
|
|
35,114
|
|
|
35,114
|
|
|
105,122
|
|
|
24,519
|
|
|
129,641
|
|
|
78,964
|
|
|
77,943
|
|
|
156,907
|
|
|
40,708
|
|
|
9,391
|
|
|
50,099
|
|
|||||||||||||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Agriculture
|
—
|
|
|
29,258
|
|
|
29,258
|
|
|
—
|
|
|
49,519
|
|
|
49,519
|
|
|
24,382
|
|
|
8,529
|
|
|
32,911
|
|
|
5,472
|
|
|
16,121
|
|
|
21,593
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Total
|
—
|
|
|
29,258
|
|
|
29,258
|
|
|
—
|
|
|
49,519
|
|
|
49,519
|
|
|
24,382
|
|
|
8,529
|
|
|
32,911
|
|
|
5,472
|
|
|
16,121
|
|
|
21,593
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Total
|
$
|
—
|
|
|
$
|
673,875
|
|
|
$
|
673,875
|
|
|
$
|
—
|
|
|
$
|
389,753
|
|
|
$
|
389,753
|
|
|
$
|
252,375
|
|
|
$
|
225,073
|
|
|
$
|
477,448
|
|
|
$
|
142,522
|
|
|
$
|
149,536
|
|
|
$
|
292,058
|
|
|
$
|
84,926
|
|
|
$
|
74,037
|
|
|
$
|
158,963
|
|
|
At December 31, 2017
|
|
At December 31, 2016
|
|
At December 31, 2015
|
|
At December 31, 2014
|
|
At December 31, 2013
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
Concentration Risk
|
|
Concentration Risk
|
|
Concentration Risk
|
|
Concentration Risk
|
|
Concentration Risk
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
Unguaranteed
|
|
Guaranteed
|
|
Total
|
|
Unguaranteed
|
|
Guaranteed
|
|
Total
|
|
Unguaranteed
|
|
Guaranteed
|
|
Total
|
|
Unguaranteed
|
|
Guaranteed
|
|
Total
|
|
Unguaranteed
|
|
Guaranteed
|
|
Total
|
||||||||||||||||||||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Agriculture
|
$
|
2,942
|
|
|
$
|
332
|
|
|
$
|
3,274
|
|
|
$
|
1,556
|
|
|
$
|
158
|
|
|
$
|
1,714
|
|
|
$
|
30
|
|
|
$
|
—
|
|
|
$
|
30
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Death Care Management
|
13,295
|
|
|
200
|
|
|
13,495
|
|
|
9,403
|
|
|
281
|
|
|
9,684
|
|
|
4,832
|
|
|
—
|
|
|
4,832
|
|
|
3,603
|
|
|
—
|
|
|
3,603
|
|
|
1,782
|
|
|
—
|
|
|
1,782
|
|
|||||||||||||||
Healthcare
|
39,123
|
|
|
4,178
|
|
|
43,301
|
|
|
31,791
|
|
|
5,479
|
|
|
37,270
|
|
|
11,900
|
|
|
3,340
|
|
|
15,240
|
|
|
8,779
|
|
|
3,540
|
|
|
12,319
|
|
|
7,164
|
|
|
1,575
|
|
|
8,739
|
|
|||||||||||||||
Independent Pharmacies
|
91,982
|
|
|
7,938
|
|
|
99,920
|
|
|
78,953
|
|
|
4,724
|
|
|
83,677
|
|
|
40,025
|
|
|
1,563
|
|
|
41,588
|
|
|
31,686
|
|
|
2,393
|
|
|
34,079
|
|
|
24,026
|
|
|
—
|
|
|
24,026
|
|
|||||||||||||||
Registered Investment Advisors
|
93,321
|
|
|
449
|
|
|
93,770
|
|
|
67,914
|
|
|
421
|
|
|
68,335
|
|
|
18,358
|
|
|
—
|
|
|
18,358
|
|
|
9,660
|
|
|
—
|
|
|
9,660
|
|
|
2,817
|
|
|
—
|
|
|
2,817
|
|
|||||||||||||||
Veterinary Industry
|
43,371
|
|
|
3,016
|
|
|
46,387
|
|
|
35,981
|
|
|
2,949
|
|
|
38,930
|
|
|
19,247
|
|
|
2,332
|
|
|
21,579
|
|
|
17,406
|
|
|
3,496
|
|
|
20,902
|
|
|
16,444
|
|
|
3,534
|
|
|
19,978
|
|
|||||||||||||||
Other Industries
|
184,393
|
|
|
510
|
|
|
184,903
|
|
|
94,436
|
|
|
400
|
|
|
94,836
|
|
|
3,124
|
|
|
106
|
|
|
3,230
|
|
|
373
|
|
|
121
|
|
|
494
|
|
|
17
|
|
|
—
|
|
|
17
|
|
|||||||||||||||
Total
|
468,427
|
|
|
16,623
|
|
|
485,050
|
|
|
320,034
|
|
|
14,412
|
|
|
334,446
|
|
|
97,516
|
|
|
7,341
|
|
|
104,857
|
|
|
71,507
|
|
|
9,550
|
|
|
81,057
|
|
|
52,250
|
|
|
5,109
|
|
|
57,359
|
|
|||||||||||||||
Construction & Development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Agriculture
|
30,224
|
|
|
3,964
|
|
|
34,188
|
|
|
32,139
|
|
|
233
|
|
|
32,372
|
|
|
11,233
|
|
|
118
|
|
|
11,351
|
|
|
3,910
|
|
|
—
|
|
|
3,910
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Death Care Management
|
6,119
|
|
|
—
|
|
|
6,119
|
|
|
3,956
|
|
|
—
|
|
|
3,956
|
|
|
769
|
|
|
—
|
|
|
769
|
|
|
92
|
|
|
—
|
|
|
92
|
|
|
989
|
|
|
—
|
|
|
989
|
|
|||||||||||||||
Healthcare
|
48,302
|
|
|
1,468
|
|
|
49,770
|
|
|
30,467
|
|
|
—
|
|
|
30,467
|
|
|
7,231
|
|
|
—
|
|
|
7,231
|
|
|
2,957
|
|
|
—
|
|
|
2,957
|
|
|
4,997
|
|
|
—
|
|
|
4,997
|
|
|||||||||||||||
Independent Pharmacies
|
1,496
|
|
|
—
|
|
|
1,496
|
|
|
2,013
|
|
|
—
|
|
|
2,013
|
|
|
101
|
|
|
—
|
|
|
101
|
|
|
215
|
|
|
—
|
|
|
215
|
|
|
101
|
|
|
—
|
|
|
101
|
|
|||||||||||||||
Registered Investment Advisors
|
376
|
|
|
—
|
|
|
376
|
|
|
294
|
|
|
—
|
|
|
294
|
|
|
378
|
|
|
—
|
|
|
378
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Veterinary Industry
|
13,184
|
|
|
—
|
|
|
13,184
|
|
|
10,173
|
|
|
1,341
|
|
|
11,514
|
|
|
3,296
|
|
|
538
|
|
|
3,834
|
|
|
2,207
|
|
|
—
|
|
|
2,207
|
|
|
4,199
|
|
|
—
|
|
|
4,199
|
|
|||||||||||||||
Other Industries
|
58,120
|
|
|
—
|
|
|
58,120
|
|
|
31,715
|
|
|
—
|
|
|
31,715
|
|
|
658
|
|
|
—
|
|
|
658
|
|
|
145
|
|
|
—
|
|
|
145
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Total
|
157,821
|
|
|
5,432
|
|
|
163,253
|
|
|
110,757
|
|
|
1,574
|
|
|
112,331
|
|
|
23,666
|
|
|
656
|
|
|
24,322
|
|
|
9,526
|
|
|
—
|
|
|
9,526
|
|
|
10,286
|
|
|
—
|
|
|
10,286
|
|
|||||||||||||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Agriculture
|
30,871
|
|
|
15,846
|
|
|
46,717
|
|
|
5,591
|
|
|
—
|
|
|
5,591
|
|
|
1,863
|
|
|
—
|
|
|
1,863
|
|
|
259
|
|
|
—
|
|
|
259
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Death Care Management
|
65,836
|
|
|
1,545
|
|
|
67,381
|
|
|
50,918
|
|
|
1,592
|
|
|
52,510
|
|
|
19,037
|
|
|
1,290
|
|
|
20,327
|
|
|
17,354
|
|
|
1,525
|
|
|
18,879
|
|
|
11,668
|
|
|
—
|
|
|
11,668
|
|
|||||||||||||||
Healthcare
|
121,635
|
|
|
4,996
|
|
|
126,631
|
|
|
106,924
|
|
|
7,357
|
|
|
114,281
|
|
|
36,885
|
|
|
799
|
|
|
37,684
|
|
|
24,254
|
|
|
1,919
|
|
|
26,173
|
|
|
10,329
|
|
|
800
|
|
|
11,129
|
|
|||||||||||||||
Independent Pharmacies
|
17,466
|
|
|
1,562
|
|
|
19,028
|
|
|
15,151
|
|
|
—
|
|
|
15,151
|
|
|
7,298
|
|
|
—
|
|
|
7,298
|
|
|
4,750
|
|
|
—
|
|
|
4,750
|
|
|
3,490
|
|
|
—
|
|
|
3,490
|
|
|||||||||||||||
Registered Investment Advisors
|
11,789
|
|
|
—
|
|
|
11,789
|
|
|
11,462
|
|
|
—
|
|
|
11,462
|
|
|
2,808
|
|
|
—
|
|
|
2,808
|
|
|
2,161
|
|
|
—
|
|
|
2,161
|
|
|
171
|
|
|
—
|
|
|
171
|
|
|||||||||||||||
Veterinary Industry
|
103,303
|
|
|
10,629
|
|
|
113,932
|
|
|
94,081
|
|
|
8,825
|
|
|
102,906
|
|
|
52,911
|
|
|
7,088
|
|
|
59,999
|
|
|
49,903
|
|
|
8,031
|
|
|
57,934
|
|
|
41,387
|
|
|
6,509
|
|
|
47,896
|
|
|||||||||||||||
Other Industries
|
133,263
|
|
|
909
|
|
|
134,172
|
|
|
45,997
|
|
|
248
|
|
|
46,245
|
|
|
4,752
|
|
|
—
|
|
|
4,752
|
|
|
1,177
|
|
|
287
|
|
|
1,464
|
|
|
107
|
|
|
—
|
|
|
107
|
|
|||||||||||||||
Total
|
484,163
|
|
|
35,487
|
|
|
519,650
|
|
|
330,124
|
|
|
18,022
|
|
|
348,146
|
|
|
125,554
|
|
|
9,177
|
|
|
134,731
|
|
|
99,858
|
|
|
11,762
|
|
|
111,620
|
|
|
67,152
|
|
|
7,309
|
|
|
74,461
|
|
|||||||||||||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Agriculture
|
136,752
|
|
|
42,145
|
|
|
178,897
|
|
|
109,918
|
|
|
3,651
|
|
|
113,569
|
|
|
16,036
|
|
|
—
|
|
|
16,036
|
|
|
1,248
|
|
|
—
|
|
|
1,248
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Total
|
136,752
|
|
|
42,145
|
|
|
178,897
|
|
|
109,918
|
|
|
3,651
|
|
|
113,569
|
|
|
16,036
|
|
|
—
|
|
|
16,036
|
|
|
1,248
|
|
|
—
|
|
|
1,248
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||||||||
Total
|
$
|
1,247,163
|
|
|
$
|
99,687
|
|
|
$
|
1,346,850
|
|
|
$
|
870,833
|
|
|
$
|
37,659
|
|
|
$
|
908,492
|
|
|
$
|
262,772
|
|
|
$
|
17,174
|
|
|
$
|
279,946
|
|
|
$
|
182,139
|
|
|
$
|
21,312
|
|
|
$
|
203,451
|
|
|
$
|
129,688
|
|
|
$
|
12,418
|
|
|
$
|
142,106
|
|
|
At December 31, 2017
|
||||||||||||||
|
Remaining Contractual Maturity of Total Held for Investment Loans and Leases (Excluding net deferred costs and discount on SBA 7(a) and USDA unguaranteed loans)
|
||||||||||||||
|
One Year or Less
|
|
After One Year and Through Five Years
|
|
After Five Years
|
|
Total
|
||||||||
Fixed rate loans and leases:
|
|
|
|
|
|
|
|
||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
$
|
807
|
|
|
$
|
44
|
|
|
$
|
—
|
|
|
$
|
851
|
|
Death Care Management
|
—
|
|
|
230
|
|
|
3,290
|
|
|
3,520
|
|
||||
Healthcare
|
—
|
|
|
—
|
|
|
3,912
|
|
|
3,912
|
|
||||
Independent Pharmacies
|
—
|
|
|
353
|
|
|
3,454
|
|
|
3,807
|
|
||||
Registered Investment Advisors
|
—
|
|
|
1,163
|
|
|
6,204
|
|
|
7,367
|
|
||||
Veterinary Industry
|
—
|
|
|
165
|
|
|
5,048
|
|
|
5,213
|
|
||||
Other Industries
|
15,261
|
|
|
1,195
|
|
|
17,618
|
|
|
34,074
|
|
||||
Total
|
16,068
|
|
|
3,150
|
|
|
39,526
|
|
|
58,744
|
|
||||
Construction & Development
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
213
|
|
|
2
|
|
|
—
|
|
|
215
|
|
||||
Death Care Management
|
—
|
|
|
—
|
|
|
351
|
|
|
351
|
|
||||
Healthcare
|
—
|
|
|
—
|
|
|
166
|
|
|
166
|
|
||||
Independent Pharmacies
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Registered Investment Advisors
|
—
|
|
|
—
|
|
|
89
|
|
|
89
|
|
||||
Veterinary Industry
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Other Industries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Total
|
213
|
|
|
2
|
|
|
606
|
|
|
821
|
|
||||
Commercial Real Estate
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
—
|
|
|
17
|
|
|
—
|
|
|
17
|
|
||||
Death Care Management
|
—
|
|
|
—
|
|
|
11,497
|
|
|
11,497
|
|
||||
Healthcare
|
—
|
|
|
—
|
|
|
17,456
|
|
|
17,456
|
|
||||
Independent Pharmacies
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Registered Investment Advisors
|
—
|
|
|
—
|
|
|
1,030
|
|
|
1,030
|
|
||||
Veterinary Industry
|
—
|
|
|
—
|
|
|
9,049
|
|
|
9,049
|
|
||||
Other Industries
|
—
|
|
|
525
|
|
|
7,513
|
|
|
8,038
|
|
||||
Total
|
—
|
|
|
542
|
|
|
46,545
|
|
|
47,087
|
|
||||
Commercial Land
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
27
|
|
|
312
|
|
|
5,763
|
|
|
6,102
|
|
||||
Total
|
27
|
|
|
312
|
|
|
5,763
|
|
|
6,102
|
|
||||
Total fixed rate loans and leases
|
16,308
|
|
|
4,006
|
|
|
92,440
|
|
|
112,754
|
|
||||
Variable rate loans and leases:
|
|
|
|
|
|
|
|
||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
702
|
|
|
316
|
|
|
1,405
|
|
|
2,423
|
|
||||
Death Care Management
|
101
|
|
|
339
|
|
|
9,535
|
|
|
9,975
|
|
||||
Healthcare
|
397
|
|
|
626
|
|
|
38,366
|
|
|
39,389
|
|
||||
Independent Pharmacies
|
12
|
|
|
6,854
|
|
|
89,247
|
|
|
96,113
|
|
||||
Registered Investment Advisors
|
—
|
|
|
4,830
|
|
|
81,573
|
|
|
86,403
|
|
||||
Veterinary Industry
|
526
|
|
|
2,097
|
|
|
38,551
|
|
|
41,174
|
|
||||
Other Industries
|
4,990
|
|
|
18,356
|
|
|
127,483
|
|
|
150,829
|
|
||||
Total
|
6,728
|
|
|
33,418
|
|
|
386,160
|
|
|
426,306
|
|
||||
Construction & Development
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
—
|
|
|
—
|
|
|
33,973
|
|
|
33,973
|
|
||||
Death Care Management
|
—
|
|
|
2,010
|
|
|
3,758
|
|
|
5,768
|
|
||||
Healthcare
|
—
|
|
|
—
|
|
|
49,604
|
|
|
49,604
|
|
||||
Independent Pharmacies
|
—
|
|
|
—
|
|
|
1,496
|
|
|
1,496
|
|
||||
Registered Investment Advisors
|
—
|
|
|
—
|
|
|
287
|
|
|
287
|
|
||||
Veterinary Industry
|
—
|
|
|
—
|
|
|
13,184
|
|
|
13,184
|
|
||||
Other Industries
|
1,173
|
|
|
—
|
|
|
56,947
|
|
|
58,120
|
|
||||
Total
|
1,173
|
|
|
2,010
|
|
|
159,249
|
|
|
162,432
|
|
||||
Commercial Real Estate
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
—
|
|
|
—
|
|
|
46,700
|
|
|
46,700
|
|
||||
Death Care Management
|
1,200
|
|
|
1,499
|
|
|
53,185
|
|
|
55,884
|
|
||||
Healthcare
|
—
|
|
|
866
|
|
|
108,309
|
|
|
109,175
|
|
||||
Independent Pharmacies
|
266
|
|
|
37
|
|
|
18,725
|
|
|
19,028
|
|
||||
Registered Investment Advisors
|
—
|
|
|
—
|
|
|
10,759
|
|
|
10,759
|
|
|
At December 31, 2017
|
||||||||||||||
|
Remaining Contractual Maturity of Total Held for Investment Loans and Leases (Excluding net deferred costs and discount on SBA 7(a) and USDA unguaranteed loans)
|
||||||||||||||
|
One Year or Less
|
|
After One Year and Through Five Years
|
|
After Five Years
|
|
Total
|
||||||||
Veterinary Industry
|
1,301
|
|
|
869
|
|
|
102,713
|
|
|
104,883
|
|
||||
Other Industries
|
1,335
|
|
|
1,744
|
|
|
123,055
|
|
|
126,134
|
|
||||
Total
|
4,102
|
|
|
5,015
|
|
|
463,446
|
|
|
472,563
|
|
||||
Commercial Land
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
—
|
|
|
125
|
|
|
172,670
|
|
|
172,795
|
|
||||
Total
|
—
|
|
|
125
|
|
|
172,670
|
|
|
172,795
|
|
||||
Total variable rate loans and leases
|
12,003
|
|
|
40,568
|
|
|
1,181,525
|
|
|
1,234,096
|
|
||||
Total
|
$
|
28,311
|
|
|
$
|
44,574
|
|
|
$
|
1,273,965
|
|
|
$
|
1,346,850
|
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Nonaccrual loans:
|
|
|
|
|
|
|
|
|
|
||||||||||
Total nonperforming loans (all on nonaccrual)
|
$
|
23,480
|
|
|
$
|
23,781
|
|
|
$
|
12,367
|
|
|
$
|
18,692
|
|
|
$
|
8,697
|
|
Total accruing loans past due 90 days or more
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Foreclosed assets
|
1,281
|
|
|
1,648
|
|
|
2,666
|
|
|
1,084
|
|
|
773
|
|
|||||
Total troubled debt restructurings
|
10,223
|
|
|
9,856
|
|
|
11,021
|
|
|
10,611
|
|
|
9,736
|
|
|||||
Less nonaccrual troubled debt restructurings
|
(8,129
|
)
|
|
(7,688
|
)
|
|
(8,814
|
)
|
|
(9,805
|
)
|
|
(5,781
|
)
|
|||||
Total performing troubled debt restructurings
|
2,094
|
|
|
2,168
|
|
|
2,207
|
|
|
806
|
|
|
3,955
|
|
|||||
Total nonperforming assets and troubled debt restructurings
|
$
|
26,855
|
|
|
$
|
27,597
|
|
|
$
|
17,240
|
|
|
$
|
20,582
|
|
|
$
|
13,425
|
|
Total nonperforming loans to total loans and leases held for investment
|
1.75
|
%
|
|
2.62
|
%
|
|
4.42
|
%
|
|
9.17
|
%
|
|
6.15
|
%
|
|||||
Total nonperforming loans to total assets
|
0.85
|
%
|
|
1.36
|
%
|
|
1.17
|
%
|
|
2.78
|
%
|
|
2.02
|
%
|
|||||
Total nonperforming assets and troubled debt restructurings to total assets
|
0.97
|
%
|
|
1.57
|
%
|
|
1.64
|
%
|
|
3.06
|
%
|
|
3.12
|
%
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Nonaccrual loans guaranteed by U.S. government:
|
|
|
|
|
|
|
|
|
|
||||||||||
Total nonperforming loans guaranteed by the SBA (all on nonaccrual)
|
$
|
19,870
|
|
|
$
|
18,997
|
|
|
$
|
10,330
|
|
|
$
|
15,555
|
|
|
$
|
6,983
|
|
Total accruing loans past due 90 days or more guaranteed by the SBA
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Foreclosed assets guaranteed by the SBA
|
1,191
|
|
|
1,402
|
|
|
2,293
|
|
|
713
|
|
|
432
|
|
|||||
Total troubled debt restructurings guaranteed by the SBA
|
7,178
|
|
|
6,723
|
|
|
7,710
|
|
|
8,433
|
|
|
6,139
|
|
|||||
Less nonaccrual troubled debt restructurings guaranteed by the SBA
|
(7,099
|
)
|
|
(6,602
|
)
|
|
(7,550
|
)
|
|
(8,433
|
)
|
|
(4,814
|
)
|
|||||
Total performing troubled debt restructurings guaranteed by SBA
|
79
|
|
|
121
|
|
|
160
|
|
|
—
|
|
|
1,325
|
|
|||||
Total nonperforming assets and troubled debt restructurings guaranteed by the SBA
|
$
|
21,140
|
|
|
$
|
20,520
|
|
|
$
|
12,783
|
|
|
$
|
16,268
|
|
|
$
|
8,740
|
|
Total nonperforming loans not guaranteed by the SBA to total held for investment loans and leases
|
0.27
|
%
|
|
0.53
|
%
|
|
0.73
|
%
|
|
1.54
|
%
|
|
1.21
|
%
|
|||||
Total nonperforming loans not guaranteed by the SBA to total assets
|
0.13
|
%
|
|
0.27
|
%
|
|
0.19
|
%
|
|
0.47
|
%
|
|
0.40
|
%
|
|||||
Total nonperforming assets and troubled debt restructurings not guaranteed by the SBA to total assets
|
0.21
|
%
|
|
0.40
|
%
|
|
0.42
|
%
|
|
0.64
|
%
|
|
1.09
|
%
|
|
2017
|
|
2016
|
|
2015
|
||||||||||||||||||||||||||||||||||||
|
Allowance
|
|
Total Loans and Leases
|
|
% of Total Allowance
|
|
% of Loans and Leases in Category of Total Loans and Leases
|
|
Allowance
|
|
Total Loans and Leases
|
|
% of Total Allowance
|
|
% of Loans and Leases in Category of Total Loans and Leases
|
|
Allowance
|
|
Total Loans and Leases
|
|
% of Total Allowance
|
|
% of Loans and Leases in Category of Total Loans and Leases
|
||||||||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Agriculture
|
$
|
56
|
|
|
$
|
3,274
|
|
|
0.23
|
%
|
|
0.24
|
%
|
|
$
|
33
|
|
|
$
|
1,714
|
|
|
0.18
|
%
|
|
0.19
|
%
|
|
$
|
5
|
|
|
$
|
30
|
|
|
0.07
|
%
|
|
0.01
|
%
|
Death Care Management
|
47
|
|
|
13,495
|
|
|
0.20
|
|
|
1.00
|
|
|
40
|
|
|
9,684
|
|
|
0.22
|
|
|
1.06
|
|
|
31
|
|
|
4,832
|
|
|
0.42
|
|
|
1.72
|
|
||||||
Healthcare
|
2,030
|
|
|
43,301
|
|
|
8.39
|
|
|
3.21
|
|
|
1,922
|
|
|
37,270
|
|
|
10.56
|
|
|
4.10
|
|
|
684
|
|
|
15,240
|
|
|
9.22
|
|
|
5.44
|
|
||||||
Independent Pharmacies
|
1,694
|
|
|
99,920
|
|
|
7.00
|
|
|
7.42
|
|
|
873
|
|
|
83,677
|
|
|
4.79
|
|
|
9.21
|
|
|
724
|
|
|
41,588
|
|
|
9.76
|
|
|
14.86
|
|
||||||
Registered Investment Advisors
|
1,234
|
|
|
93,770
|
|
|
5.10
|
|
|
6.96
|
|
|
1,907
|
|
|
68,335
|
|
|
10.47
|
|
|
7.52
|
|
|
220
|
|
|
18,358
|
|
|
2.97
|
|
|
6.56
|
|
||||||
Veterinary Industry
|
632
|
|
|
46,387
|
|
|
2.61
|
|
|
3.45
|
|
|
834
|
|
|
38,930
|
|
|
4.58
|
|
|
4.29
|
|
|
555
|
|
|
21,579
|
|
|
7.48
|
|
|
7.71
|
|
||||||
Other Industries
|
5,058
|
|
|
184,903
|
|
|
20.91
|
|
|
13.73
|
|
|
2,804
|
|
|
94,836
|
|
|
15.40
|
|
|
10.44
|
|
|
547
|
|
|
3,230
|
|
|
7.38
|
|
|
1.15
|
|
||||||
Total
|
10,751
|
|
|
485,050
|
|
|
44.44
|
|
|
36.01
|
|
|
8,413
|
|
|
334,446
|
|
|
46.20
|
|
|
36.81
|
|
|
2,766
|
|
|
104,857
|
|
|
37.30
|
|
|
37.45
|
|
||||||
Construction & Development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Agriculture
|
494
|
|
|
34,188
|
|
|
2.04
|
|
|
2.54
|
|
|
635
|
|
|
32,372
|
|
|
3.49
|
|
|
3.56
|
|
|
811
|
|
|
11,351
|
|
|
10.94
|
|
|
4.05
|
|
||||||
Death Care Management
|
15
|
|
|
6,119
|
|
|
0.06
|
|
|
0.45
|
|
|
14
|
|
|
3,956
|
|
|
0.08
|
|
|
0.44
|
|
|
9
|
|
|
769
|
|
|
0.12
|
|
|
0.27
|
|
||||||
Healthcare
|
359
|
|
|
49,770
|
|
|
1.48
|
|
|
3.70
|
|
|
122
|
|
|
30,467
|
|
|
0.67
|
|
|
3.35
|
|
|
152
|
|
|
7,231
|
|
|
2.05
|
|
|
2.58
|
|
||||||
Independent Pharmacies
|
5
|
|
|
1,496
|
|
|
0.02
|
|
|
0.11
|
|
|
7
|
|
|
2,013
|
|
|
0.04
|
|
|
0.22
|
|
|
1
|
|
|
101
|
|
|
0.01
|
|
|
0.04
|
|
||||||
Registered Investment Advisors
|
1
|
|
|
376
|
|
|
0.01
|
|
|
0.03
|
|
|
6
|
|
|
294
|
|
|
0.03
|
|
|
0.03
|
|
|
7
|
|
|
378
|
|
|
0.09
|
|
|
0.14
|
|
||||||
Veterinary Industry
|
46
|
|
|
13,184
|
|
|
0.19
|
|
|
0.98
|
|
|
59
|
|
|
11,514
|
|
|
0.32
|
|
|
1.27
|
|
|
29
|
|
|
3,834
|
|
|
0.39
|
|
|
1.37
|
|
||||||
Other Industries
|
1,110
|
|
|
58,120
|
|
|
4.59
|
|
|
4.32
|
|
|
850
|
|
|
31,715
|
|
|
4.67
|
|
|
3.49
|
|
|
55
|
|
|
658
|
|
|
0.74
|
|
|
0.24
|
|
||||||
Total
|
2,030
|
|
|
163,253
|
|
|
8.39
|
|
|
12.13
|
|
|
1,693
|
|
|
112,331
|
|
|
9.30
|
|
|
12.36
|
|
|
1,064
|
|
|
24,322
|
|
|
14.34
|
|
|
8.69
|
|
||||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Agriculture
|
484
|
|
|
46,717
|
|
|
2.00
|
|
|
3.47
|
|
|
108
|
|
|
5,591
|
|
|
0.59
|
|
|
0.62
|
|
|
129
|
|
|
1,863
|
|
|
1.74
|
|
|
0.67
|
|
||||||
Death Care Management
|
612
|
|
|
67,381
|
|
|
2.53
|
|
|
5.00
|
|
|
410
|
|
|
52,510
|
|
|
2.25
|
|
|
5.78
|
|
|
99
|
|
|
20,327
|
|
|
1.34
|
|
|
7.26
|
|
||||||
Healthcare
|
1,128
|
|
|
126,631
|
|
|
4.67
|
|
|
9.40
|
|
|
693
|
|
|
114,281
|
|
|
3.81
|
|
|
12.58
|
|
|
561
|
|
|
37,684
|
|
|
7.57
|
|
|
13.46
|
|
||||||
Independent Pharmacies
|
425
|
|
|
19,028
|
|
|
1.76
|
|
|
1.41
|
|
|
434
|
|
|
15,151
|
|
|
2.38
|
|
|
1.67
|
|
|
33
|
|
|
7,298
|
|
|
0.45
|
|
|
2.61
|
|
||||||
Registered Investment Advisors
|
50
|
|
|
11,789
|
|
|
0.21
|
|
|
0.88
|
|
|
220
|
|
|
11,462
|
|
|
1.21
|
|
|
1.26
|
|
|
30
|
|
|
2,808
|
|
|
0.40
|
|
|
1.00
|
|
||||||
Veterinary Industry
|
2,470
|
|
|
113,932
|
|
|
10.21
|
|
|
8.46
|
|
|
2,230
|
|
|
102,906
|
|
|
12.25
|
|
|
11.33
|
|
|
1,302
|
|
|
59,999
|
|
|
17.56
|
|
|
21.43
|
|
||||||
Other Industries
|
4,011
|
|
|
134,172
|
|
|
16.58
|
|
|
9.96
|
|
|
1,802
|
|
|
46,245
|
|
|
9.90
|
|
|
5.09
|
|
|
332
|
|
|
4,752
|
|
|
4.48
|
|
|
1.70
|
|
||||||
Total
|
9,180
|
|
|
519,650
|
|
|
37.96
|
|
|
38.58
|
|
|
5,897
|
|
|
348,146
|
|
|
32.39
|
|
|
38.33
|
|
|
2,486
|
|
|
134,731
|
|
|
33.54
|
|
|
48.13
|
|
||||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Agriculture
|
2,229
|
|
|
178,897
|
|
|
9.21
|
|
|
13.28
|
|
|
2,206
|
|
|
113,569
|
|
|
12.11
|
|
|
12.50
|
|
|
1,099
|
|
|
16,036
|
|
|
14.82
|
|
|
5.73
|
|
||||||
Total
|
2,229
|
|
|
178,897
|
|
|
9.21
|
|
|
13.28
|
|
|
2,206
|
|
|
113,569
|
|
|
12.11
|
|
|
12.50
|
|
|
1,099
|
|
|
16,036
|
|
|
14.82
|
|
|
5.73
|
|
||||||
Total
|
$
|
24,190
|
|
|
$
|
1,346,850
|
|
|
100.00
|
%
|
|
100.00
|
%
|
|
$
|
18,209
|
|
|
$
|
908,492
|
|
|
100.00
|
%
|
|
100.00
|
%
|
|
$
|
7,415
|
|
|
$
|
279,946
|
|
|
100.00
|
%
|
|
100.00
|
%
|
|
2014
|
|
2013
|
||||||||||||||||||||||||
|
Allowance
|
|
Total Loans and Leases
|
|
% of Total Allowance
|
|
% of Loans and Leases in Category of Total Loans and Leases
|
|
Allowance
|
|
Total Loans and Leases
|
|
% of Total Allowance
|
|
% of Loans and Leases in Category of Total Loans and Leases
|
||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agriculture
|
$
|
—
|
|
|
$
|
—
|
|
|
—
|
%
|
|
—
|
%
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—
|
%
|
|
—
|
%
|
Death Care Management
|
2
|
|
|
3,603
|
|
|
0.05
|
|
|
1.77
|
|
|
2
|
|
|
1,782
|
|
|
0.07
|
|
|
1.25
|
|
||||
Healthcare
|
875
|
|
|
12,319
|
|
|
19.85
|
|
|
6.06
|
|
|
334
|
|
|
8,739
|
|
|
12.27
|
|
|
6.15
|
|
||||
Independent Pharmacies
|
336
|
|
|
34,079
|
|
|
7.62
|
|
|
16.75
|
|
|
132
|
|
|
24,026
|
|
|
4.85
|
|
|
16.91
|
|
||||
Registered Investment Advisors
|
7
|
|
|
9,660
|
|
|
0.16
|
|
|
4.75
|
|
|
74
|
|
|
2,817
|
|
|
2.72
|
|
|
1.98
|
|
||||
Veterinary Industry
|
114
|
|
|
20,902
|
|
|
2.59
|
|
|
10.27
|
|
|
304
|
|
|
19,978
|
|
|
11.16
|
|
|
14.06
|
|
||||
Other Industries
|
35
|
|
|
494
|
|
|
0.79
|
|
|
0.24
|
|
|
16
|
|
|
17
|
|
|
0.59
|
|
|
0.01
|
|
||||
Total
|
1,369
|
|
|
81,057
|
|
|
31.06
|
|
|
39.84
|
|
|
862
|
|
|
57,359
|
|
|
31.66
|
|
|
40.36
|
|
||||
Construction & Development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agriculture
|
362
|
|
|
3,910
|
|
|
8.21
|
|
|
1.92
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Death Care Management
|
1
|
|
|
92
|
|
|
0.02
|
|
|
0.05
|
|
|
10
|
|
|
989
|
|
|
0.37
|
|
|
0.70
|
|
||||
Healthcare
|
145
|
|
|
2,957
|
|
|
3.29
|
|
|
1.45
|
|
|
242
|
|
|
4,997
|
|
|
8.89
|
|
|
3.52
|
|
||||
Independent Pharmacies
|
4
|
|
|
215
|
|
|
0.09
|
|
|
0.11
|
|
|
2
|
|
|
101
|
|
|
0.07
|
|
|
0.07
|
|
||||
Registered Investment Advisors
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Veterinary Industry
|
27
|
|
|
2,207
|
|
|
0.61
|
|
|
1.09
|
|
|
96
|
|
|
4,199
|
|
|
3.52
|
|
|
2.95
|
|
||||
Other Industries
|
47
|
|
|
145
|
|
|
1.07
|
|
|
0.07
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Total
|
586
|
|
|
9,526
|
|
|
13.29
|
|
|
4.69
|
|
|
350
|
|
|
10,286
|
|
|
12.85
|
|
|
7.24
|
|
||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agriculture
|
25
|
|
|
259
|
|
|
0.57
|
|
|
0.13
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Death Care Management
|
77
|
|
|
18,879
|
|
|
1.75
|
|
|
9.28
|
|
|
60
|
|
|
11,668
|
|
|
2.20
|
|
|
8.21
|
|
||||
Healthcare
|
794
|
|
|
26,173
|
|
|
18.02
|
|
|
12.86
|
|
|
320
|
|
|
11,129
|
|
|
11.75
|
|
|
7.83
|
|
||||
Independent Pharmacies
|
32
|
|
|
4,750
|
|
|
0.73
|
|
|
2.33
|
|
|
54
|
|
|
3,490
|
|
|
1.98
|
|
|
2.46
|
|
||||
Registered Investment Advisors
|
—
|
|
|
2,161
|
|
|
—
|
|
|
1.06
|
|
|
4
|
|
|
171
|
|
|
0.15
|
|
|
0.12
|
|
||||
Veterinary Industry
|
1,122
|
|
|
57,934
|
|
|
25.46
|
|
|
28.48
|
|
|
965
|
|
|
47,896
|
|
|
35.44
|
|
|
33.70
|
|
||||
Other Industries
|
241
|
|
|
1,464
|
|
|
5.47
|
|
|
0.72
|
|
|
108
|
|
|
107
|
|
|
3.97
|
|
|
0.08
|
|
||||
Total
|
2,291
|
|
|
111,620
|
|
|
52.00
|
|
|
54.86
|
|
|
1,511
|
|
|
74,461
|
|
|
55.49
|
|
|
52.40
|
|
||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agriculture
|
161
|
|
|
1,248
|
|
|
3.65
|
|
|
0.61
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Total
|
161
|
|
|
1,248
|
|
|
3.65
|
|
|
0.61
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Total
|
$
|
4,407
|
|
|
$
|
203,451
|
|
|
100.00
|
%
|
|
100.00
|
%
|
|
$
|
2,723
|
|
|
$
|
142,106
|
|
|
100.00
|
%
|
|
100.00
|
%
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
Allowance for Loan and Lease Losses:
|
|
|
|
|
|
|
|
|
|
||||||||||
Beginning Balance
|
$
|
18,209
|
|
|
$
|
7,415
|
|
|
$
|
4,407
|
|
|
$
|
2,723
|
|
|
$
|
5,108
|
|
Provision
|
9,536
|
|
|
12,536
|
|
|
3,806
|
|
|
2,793
|
|
|
(858
|
)
|
|||||
Charge-offs:
|
|
|
|
|
|
|
|
|
|
||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
||||||||||
Healthcare
|
(1,367
|
)
|
|
(1,137
|
)
|
|
(44
|
)
|
|
(209
|
)
|
|
(419
|
)
|
|||||
Independent Pharmacies
|
(882
|
)
|
|
(6
|
)
|
|
(274
|
)
|
|
(294
|
)
|
|
—
|
|
|||||
Registered Investment Advisors
|
(236
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Veterinary Industry
|
(132
|
)
|
|
(321
|
)
|
|
(660
|
)
|
|
(195
|
)
|
|
(269
|
)
|
|||||
Total
|
(2,617
|
)
|
|
(1,464
|
)
|
|
(978
|
)
|
|
(698
|
)
|
|
(688
|
)
|
|||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
||||||||||
Death Care Management
|
—
|
|
|
—
|
|
|
—
|
|
|
(135
|
)
|
|
—
|
|
|||||
Healthcare
|
(14
|
)
|
|
—
|
|
|
(29
|
)
|
|
(25
|
)
|
|
(76
|
)
|
|||||
Independent Pharmacies
|
(541
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Veterinary Industry
|
(622
|
)
|
|
(707
|
)
|
|
(135
|
)
|
|
(263
|
)
|
|
(819
|
)
|
|||||
Other Industries
|
—
|
|
|
—
|
|
|
—
|
|
|
(92
|
)
|
|
(365
|
)
|
|||||
Total
|
(1,177
|
)
|
|
(707
|
)
|
|
(164
|
)
|
|
(515
|
)
|
|
(1,260
|
)
|
|||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
||||||||||
Agriculture
|
(58
|
)
|
|
(63
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
(58
|
)
|
|
(63
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total charge-offs
|
(3,852
|
)
|
|
(2,234
|
)
|
|
(1,142
|
)
|
|
(1,213
|
)
|
|
(1,948
|
)
|
|||||
Recoveries:
|
|
|
|
|
|
|
|
|
|
||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
||||||||||
Healthcare
|
79
|
|
|
104
|
|
|
126
|
|
|
17
|
|
|
2
|
|
|||||
Independent Pharmacies
|
3
|
|
|
40
|
|
|
70
|
|
|
—
|
|
|
—
|
|
|||||
Veterinary Industry
|
19
|
|
|
342
|
|
|
17
|
|
|
15
|
|
|
25
|
|
|||||
Total
|
101
|
|
|
486
|
|
|
213
|
|
|
32
|
|
|
27
|
|
|||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
||||||||||
Independent Pharmacies
|
170
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Veterinary Industry
|
21
|
|
|
6
|
|
|
131
|
|
|
72
|
|
|
32
|
|
|||||
Other Industries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|||||
Total
|
191
|
|
|
6
|
|
|
131
|
|
|
72
|
|
|
33
|
|
|||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
||||||||||
Agriculture
|
5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total recoveries
|
297
|
|
|
492
|
|
|
344
|
|
|
104
|
|
|
60
|
|
|||||
Net transfer to loans held for sale
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
361
|
|
|||||
Ending Balance
|
$
|
24,190
|
|
|
$
|
18,209
|
|
|
$
|
7,415
|
|
|
$
|
4,407
|
|
|
$
|
2,723
|
|
|
2017
|
|
2016
|
|
2015
|
||||||||||||||||||
|
Amortized Cost
|
|
Fair
Value |
|
Amortized Cost
|
|
Fair
Value |
|
Amortized Cost
|
|
Fair
Value |
||||||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
US government agencies
|
$
|
22,778
|
|
|
$
|
22,624
|
|
|
$
|
17,803
|
|
|
$
|
17,823
|
|
|
$
|
21,992
|
|
|
$
|
22,068
|
|
Residential mortgage-backed securities
|
70,167
|
|
|
68,696
|
|
|
52,301
|
|
|
51,273
|
|
|
30,131
|
|
|
29,758
|
|
||||||
Mutual fund
|
2,090
|
|
|
2,035
|
|
|
2,012
|
|
|
1,960
|
|
|
1,951
|
|
|
1,936
|
|
||||||
Total available-for-sale
|
$
|
95,035
|
|
|
$
|
93,355
|
|
|
$
|
72,116
|
|
|
$
|
71,056
|
|
|
$
|
54,074
|
|
|
$
|
53,762
|
|
Total securities
|
$
|
95,035
|
|
|
$
|
93,355
|
|
|
$
|
72,116
|
|
|
$
|
71,056
|
|
|
$
|
54,074
|
|
|
$
|
53,762
|
|
|
|
|
Within One Year
|
|
After One
to Five Years |
|
After Five
to Ten Years |
|
After Ten Years
|
||||||||||||||||||||||
|
Total
Amortized Cost |
|
Amortized
Cost |
|
Average
Yield |
|
Amortized
Cost |
|
Average
Yield |
|
Amortized
Cost |
|
Average
Yield |
|
Amortized
Cost |
|
Average
Yield |
||||||||||||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
US government securities
|
$
|
22,778
|
|
|
$
|
6,323
|
|
|
1.32
|
%
|
|
$
|
16,455
|
|
|
1.69
|
%
|
|
$
|
—
|
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
%
|
Residential mortgage-backed securities
|
70,167
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,815
|
|
|
2.40
|
|
|
63,352
|
|
|
3.18
|
|
|||||
Total available-for-sale securities
|
$
|
92,945
|
|
|
$
|
6,323
|
|
|
1.32
|
%
|
|
$
|
16,455
|
|
|
1.69
|
%
|
|
$
|
6,815
|
|
|
2.40
|
%
|
|
$
|
63,352
|
|
|
3.18
|
%
|
Total securities
|
$
|
92,945
|
|
|
$
|
6,323
|
|
|
1.32
|
%
|
|
$
|
16,455
|
|
|
1.69
|
%
|
|
$
|
6,815
|
|
|
2.40
|
%
|
|
$
|
63,352
|
|
|
3.18
|
%
|
|
2017
|
|
2016
|
|
2015
|
|||||||||||||||
|
Total
|
|
Percent
|
|
Total
|
|
Percent
|
|
Total
|
|
Percent
|
|||||||||
Period end:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Noninterest-bearing demand deposits
|
$
|
57,868
|
|
|
2.56
|
%
|
|
$
|
27,990
|
|
|
1.88
|
%
|
|
$
|
21,502
|
|
|
2.67
|
%
|
Interest-bearing deposits:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Interest-bearing checking
|
36,978
|
|
|
1.64
|
|
|
27,402
|
|
|
1.85
|
|
|
7,937
|
|
|
0.99
|
|
|||
Money market
|
188,146
|
|
|
8.32
|
|
|
489,978
|
|
|
32.99
|
|
|
367,573
|
|
|
45.67
|
|
|||
Savings
|
696,989
|
|
|
30.84
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Time deposits
|
1,280,282
|
|
|
56.64
|
|
|
939,706
|
|
|
63.28
|
|
|
407,776
|
|
|
50.67
|
|
|||
Total
|
2,202,395
|
|
|
97.44
|
|
|
1,457,086
|
|
|
98.12
|
|
|
783,286
|
|
|
97.33
|
|
|||
Total period end deposits
|
$
|
2,260,263
|
|
|
100.00
|
%
|
|
$
|
1,485,076
|
|
|
100.00
|
%
|
|
$
|
804,788
|
|
|
100.00
|
%
|
|
2017
|
|
2016
|
|
2015
|
||||||||||||||||||||||||
|
Total
|
|
Percent
|
|
Average Rate
|
|
Total
|
|
Percent
|
|
Average Rate
|
|
Total
|
|
Percent
|
|
Average Rate
|
||||||||||||
Average:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Noninterest-bearing demand deposits
|
$
|
40,831
|
|
|
2.21
|
%
|
|
—
|
%
|
|
$
|
21,665
|
|
|
1.84
|
%
|
|
—
|
%
|
|
$
|
15,131
|
|
|
2.12
|
%
|
|
—
|
%
|
Interest-bearing deposits:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest-bearing checking
|
39,213
|
|
|
2.12
|
|
|
0.65
|
|
|
20,410
|
|
|
1.73
|
|
|
0.57
|
|
|
6,604
|
|
|
0.93
|
|
|
0.59
|
|
|||
Money market
|
413,648
|
|
|
22.38
|
|
|
0.98
|
|
|
423,035
|
|
|
35.93
|
|
|
0.76
|
|
|
347,429
|
|
|
48.74
|
|
|
0.73
|
|
|||
Savings
|
193,083
|
|
|
10.45
|
|
|
1.39
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Time deposits
|
1,161,651
|
|
|
62.84
|
|
|
1.48
|
|
|
712,327
|
|
|
60.50
|
|
|
1.45
|
|
|
343,625
|
|
|
48.21
|
|
|
1.39
|
|
|||
Total average deposits
|
$
|
1,848,426
|
|
|
100.00
|
%
|
|
1.34
|
%
|
|
$
|
1,177,437
|
|
|
100.00
|
%
|
|
1.18
|
%
|
|
$
|
712,789
|
|
|
100.00
|
%
|
|
1.06
|
%
|
Maturity Period
|
Three months
or less |
|
More than
three months to six months |
|
More than
six months to twelve months |
|
More than
twelve months |
||||||||
Time deposits, $100,000 and over
|
$
|
368,747
|
|
|
$
|
136,004
|
|
|
$
|
135,964
|
|
|
$
|
128,799
|
|
Other time deposits
|
117,668
|
|
|
85,388
|
|
|
48,393
|
|
|
259,319
|
|
||||
Total time deposits
|
$
|
486,415
|
|
|
$
|
221,392
|
|
|
$
|
184,357
|
|
|
$
|
388,118
|
|
|
Actual
|
|
Minimum Capital Requirement
|
|
Minimum To Be Well Capitalized Under Prompt Corrective Action Provisions
(1)
|
||||||||||||
|
Amount
|
Ratio
|
|
Amount
|
Ratio
|
|
Amount
|
Ratio
|
|||||||||
Consolidated - December 31, 2017
|
|
|
|
|
|
|
|
|
|||||||||
Common Equity Tier 1 (to Risk-Weighted Assets)
|
$
|
390,816
|
|
17.81
|
%
|
|
$
|
98,764
|
|
4.50
|
%
|
|
N/A
|
|
N/A
|
|
|
Total Capital (to Risk-Weighted Assets)
|
$
|
415,006
|
|
18.91
|
%
|
|
$
|
175,580
|
|
8.00
|
%
|
|
N/A
|
|
N/A
|
|
|
Tier 1 Capital (to Risk-Weighted Assets)
|
$
|
390,816
|
|
17.81
|
%
|
|
$
|
131,685
|
|
6.00
|
%
|
|
N/A
|
|
N/A
|
|
|
Tier 1 Capital (to Average Assets)
|
$
|
390,816
|
|
15.50
|
%
|
|
$
|
100,828
|
|
4.00
|
%
|
|
N/A
|
|
N/A
|
|
|
Bank - December 31, 2017
|
|
|
|
|
|
|
|
|
|||||||||
Common Equity Tier 1 (to Risk-Weighted Assets)
|
$
|
277,943
|
|
12.89
|
%
|
|
$
|
97,060
|
|
4.50
|
%
|
|
$
|
140,197
|
|
6.50
|
%
|
Total Capital (to Risk-Weighted Assets)
|
$
|
302,385
|
|
14.02
|
%
|
|
$
|
172,551
|
|
8.00
|
%
|
|
$
|
215,688
|
|
10.00
|
%
|
Tier 1 Capital (to Risk-Weighted Assets)
|
$
|
277,943
|
|
12.89
|
%
|
|
$
|
129,413
|
|
6.00
|
%
|
|
$
|
172,551
|
|
8.00
|
%
|
Tier 1 Capital (to Average Assets)
|
$
|
277,943
|
|
11.36
|
%
|
|
$
|
97,864
|
|
4.00
|
%
|
|
$
|
122,330
|
|
5.00
|
%
|
Consolidated - December 31, 2016
|
|
|
|
|
|
|
|
|
|||||||||
Common Equity Tier 1 (to Risk-Weighted Assets)
|
$
|
206,670
|
|
15.31
|
%
|
|
$
|
60,732
|
|
4.50
|
%
|
|
N/A
|
|
N/A
|
|
|
Total Capital (to Risk-Weighted Assets)
|
$
|
223,559
|
|
16.56
|
%
|
|
$
|
107,968
|
|
8.00
|
%
|
|
N/A
|
|
N/A
|
|
|
Tier 1 Capital (to Risk-Weighted Assets)
|
$
|
206,670
|
|
15.31
|
%
|
|
$
|
80,976
|
|
6.00
|
%
|
|
N/A
|
|
N/A
|
|
|
Tier 1 Capital (to Average Assets)
|
$
|
206,670
|
|
12.00
|
%
|
|
$
|
68,919
|
|
4.00
|
%
|
|
N/A
|
|
N/A
|
|
|
Bank - December 31, 2016
|
|
|
|
|
|
|
|
|
|||||||||
Common Equity Tier 1 (to Risk-Weighted Assets)
|
$
|
139,078
|
|
10.68
|
%
|
|
$
|
58,579
|
|
4.50
|
%
|
|
$
|
84,615
|
|
6.50
|
%
|
Total Capital (to Risk-Weighted Assets)
|
$
|
155,423
|
|
11.94
|
%
|
|
$
|
104,141
|
|
8.00
|
%
|
|
$
|
130,177
|
|
10.00
|
%
|
Tier 1 Capital (to Risk-Weighted Assets)
|
$
|
139,078
|
|
10.68
|
%
|
|
$
|
78,106
|
|
6.00
|
%
|
|
$
|
104,141
|
|
8.00
|
%
|
Tier 1 Capital (to Average Assets)
|
$
|
139,078
|
|
8.41
|
%
|
|
$
|
66,142
|
|
4.00
|
%
|
|
$
|
82,678
|
|
5.00
|
%
|
Consolidated - December 31, 2015
|
|
|
|
|
|
|
|
|
|||||||||
Common Equity Tier 1 (to Risk-Weighted Assets)
|
$
|
191,366
|
|
23.22
|
%
|
|
$
|
37,087
|
|
4.50
|
%
|
|
N/A
|
|
N/A
|
|
|
Total Capital (to Risk-Weighted Assets)
|
$
|
198,781
|
|
24.12
|
%
|
|
$
|
65,933
|
|
8.00
|
%
|
|
N/A
|
|
N/A
|
|
|
Tier 1 Capital (to Risk-Weighted Assets)
|
$
|
191,366
|
|
23.22
|
%
|
|
$
|
49,450
|
|
6.00
|
%
|
|
N/A
|
|
N/A
|
|
|
Tier 1 Capital (to Average Assets)
|
$
|
191,366
|
|
18.36
|
%
|
|
$
|
41,702
|
|
4.00
|
%
|
|
N/A
|
|
N/A
|
|
|
Bank - December 31, 2015
|
|
|
|
|
|
|
|
|
|||||||||
Common Equity Tier 1 (to Risk-Weighted Assets)
|
$
|
96,056
|
|
12.28
|
%
|
|
$
|
35,207
|
|
4.50
|
%
|
|
$
|
50,855
|
|
6.50
|
%
|
Total Capital (to Risk-Weighted Assets)
|
$
|
103,471
|
|
13.23
|
%
|
|
$
|
62,591
|
|
8.00
|
%
|
|
$
|
78,238
|
|
10.00
|
%
|
Tier 1 Capital (to Risk-Weighted Assets)
|
$
|
96,056
|
|
12.28
|
%
|
|
$
|
46,943
|
|
6.00
|
%
|
|
$
|
62,591
|
|
6.00
|
%
|
Tier 1 Capital (to Average Assets)
|
$
|
96,056
|
|
9.75
|
%
|
|
$
|
39,398
|
|
4.00
|
%
|
|
$
|
49,248
|
|
5.00
|
%
|
|
Payments Due by Period
|
||||||||||||||||||
|
Total
|
|
Less than
One Year |
|
One to
Three Years |
|
Three to
Five Years |
|
More Than Five Years
|
||||||||||
Contractual Obligations
|
|
|
|
|
|
|
|
|
|
||||||||||
Deposits without stated maturity
|
$
|
979,981
|
|
|
$
|
979,981
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Time deposits
|
1,280,282
|
|
|
892,164
|
|
|
222,361
|
|
|
89,683
|
|
|
76,074
|
|
|||||
Long term borrowings
|
26,564
|
|
|
853
|
|
|
5,386
|
|
|
20,325
|
|
|
—
|
|
|||||
Operating lease obligations
|
2,836
|
|
|
964
|
|
|
1,173
|
|
|
469
|
|
|
230
|
|
|||||
Total
|
$
|
2,289,663
|
|
|
$
|
1,873,962
|
|
|
$
|
228,920
|
|
|
$
|
110,477
|
|
|
$
|
76,304
|
|
|
2017
|
|
2016
|
|
2015
|
||||||
Commitments to extend credit (1)
|
$
|
1,701,137
|
|
|
$
|
1,342,271
|
|
|
$
|
737,572
|
|
Standby letters of credit
|
2,298
|
|
|
343
|
|
|
—
|
|
|||
Solar purchase commitments
|
106,921
|
|
|
—
|
|
|
—
|
|
|||
Airplane purchase agreement commitments
|
25,450
|
|
|
21,500
|
|
|
—
|
|
|||
Total commitments
|
$
|
1,835,806
|
|
|
$
|
1,364,114
|
|
|
$
|
737,572
|
|
(1)
|
Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments may require payment of a fee and generally have fixed expiration dates or other termination clauses.
|
•
|
Determination of the allowance for loan and lease losses;
|
•
|
Valuation of servicing assets;
|
•
|
Income taxes;
|
•
|
Restricted stock unit awards with market price conditions;
|
•
|
Valuation of foreclosed assets;
|
•
|
Business combinations and goodwill; and
|
•
|
Unconsolidated joint ventures.
|
•
|
“Tangible shareholders’ equity” is total shareholders’ equity less goodwill and other intangible assets. Management has not considered loan servicing rights as an intangible asset for purposes of this calculation.
|
•
|
“Tangible assets” is total assets less goodwill and other intangible assets. Management has not considered loan servicing rights as an intangible asset for purposes of this calculation.
|
•
|
“Tangible shareholders’ equity to tangible assets” is defined as the ratio of shareholders’ equity less goodwill and other intangible assets, divided by total assets less goodwill and other intangible assets. Management believes this measure is important because it shows relative changes from period to period in equity and total assets, each exclusive of changes in intangible assets. Management has not considered loan servicing rights as an intangible asset for purposes of this calculation.
|
•
|
“Tangible book value per share” is defined as total equity reduced by goodwill and other intangible assets divided by total common shares outstanding. Management believes this measure is important because it shows changes from period to period in book value per share exclusive of changes in intangible assets. Management has not considered loan servicing rights as an intangible asset for purposes of this calculation.
|
•
|
“Efficiency ratio” is defined as total noninterest expense divided by the sum of net interest income and noninterest income less gain (loss) on sale of securities. Management believes this measure is important as an indicator of productivity because it shows the amount of noninterest expense that was required to generate a dollar of revenue. While the efficiency ratio is a measure of productivity, its value reflects the unique attributes of the “high-touch business model” the Company employs.
|
•
|
“Non-GAAP net income” is defined as net income adjusted to exclude significant non-routine sources of income and uses of expenses and an estimated corporate income tax expense across all periods being compared. Management believes these measures are important as they allow for an evaluation of the core profitability of the Company's business.
|
•
|
“Noninterest income, as adjusted” is defined as noninterest income adjusted to exclude significant non-routine sources of income, including the gain on contribution to equity method investment and a loss associated with the 2016 renewable energy tax credit investment. Management believes these measures are important as they allow for an evaluation of the core profitability of the Company's business.
|
•
|
"Provision for loan and lease losses, as adjusted" is defined as provision for loan and lease losses adjusted to exclude significant non-routine sources of provision, including provision for loans reclassified from held for sale to held for investment. Management believes these measures are important as they allow for an evaluation of the core profitability of the Company's business.
|
•
|
“Noninterest expense, as adjusted” is defined as noninterest expense adjusted to exclude significant non-routine sources of expenses, including stock based compensation expense of restricted stock awards for key employee retention with an effective date of May 24, 2016, merger costs associated with the Reltco acquisition and Apiture investment, trade-in loss on an aircraft and a contract modification for Reltco. Other non-routine sources of noninterest expense included impairments of: an aircraft held for sale, goodwill and other intangibles and the 2016 renewable energy tax credit investment. Management believes these measures are important as they allow for an evaluation of the core profitability of the Company's business.
|
•
|
“Income tax (benefit) expense, as adjusted” is defined as income tax expense adjusted to exclude significant non-routine sources of expense or income, as discussed above, the impact of revaluing the Company's net deferred tax liability as a result of reduced federal tax rates arising from the December 22, 2017 Tax Act legislation, other renewable energy tax expense and renewable energy tax credits arising from the 2016 investment. Management believes these measures are important as they allow for an evaluation of the core profitability of the Company's business.
|
|
|
Years Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Total shareholders' equity
|
|
$
|
436,933
|
|
|
$
|
222,847
|
|
|
$
|
199,488
|
|
Less:
|
|
|
|
|
|
|
||||||
Goodwill
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Other intangible assets
|
|
4,264
|
|
|
—
|
|
|
—
|
|
|||
Tangible shareholders' equity (a)
|
|
$
|
432,669
|
|
|
$
|
222,847
|
|
|
$
|
199,488
|
|
|
|
|
|
|
|
|
||||||
Shares outstanding (c)
|
|
39,895,583
|
|
|
34,253,602
|
|
|
34,172,899
|
|
|||
|
|
|
|
|
|
|
||||||
Total assets
|
|
$
|
2,758,474
|
|
|
$
|
1,755,261
|
|
|
$
|
1,052,622
|
|
Less:
|
|
|
|
|
|
|
||||||
Goodwill
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Other intangible assets
|
|
4,264
|
|
|
—
|
|
|
—
|
|
|||
Tangible assets (b)
|
|
$
|
2,754,210
|
|
|
$
|
1,755,261
|
|
|
$
|
1,052,622
|
|
|
|
|
|
|
|
|
||||||
Tangible shareholders' equity to tangible assets (a/b)
|
|
15.71
|
%
|
|
12.70
|
%
|
|
18.95
|
%
|
|||
Tangible book value per share (a/c)
|
|
10.85
|
|
|
6.51
|
|
|
5.84
|
|
|||
|
|
|
|
|
|
|
||||||
Efficiency ratio:
|
|
|
|
|
|
|
||||||
Noninterest expense (d)
|
|
$
|
143,165
|
|
|
$
|
106,445
|
|
|
$
|
71,715
|
|
Net interest income
|
|
78,034
|
|
|
42,649
|
|
|
25,589
|
|
|||
Noninterest income
|
|
172,921
|
|
|
93,539
|
|
|
84,328
|
|
|||
Less: gain (loss) on sale of securities
|
|
—
|
|
|
1
|
|
|
13
|
|
|||
Adjusted operating revenue (e)
|
|
$
|
250,955
|
|
|
$
|
136,187
|
|
|
$
|
109,904
|
|
|
|
|
|
|
|
|
||||||
Efficiency ratio (d/e)
|
|
57.05
|
%
|
|
78.16
|
%
|
|
65.25
|
%
|
|
|
Years Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Reconciliation of net income to non-GAAP net income adjusted for non-routine income and expenses:
|
|
|
|
|
|
|
||||||
Net income attributable to Live Oak Bancshares, Inc.
|
|
$
|
100,499
|
|
|
$
|
13,773
|
|
|
$
|
20,625
|
|
Gain on sale of investment in non-consolidated affiliate
|
|
—
|
|
|
—
|
|
|
(3,782
|
)
|
|||
Provision for loans reclassified as held for investment
|
|
—
|
|
|
4,023
|
|
|
—
|
|
|||
Gain on contribution to equity method investment
|
|
(68,000
|
)
|
|
—
|
|
|
—
|
|
|||
Stock based compensation expense for restricted stock awards with an effective date of May 24, 2016, as discussed in Note 10 of the Notes to Unaudited Consolidated Financial Statements included in our March 31, 2016 Form 10-Q
|
|
1,370
|
|
|
8,973
|
|
|
—
|
|
|||
Merger costs associated with Reltco acquisition and Apiture investment
|
|
2,874
|
|
|
—
|
|
|
—
|
|
|||
Trade-in loss on aircraft
|
|
206
|
|
|
—
|
|
|
—
|
|
|||
Impairment charge taken on aircraft held for sale
|
|
—
|
|
|
1,422
|
|
|
—
|
|
|||
Impairment expense on goodwill and other intangibles
|
|
3,648
|
|
|
—
|
|
|
—
|
|
|||
Contract modification of Reltco
|
|
1,600
|
|
|
—
|
|
|
—
|
|
|||
Renewable energy tax credit investment income, impairment and loss
|
|
690
|
|
|
3,239
|
|
|
—
|
|
|||
Income tax effects and adjustments for non-GAAP items*
|
|
23,045
|
|
|
(7,062
|
)
|
|
1,513
|
|
|||
Deferred tax liability revaluation
|
|
(18,921
|
)
|
|
—
|
|
|
—
|
|
|||
Other renewable energy tax expense
|
|
176
|
|
|
176
|
|
|
—
|
|
|||
Renewable energy tax credit
|
|
—
|
|
|
(4,396
|
)
|
|
—
|
|
|||
Non-GAAP net income
|
|
$
|
47,187
|
|
|
$
|
20,148
|
|
|
$
|
18,356
|
|
*Estimated at 40.0%
|
|
|
|
|
|
|
||||||
Earnings per share:
|
|
|
|
|
|
|
||||||
Basic
|
|
$
|
1.29
|
|
|
$
|
0.59
|
|
|
$
|
0.59
|
|
Diluted
|
|
$
|
1.25
|
|
|
$
|
0.57
|
|
|
$
|
0.57
|
|
|
|
|
|
|
|
|
||||||
Weighted-average shares outstanding:
|
|
|
|
|
|
|
||||||
Basic
|
|
36,592,893
|
|
|
34,202,168
|
|
|
31,079,032
|
|
|||
Diluted
|
|
37,859,535
|
|
|
35,086,959
|
|
|
31,973,146
|
|
|||
|
|
|
|
|
|
|
||||||
Reconciliation of financial statement line items as reported to adjusted for non-routine income and expenses:
|
|
|
|
|
|
|
||||||
Noninterest income, as reported
|
|
$
|
172,921
|
|
|
$
|
93,539
|
|
|
$
|
84,328
|
|
Gain on sale of investment in non-consolidated affiliate
|
|
—
|
|
|
—
|
|
|
(3,782
|
)
|
|||
Gain on contribution to equity method investment
|
|
(68,000
|
)
|
|
—
|
|
|
—
|
|
|||
Renewable energy tax credit investment loss
|
|
—
|
|
|
42
|
|
|
—
|
|
|||
Noninterest income, as adjusted
|
|
104,921
|
|
|
93,581
|
|
|
80,546
|
|
|||
|
|
|
|
|
|
|
||||||
Provision for loan and lease losses, as reported
|
|
9,536
|
|
|
12,536
|
|
|
3,806
|
|
|||
Provision for loans reclassified as held for investment
|
|
—
|
|
|
(4,023
|
)
|
|
—
|
|
|||
Provision for loan and lease losses, as adjusted
|
|
$
|
9,536
|
|
|
$
|
8,513
|
|
|
$
|
3,806
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Noninterest expense, as reported
|
|
$
|
143,165
|
|
|
$
|
106,445
|
|
|
$
|
71,715
|
|
Stock based compensation expense
|
|
(1,370
|
)
|
|
(8,973
|
)
|
|
—
|
|
|||
Merger costs associated with Reltco acquisition and Apiture investment
|
|
(2,874
|
)
|
|
—
|
|
|
—
|
|
|||
Trade-in loss on aircraft
|
|
(206
|
)
|
|
—
|
|
|
—
|
|
|||
Impairment charge taken on aircraft held for sale
|
|
—
|
|
|
(1,422
|
)
|
|
—
|
|
|||
Impairment expense on goodwill and other intangibles
|
|
(3,648
|
)
|
|
—
|
|
|
—
|
|
|||
Contract modification of Reltco
|
|
(1,600
|
)
|
|
—
|
|
|
—
|
|
|||
Renewable energy tax credit investment impairment and loss
|
|
(690
|
)
|
|
(3,197
|
)
|
|
—
|
|
|||
Noninterest expense, as adjusted
|
|
132,777
|
|
|
92,853
|
|
|
71,715
|
|
|||
|
|
|
|
|
|
|
||||||
Income tax (benefit) expense, as reported
|
|
(2,245
|
)
|
|
3,443
|
|
|
13,795
|
|
|||
Income tax effects and adjustment for non-routine income and expenses
|
|
(23,045
|
)
|
|
7,062
|
|
|
(1,513
|
)
|
|||
Deferred tax liability revaluation
|
|
18,921
|
|
|
—
|
|
|
—
|
|
|||
Other renewable energy tax expense
|
|
(176
|
)
|
|
(176
|
)
|
|
—
|
|
|||
Renewable energy tax credit
|
|
—
|
|
|
4,396
|
|
|
—
|
|
|||
Income tax (benefit) expense, as adjusted
|
|
$
|
(6,545
|
)
|
|
$
|
14,725
|
|
|
$
|
12,282
|
|
Item 7A.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
|
|
Estimated Increase/Decrease
in Net Interest Income
|
|
Estimated
Percentage Change in EVE
|
||
Basis Point ("bp") Change in
Interest Rates
|
|
12 Months Ending
December 31, 2018
|
|
12 Months Ending
December 31, 2019
|
|
As of
December 31, 2017
|
+400
|
|
22.0%
|
|
18.3%
|
|
(7.3)%
|
+300
|
|
16.5
|
|
13.7
|
|
(5.9)
|
+200
|
|
11.0
|
|
9.1
|
|
(4.4)
|
+100
|
|
5.5
|
|
4.6
|
|
(2.8)
|
-100
|
|
(6.1)
|
|
(4.9)
|
|
2.0
|
Item 8.
|
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
|
(dollars in thousands, except per share data)
|
2017
|
||||||||||||||
|
4th Qtr
|
|
3rd Qtr
|
|
2nd Qtr
|
|
1st Qtr
|
||||||||
Interest income
|
$
|
30,536
|
|
|
$
|
28,172
|
|
|
$
|
24,345
|
|
|
$
|
20,419
|
|
Interest expense
|
7,560
|
|
|
7,147
|
|
|
5,953
|
|
|
4,778
|
|
||||
Net interest income
|
22,976
|
|
|
21,025
|
|
|
18,392
|
|
|
15,641
|
|
||||
Provision for loan and lease losses
|
4,055
|
|
|
2,426
|
|
|
1,556
|
|
|
1,499
|
|
||||
Net interest income after provision for loan and lease losses
|
18,921
|
|
|
18,599
|
|
|
16,836
|
|
|
14,142
|
|
||||
Noninterest income
|
95,441
|
|
|
25,060
|
|
|
26,667
|
|
|
25,753
|
|
||||
Noninterest expense
|
41,024
|
|
|
35,856
|
|
|
33,300
|
|
|
32,985
|
|
||||
Income before income taxes
|
73,338
|
|
|
7,803
|
|
|
10,203
|
|
|
6,910
|
|
||||
Income tax expense (benefit)
|
1,608
|
|
|
(5,059
|
)
|
|
408
|
|
|
798
|
|
||||
Net income to common shareholders
|
$
|
71,730
|
|
|
$
|
12,862
|
|
|
$
|
9,795
|
|
|
$
|
6,112
|
|
Net income per share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
1.80
|
|
|
$
|
0.34
|
|
|
$
|
0.28
|
|
|
$
|
0.18
|
|
Diluted
|
$
|
1.74
|
|
|
$
|
0.33
|
|
|
$
|
0.27
|
|
|
$
|
0.17
|
|
|
2016
|
||||||||||||||
|
4th Qtr
|
|
3rd Qtr
|
|
2nd Qtr
|
|
1st Qtr
|
||||||||
Interest income
|
$
|
16,914
|
|
|
$
|
15,562
|
|
|
$
|
13,402
|
|
|
$
|
11,394
|
|
Interest expense
|
4,522
|
|
|
3,931
|
|
|
3,485
|
|
|
2,685
|
|
||||
Net interest income
|
12,392
|
|
|
11,631
|
|
|
9,917
|
|
|
8,709
|
|
||||
Provision for loan and lease losses
|
3,844
|
|
|
3,806
|
|
|
3,453
|
|
|
1,433
|
|
||||
Net interest income after provision for loan and lease losses
|
8,548
|
|
|
7,825
|
|
|
6,464
|
|
|
7,276
|
|
||||
Noninterest income
|
26,327
|
|
|
25,432
|
|
|
19,348
|
|
|
22,432
|
|
||||
Noninterest expense
|
32,384
|
|
|
27,218
|
|
|
25,132
|
|
|
21,711
|
|
||||
Income before income taxes
|
2,491
|
|
|
6,039
|
|
|
680
|
|
|
7,997
|
|
||||
Income tax (benefit) expense
|
(2,989
|
)
|
|
2,561
|
|
|
557
|
|
|
3,314
|
|
||||
Net income
|
5,480
|
|
|
3,478
|
|
|
123
|
|
|
4,683
|
|
||||
Net loss attributable to noncontrolling interest
|
—
|
|
|
1
|
|
|
—
|
|
|
8
|
|
||||
Net income to common shareholders
|
$
|
5,480
|
|
|
$
|
3,479
|
|
|
$
|
123
|
|
|
$
|
4,691
|
|
Net income per share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
0.16
|
|
|
$
|
0.10
|
|
|
$
|
0.00
|
|
|
$
|
0.14
|
|
Diluted
|
$
|
0.16
|
|
|
$
|
0.10
|
|
|
$
|
0.00
|
|
|
$
|
0.13
|
|
|
December 31,
2017 |
|
December 31,
2016 |
||||
Assets
|
|
|
|
||||
Cash and due from banks
|
$
|
295,271
|
|
|
$
|
238,008
|
|
Certificates of deposit with other banks
|
3,000
|
|
|
7,250
|
|
||
Investment securities available-for-sale
|
93,355
|
|
|
71,056
|
|
||
Loans held for sale
|
680,454
|
|
|
394,278
|
|
||
Loans and leases held for investment
|
1,343,973
|
|
|
907,566
|
|
||
Allowance for loan and lease losses
|
(24,190
|
)
|
|
(18,209
|
)
|
||
Net loans and leases
|
1,319,783
|
|
|
889,357
|
|
||
Premises and equipment, net
|
178,790
|
|
|
64,661
|
|
||
Foreclosed assets
|
1,281
|
|
|
1,648
|
|
||
Servicing assets
|
52,298
|
|
|
51,994
|
|
||
Other assets
|
134,242
|
|
|
37,009
|
|
||
Total assets
|
$
|
2,758,474
|
|
|
$
|
1,755,261
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
||||
Liabilities
|
|
|
|
||||
Deposits:
|
|
|
|
||||
Noninterest-bearing
|
$
|
57,868
|
|
|
$
|
27,990
|
|
Interest-bearing
|
2,202,395
|
|
|
1,457,086
|
|
||
Total deposits
|
2,260,263
|
|
|
1,485,076
|
|
||
Long term borrowings
|
26,564
|
|
|
27,843
|
|
||
Other liabilities
|
34,714
|
|
|
19,495
|
|
||
Total liabilities
|
2,321,541
|
|
|
1,532,414
|
|
||
Shareholders’ equity
|
|
|
|
||||
Preferred stock, no par value, 1,000,000 authorized, none issued or outstanding at December 31, 2017 and December 31, 2016
|
—
|
|
|
—
|
|
||
Class A common stock, no par value, 100,000,000 shares authorized, 35,252,053 and 29,530,072, shares issued and outstanding at December 31, 2017 and December 31, 2016, respectively
|
268,557
|
|
|
149,966
|
|
||
Class B common stock, no par value, 10,000,000 shares authorized, 4,723,530 shares issued, 4,643,530 and 4,723,530 shares outstanding at December 31, 2017 and December 31, 2016, respectively
|
49,168
|
|
|
50,015
|
|
||
Retained earnings
|
120,241
|
|
|
23,518
|
|
||
Accumulated other comprehensive loss
|
(1,033
|
)
|
|
(652
|
)
|
||
Total equity
|
436,933
|
|
|
222,847
|
|
||
Total liabilities and shareholders’ equity
|
$
|
2,758,474
|
|
|
$
|
1,755,261
|
|
|
Years Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Interest income
|
|
|
|
|
|
||||||
Loans and fees on loans
|
$
|
99,633
|
|
|
$
|
55,107
|
|
|
$
|
33,340
|
|
Investment securities, taxable
|
1,432
|
|
|
1,132
|
|
|
811
|
|
|||
Other interest earning assets
|
2,407
|
|
|
1,033
|
|
|
300
|
|
|||
Total interest income
|
103,472
|
|
|
57,272
|
|
|
34,451
|
|
|||
Interest expense
|
|
|
|
|
|
||||||
Deposits
|
24,223
|
|
|
13,659
|
|
|
7,379
|
|
|||
Borrowings
|
1,215
|
|
|
964
|
|
|
1,483
|
|
|||
Total interest expense
|
25,438
|
|
|
14,623
|
|
|
8,862
|
|
|||
Net interest income
|
78,034
|
|
|
42,649
|
|
|
25,589
|
|
|||
Provision for loan and lease losses
|
9,536
|
|
|
12,536
|
|
|
3,806
|
|
|||
Net interest income after provision for loan and lease losses
|
68,498
|
|
|
30,113
|
|
|
21,783
|
|
|||
Noninterest income
|
|
|
|
|
|
||||||
Loan servicing revenue
|
24,588
|
|
|
21,393
|
|
|
16,081
|
|
|||
Loan servicing asset revaluation
|
(13,171
|
)
|
|
(8,391
|
)
|
|
(6,229
|
)
|
|||
Net gains on sales of loans
|
78,590
|
|
|
75,326
|
|
|
67,385
|
|
|||
Equity in loss of non-consolidated affiliates
|
—
|
|
|
—
|
|
|
(26
|
)
|
|||
Gain on sale of investment in non-consolidated affiliate
|
—
|
|
|
—
|
|
|
3,782
|
|
|||
Gain on contribution to equity method investment
|
68,000
|
|
|
—
|
|
|
—
|
|
|||
Gain (loss) on sale of investment securities available-for-sale
|
—
|
|
|
1
|
|
|
13
|
|
|||
Construction supervision fee income
|
1,776
|
|
|
2,667
|
|
|
1,623
|
|
|||
Title insurance income
|
7,565
|
|
|
—
|
|
|
—
|
|
|||
Other noninterest income
|
5,573
|
|
|
2,543
|
|
|
1,699
|
|
|||
Total noninterest income
|
172,921
|
|
|
93,539
|
|
|
84,328
|
|
|||
Noninterest expense
|
|
|
|
|
|
||||||
Salaries and employee benefits
|
74,669
|
|
|
62,996
|
|
|
40,323
|
|
|||
Travel expense
|
8,124
|
|
|
8,205
|
|
|
7,379
|
|
|||
Professional services expense
|
4,937
|
|
|
3,482
|
|
|
2,643
|
|
|||
Advertising and marketing expense
|
6,363
|
|
|
4,534
|
|
|
4,333
|
|
|||
Occupancy expense
|
6,195
|
|
|
4,573
|
|
|
3,475
|
|
|||
Data processing expense
|
8,449
|
|
|
5,299
|
|
|
3,583
|
|
|||
Equipment expense
|
7,479
|
|
|
2,246
|
|
|
2,119
|
|
|||
Other loan origination and maintenance expense
|
4,970
|
|
|
2,825
|
|
|
2,069
|
|
|||
Renewable energy tax credit investment impairment
|
690
|
|
|
3,197
|
|
|
—
|
|
|||
FDIC insurance
|
3,206
|
|
|
1,417
|
|
|
514
|
|
|||
Title insurance closing services expense
|
2,418
|
|
|
—
|
|
|
—
|
|
|||
Impairment expense on goodwill and other intangibles
|
3,648
|
|
|
—
|
|
|
—
|
|
|||
Other expense
|
12,017
|
|
|
7,671
|
|
|
5,277
|
|
|||
Total noninterest expense
|
143,165
|
|
|
106,445
|
|
|
71,715
|
|
|||
Income before taxes
|
98,254
|
|
|
17,207
|
|
|
34,396
|
|
|||
Income tax (benefit) expense
|
(2,245
|
)
|
|
3,443
|
|
|
13,795
|
|
|||
Net income
|
100,499
|
|
|
13,764
|
|
|
20,601
|
|
|||
Net loss attributable to noncontrolling interest
|
—
|
|
|
9
|
|
|
24
|
|
|||
Net income attributable to Live Oak Bancshares, Inc.
|
$
|
100,499
|
|
|
$
|
13,773
|
|
|
$
|
20,625
|
|
Basic earnings per share
|
$
|
2.75
|
|
|
$
|
0.40
|
|
|
$
|
0.66
|
|
Diluted earnings per share
|
$
|
2.65
|
|
|
$
|
0.39
|
|
|
$
|
0.65
|
|
|
Years Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Net income
|
$
|
100,499
|
|
|
$
|
13,764
|
|
|
$
|
20,601
|
|
Other comprehensive loss before tax:
|
|
|
|
|
|
||||||
Net unrealized loss on investment securities arising during the period
|
(619
|
)
|
|
(746
|
)
|
|
(437
|
)
|
|||
Reclassification adjustment for gain on sale of securities available-for-sale included in net income
|
—
|
|
|
(1
|
)
|
|
(13
|
)
|
|||
Other comprehensive loss before tax
|
(619
|
)
|
|
(747
|
)
|
|
(450
|
)
|
|||
Income tax benefit
|
238
|
|
|
287
|
|
|
173
|
|
|||
Other comprehensive loss, net of tax
|
(381
|
)
|
|
(460
|
)
|
|
(277
|
)
|
|||
Total comprehensive income
|
$
|
100,118
|
|
|
$
|
13,304
|
|
|
$
|
20,324
|
|
|
Years Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Cash flows from operating activities
|
|
|
|
|
|
||||||
Net income
|
$
|
100,499
|
|
|
$
|
13,764
|
|
|
$
|
20,601
|
|
Adjustments to reconcile net income to net cash used by operating activities:
|
|
|
|
|
|
||||||
Depreciation and amortization
|
10,279
|
|
|
4,260
|
|
|
3,435
|
|
|||
Provision for loan and lease losses
|
9,536
|
|
|
12,536
|
|
|
3,806
|
|
|||
Amortization of premium on securities, net of accretion
|
460
|
|
|
242
|
|
|
66
|
|
|||
Amortization of discount on unguaranteed loans, net
|
2,848
|
|
|
2,854
|
|
|
3,146
|
|
|||
Impairment expense on goodwill and other intangibles
|
3,648
|
|
|
—
|
|
|
—
|
|
|||
Deferred tax expense (benefit)
|
12,017
|
|
|
(4,288
|
)
|
|
936
|
|
|||
Originations of loans held for sale
|
(1,149,617
|
)
|
|
(1,013,643
|
)
|
|
(1,034,769
|
)
|
|||
Proceeds from sales of loans held for sale
|
883,366
|
|
|
837,830
|
|
|
745,072
|
|
|||
Net gains on sale of loans held for sale
|
(78,590
|
)
|
|
(75,326
|
)
|
|
(67,385
|
)
|
|||
Net loss on sale of foreclosed assets
|
59
|
|
|
18
|
|
|
14
|
|
|||
Gain on contribution to equity method investment
|
(68,000
|
)
|
|
—
|
|
|
—
|
|
|||
Net increase in servicing assets
|
(304
|
)
|
|
(7,764
|
)
|
|
(9,231
|
)
|
|||
Gain on sale of securities available-for-sale
|
—
|
|
|
(1
|
)
|
|
(13
|
)
|
|||
Gain on sale of investment in non-consolidated affiliate
|
—
|
|
|
—
|
|
|
(3,782
|
)
|
|||
Net loss on disposal of premises and equipment
|
215
|
|
|
—
|
|
|
17
|
|
|||
Renewable energy tax credit investment impairment
|
690
|
|
|
3,197
|
|
|
—
|
|
|||
Stock option based compensation expense
|
1,786
|
|
|
2,349
|
|
|
1,277
|
|
|||
Restricted stock expense
|
5,717
|
|
|
9,724
|
|
|
148
|
|
|||
Equity in loss of non-consolidated affiliates
|
—
|
|
|
—
|
|
|
26
|
|
|||
Stock based compensation expense excess tax benefits
|
1,002
|
|
|
—
|
|
|
—
|
|
|||
Business combination contingent consideration fair value adjustment
|
1,950
|
|
|
—
|
|
|
—
|
|
|||
Changes in assets and liabilities:
|
|
|
|
|
|
||||||
Other assets
|
(25,247
|
)
|
|
(8,929
|
)
|
|
(4,201
|
)
|
|||
Other liabilities
|
157
|
|
|
1,227
|
|
|
6,154
|
|
|||
Net cash used by operating activities
|
(287,529
|
)
|
|
(221,950
|
)
|
|
(334,683
|
)
|
|||
Cash flows from investing activities
|
|
|
|
|
|
||||||
Purchases of securities available-for-sale
|
(43,071
|
)
|
|
(37,421
|
)
|
|
(24,927
|
)
|
|||
Proceeds from sales, maturities, calls, and principal paydown of securities available-for-sale
|
19,693
|
|
|
19,139
|
|
|
19,980
|
|
|||
Proceeds from sale/collection of foreclosed assets
|
1,498
|
|
|
1,221
|
|
|
513
|
|
|||
Business combination, net of cash acquired
|
(7,696
|
)
|
|
—
|
|
|
—
|
|
|||
Investment in certificates of deposit with other banks
|
—
|
|
|
(250
|
)
|
|
(250
|
)
|
|||
Maturities of certificates of deposit with other banks
|
4,250
|
|
|
3,250
|
|
|
—
|
|
|||
Proceeds from sale of investment in non-consolidated affiliate
|
—
|
|
|
—
|
|
|
9,896
|
|
|||
Net cash acquired in consolidation of equity method investment
|
—
|
|
|
—
|
|
|
319
|
|
|||
Capital contribution from non-controlling interest
|
—
|
|
|
—
|
|
|
22
|
|
|||
Loan and lease originations and principal collections, net
|
(385,551
|
)
|
|
(295,119
|
)
|
|
84,475
|
|
|||
Purchases of premises and equipment, net
|
(124,139
|
)
|
|
(10,889
|
)
|
|
(30,452
|
)
|
|||
Net cash (used) provided by investing activities
|
(535,016
|
)
|
|
(320,069
|
)
|
|
59,576
|
|
|
Years Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Cash flows from financing activities
|
|
|
|
|
|
||||||
Net increase in deposits
|
$
|
775,187
|
|
|
$
|
680,288
|
|
|
$
|
282,708
|
|
Proceeds from long term borrowings
|
16,900
|
|
|
—
|
|
|
12,960
|
|
|||
Repayment of long term borrowings
|
(26,279
|
)
|
|
(532
|
)
|
|
(26,434
|
)
|
|||
Proceeds from short term borrowings
|
23,100
|
|
|
—
|
|
|
—
|
|
|||
Repayment of short term borrowings
|
(15,000
|
)
|
|
—
|
|
|
(6,100
|
)
|
|||
Stock option exercises
|
1,026
|
|
|
401
|
|
|
239
|
|
|||
Employee stock purchase program
|
445
|
|
|
—
|
|
|
—
|
|
|||
Withholding cash issued in lieu of restricted stock
|
(4,891
|
)
|
|
—
|
|
|
—
|
|
|||
Sale of common stock, net of issuance costs
|
113,096
|
|
|
—
|
|
|
87,171
|
|
|||
Shareholder dividend distributions
|
(3,776
|
)
|
|
(2,737
|
)
|
|
(2,732
|
)
|
|||
Net cash provided by financing activities
|
879,808
|
|
|
677,420
|
|
|
347,812
|
|
|||
Net increase in cash and cash equivalents
|
57,263
|
|
|
135,401
|
|
|
72,705
|
|
|||
Cash and cash equivalents, beginning
|
238,008
|
|
|
102,607
|
|
|
29,902
|
|
|||
Cash and cash equivalents, ending
|
$
|
295,271
|
|
|
$
|
238,008
|
|
|
$
|
102,607
|
|
|
|
|
|
|
|
||||||
Supplemental disclosure of cash flow information
|
|
|
|
|
|
||||||
Interest paid
|
$
|
25,390
|
|
|
$
|
14,516
|
|
|
$
|
8,840
|
|
Income tax
|
7,084
|
|
|
8,238
|
|
|
12,326
|
|
|||
|
|
|
|
|
|
||||||
Supplemental disclosures of noncash operating, investing, and financing activities
|
|
|
|
|
|
||||||
Unrealized holding losses on available-for-sale securities, net of taxes
|
$
|
(381
|
)
|
|
$
|
(460
|
)
|
|
$
|
(277
|
)
|
Transfers from loans to foreclosed real estate and other repossessions
|
1,406
|
|
|
406
|
|
|
2,616
|
|
|||
Transfers from foreclosed real estate to SBA receivable
|
216
|
|
|
185
|
|
|
507
|
|
|||
Transfers of loans accounted for as secured borrowing collateral to other assets
|
—
|
|
|
—
|
|
|
4,575
|
|
|||
Transfer from fixed assets to other assets held for sale
|
—
|
|
|
4,621
|
|
|
—
|
|
|||
Dividends declared but not paid
|
—
|
|
|
—
|
|
|
342
|
|
|||
Transfer of loans held for sale to loans held for investment
|
63,643
|
|
|
339,567
|
|
|
9,033
|
|
|||
Transfer of loans held for investment to loans held for sale
|
19,534
|
|
|
2,296
|
|
|
3,243
|
|
|||
Contingent consideration in acquisition of controlling interest in equity method investment
|
—
|
|
|
24
|
|
|
170
|
|
|||
Transfers from short term borrowings to long term borrowings
|
8,100
|
|
|
—
|
|
|
—
|
|
|||
Business combination:
|
|
|
|
|
|
||||||
Assets acquired (excluding goodwill)
|
5,766
|
|
|
—
|
|
|
—
|
|
|||
Liabilities assumed
|
4,681
|
|
|
—
|
|
|
—
|
|
|||
Purchase price
|
8,363
|
|
|
—
|
|
|
—
|
|
|||
Goodwill recorded
|
7,278
|
|
|
—
|
|
|
—
|
|
|
|
2017
|
|
2016
|
||||
Investment carrying amount
|
|
$
|
705
|
|
|
$
|
1,394
|
|
Unfunded capital
|
|
—
|
|
|
690
|
|
||
Maximum exposure to loss
|
|
4,221
|
|
|
5,100
|
|
|
2017
|
|
2016
|
||||
Balance at beginning of year
|
$
|
394,278
|
|
|
$
|
480,619
|
|
Originations
|
1,149,617
|
|
|
1,013,643
|
|
||
Proceeds from sale
|
(883,366
|
)
|
|
(837,830
|
)
|
||
Gain on sale of loans
|
78,590
|
|
|
75,326
|
|
||
Principal collections, net of deferred fees and costs
|
(14,556
|
)
|
|
(209
|
)
|
||
Non-cash transfers, net
|
(44,109
|
)
|
|
(337,271
|
)
|
||
Balance at end of period
|
$
|
680,454
|
|
|
$
|
394,278
|
|
As of December 31, 2017
|
|
Amount
|
||
2018
|
|
$
|
5,162
|
|
2019
|
|
5,408
|
|
|
2020
|
|
5,428
|
|
|
2021
|
|
5,455
|
|
|
2022
|
|
5,458
|
|
|
Thereafter
|
|
34,046
|
|
|
Total
|
|
$
|
60,957
|
|
Intangible assets
|
$
|
720
|
|
Goodwill
|
7,278
|
|
|
Contingent consideration liability
|
(4,350
|
)
|
|
Total impairment expense on goodwill and other intangibles
|
$
|
3,648
|
|
|
|
Year Ended
|
||
|
|
December 31, 2017
|
||
Decrease in:
|
|
|
||
Net income
|
|
$
|
894
|
|
Basic EPS
|
|
$
|
0.02
|
|
Diluted EPS
|
|
$
|
0.02
|
|
|
December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
||||||
Basic earnings per share:
|
|
|
|
|
|
||||||
Net income available to common shareholders
|
$
|
100,499
|
|
|
$
|
13,773
|
|
|
$
|
20,625
|
|
Weighted-average basic shares outstanding
|
36,592,893
|
|
|
34,202,168
|
|
|
31,079,032
|
|
|||
Basic earnings per share
|
$
|
2.75
|
|
|
$
|
0.40
|
|
|
$
|
0.66
|
|
Diluted earnings per share:
|
|
|
|
|
|
||||||
Net income available to common shareholders, for diluted earnings per share
|
$
|
100,499
|
|
|
$
|
13,773
|
|
|
$
|
20,625
|
|
Total weighted-average basic shares outstanding
|
36,592,893
|
|
|
34,202,168
|
|
|
31,079,032
|
|
|||
Add effect of dilutive stock options and restricted stock grants
|
1,266,642
|
|
|
884,791
|
|
|
894,114
|
|
|||
Total weighted-average diluted shares outstanding
|
37,859,535
|
|
|
35,086,959
|
|
|
31,973,146
|
|
|||
Diluted earnings per share
|
$
|
2.65
|
|
|
$
|
0.39
|
|
|
$
|
0.65
|
|
Anti-dilutive shares
|
253,338
|
|
|
1,777,035
|
|
|
1,811,776
|
|
Fair value of assets acquired
|
|
||
Cash
|
$
|
102
|
|
Accounts receivable
|
159
|
|
|
Intangible assets
|
5,505
|
|
|
Total assets acquired
|
5,766
|
|
|
Fair value of liabilities assumed
|
|
||
Contingent consideration
|
4,300
|
|
|
Accounts payable and other liabilities
|
381
|
|
|
Total liabilities assumed
|
4,681
|
|
|
Net assets acquired
|
$
|
1,085
|
|
Purchase price
|
|
||
Common shares issued
|
27,724
|
|
|
Purchase price per share of the Company’s common stock
|
$
|
20.38
|
|
Company common stock issued
|
565
|
|
|
Cash
|
$
|
7,798
|
|
Total purchase price
|
8,363
|
|
|
Goodwill
|
$
|
7,278
|
|
Balance, December 31, 2016
|
$
|
—
|
|
Goodwill acquired during 2017
|
7,278
|
|
|
Accumulated impairment losses
|
(7,278
|
)
|
|
Balance, December 31, 2017
|
$
|
—
|
|
Balance, December 31, 2016
|
$
|
—
|
|
Contingent consideration recorded upon acquisition
|
4,300
|
|
|
Fair value adjustments prior to October 31, 2017 impairment assessment
|
350
|
|
|
Impact of impairment assessment
|
(4,350
|
)
|
|
Effect of purchase contract modification
|
1,600
|
|
|
Balance, December 31, 2017
|
$
|
1,900
|
|
|
2017
|
|
2016
|
|
2015
|
||||||
Revenue (net interest income and noninterest income)
|
$
|
251,723
|
|
|
$
|
148,322
|
|
|
$
|
116,582
|
|
Net income available to common shareholders
|
100,537
|
|
|
15,363
|
|
|
21,451
|
|
|||
Basic earnings per share
|
2.75
|
|
|
0.45
|
|
|
0.69
|
|
|||
Diluted earnings per share
|
2.66
|
|
|
0.44
|
|
|
0.67
|
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair
Value
|
||||||||
December 31, 2017
|
|
|
|
|
|
|
|
||||||||
US government agencies
|
$
|
22,778
|
|
|
$
|
3
|
|
|
$
|
157
|
|
|
$
|
22,624
|
|
Residential mortgage-backed securities
|
70,167
|
|
|
1
|
|
|
1,472
|
|
|
68,696
|
|
||||
Mutual fund
|
2,090
|
|
|
—
|
|
|
55
|
|
|
2,035
|
|
||||
Total
|
$
|
95,035
|
|
|
$
|
4
|
|
|
$
|
1,684
|
|
|
$
|
93,355
|
|
|
|
|
|
|
|
|
|
||||||||
December 31, 2016
|
|
|
|
|
|
|
|
||||||||
US government agencies
|
$
|
17,803
|
|
|
$
|
52
|
|
|
$
|
32
|
|
|
$
|
17,823
|
|
Residential mortgage-backed securities
|
52,301
|
|
|
3
|
|
|
1,031
|
|
|
51,273
|
|
||||
Mutual fund
|
2,012
|
|
|
—
|
|
|
52
|
|
|
1,960
|
|
||||
Total
|
$
|
72,116
|
|
|
$
|
55
|
|
|
$
|
1,115
|
|
|
$
|
71,056
|
|
|
Less Than 12 Months
|
|
12 Months or More
|
|
Total
|
||||||||||||||||||
December 31, 2017
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
||||||||||||
US government agencies
|
$
|
14,842
|
|
|
$
|
100
|
|
|
$
|
6,465
|
|
|
$
|
57
|
|
|
$
|
21,307
|
|
|
$
|
157
|
|
Residential mortgage-backed securities
|
23,481
|
|
|
439
|
|
|
40,648
|
|
|
1,033
|
|
|
64,129
|
|
|
1,472
|
|
||||||
Mutual fund
|
—
|
|
|
—
|
|
|
2,035
|
|
|
55
|
|
|
2,035
|
|
|
55
|
|
||||||
Total
|
$
|
38,323
|
|
|
$
|
539
|
|
|
$
|
49,148
|
|
|
$
|
1,145
|
|
|
$
|
87,471
|
|
|
$
|
1,684
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Less Than 12 Months
|
|
12 Months or More
|
|
Total
|
||||||||||||||||||
December 31, 2016
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
||||||||||||
US government agencies
|
$
|
6,508
|
|
|
$
|
32
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6,508
|
|
|
$
|
32
|
|
Residential mortgage-backed securities
|
49,109
|
|
|
1,017
|
|
|
1,635
|
|
|
14
|
|
|
50,744
|
|
|
1,031
|
|
||||||
Mutual fund
|
1,960
|
|
|
52
|
|
|
—
|
|
|
—
|
|
|
1,960
|
|
|
52
|
|
||||||
Total
|
$
|
57,577
|
|
|
$
|
1,101
|
|
|
$
|
1,635
|
|
|
$
|
14
|
|
|
$
|
59,212
|
|
|
$
|
1,115
|
|
|
Available-for-sale
|
||||||
|
Amortized
cost
|
|
Fair
value
|
||||
US government agencies
|
|
|
|
||||
Within one year
|
$
|
6,323
|
|
|
$
|
6,295
|
|
One to five years
|
16,455
|
|
|
16,329
|
|
||
Total
|
22,778
|
|
|
22,624
|
|
||
|
|
|
|
||||
Residential mortgage-backed securities
|
|
|
|
||||
Five to ten years
|
6,815
|
|
|
6,701
|
|
||
After 10 years
|
63,352
|
|
|
61,995
|
|
||
Total
|
70,167
|
|
|
68,696
|
|
||
|
|
|
|
||||
Total
|
$
|
92,945
|
|
|
$
|
91,320
|
|
|
December 31,
2017 |
|
December 31,
2016 |
||||
Commercial & Industrial
|
|
|
|
||||
Agriculture
|
$
|
3,274
|
|
|
$
|
1,714
|
|
Death Care Management
|
13,495
|
|
|
9,684
|
|
||
Healthcare
|
43,301
|
|
|
37,270
|
|
||
Independent Pharmacies
|
99,920
|
|
|
83,677
|
|
||
Registered Investment Advisors
|
93,770
|
|
|
68,335
|
|
||
Veterinary Industry
|
46,387
|
|
|
38,930
|
|
||
Other Industries
|
184,903
|
|
|
94,836
|
|
||
Total
|
485,050
|
|
|
334,446
|
|
||
Construction & Development
|
|
|
|
||||
Agriculture
|
34,188
|
|
|
32,372
|
|
||
Death Care Management
|
6,119
|
|
|
3,956
|
|
||
Healthcare
|
49,770
|
|
|
30,467
|
|
||
Independent Pharmacies
|
1,496
|
|
|
2,013
|
|
||
Registered Investment Advisors
|
376
|
|
|
294
|
|
||
Veterinary Industry
|
13,184
|
|
|
11,514
|
|
||
Other Industries
|
58,120
|
|
|
31,715
|
|
||
Total
|
163,253
|
|
|
112,331
|
|
||
Commercial Real Estate
|
|
|
|
||||
Agriculture
|
46,717
|
|
|
5,591
|
|
||
Death Care Management
|
67,381
|
|
|
52,510
|
|
||
Healthcare
|
126,631
|
|
|
114,281
|
|
||
Independent Pharmacies
|
19,028
|
|
|
15,151
|
|
||
Registered Investment Advisors
|
11,789
|
|
|
11,462
|
|
||
Veterinary Industry
|
113,932
|
|
|
102,906
|
|
||
Other Industries
|
134,172
|
|
|
46,245
|
|
||
Total
|
519,650
|
|
|
348,146
|
|
||
Commercial Land
|
|
|
|
||||
Agriculture
|
178,897
|
|
|
113,569
|
|
||
Total
|
178,897
|
|
|
113,569
|
|
||
Total Loans and Leases
1
|
1,346,850
|
|
|
908,492
|
|
||
Net Deferred Costs
|
8,545
|
|
|
7,648
|
|
||
Discount on SBA 7(a) and USDA Unguaranteed
2
|
(11,422
|
)
|
|
(8,574
|
)
|
||
Loans and Leases, Net of Unearned
|
$
|
1,343,973
|
|
|
$
|
907,566
|
|
1
|
Total loans and leases include $
99.7 million
and $
37.7 million
of U.S. government guaranteed loans as of
December 31, 2017
and
December 31, 2016
, respectively.
|
2
|
The Company measures the carrying value of the retained portion of loans sold at fair value under ASC Subtopic 825-10. The value of these retained loan balances is discounted based on the estimates derived from comparable unguaranteed loan sales.
|
|
Risk Grades
1 - 4
|
|
Risk Grade
5
|
|
Risk Grades
6 - 8
|
|
Total
|
||||||||
December 31, 2017
|
|
|
|
|
|
|
|
||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
$
|
3,052
|
|
|
$
|
222
|
|
|
$
|
—
|
|
|
$
|
3,274
|
|
Death Care Management
|
13,371
|
|
|
117
|
|
|
7
|
|
|
13,495
|
|
||||
Healthcare
|
36,530
|
|
|
2,246
|
|
|
4,525
|
|
|
43,301
|
|
||||
Independent Pharmacies
|
86,152
|
|
|
5,541
|
|
|
8,227
|
|
|
99,920
|
|
||||
Registered Investment Advisors
|
90,911
|
|
|
2,134
|
|
|
725
|
|
|
93,770
|
|
||||
Veterinary Industry
|
42,313
|
|
|
1,704
|
|
|
2,370
|
|
|
46,387
|
|
||||
Other Industries
|
184,540
|
|
|
363
|
|
|
—
|
|
|
184,903
|
|
||||
Total
|
456,869
|
|
|
12,327
|
|
|
15,854
|
|
|
485,050
|
|
||||
Construction & Development
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
31,738
|
|
|
2,450
|
|
|
—
|
|
|
34,188
|
|
||||
Death Care Management
|
6,119
|
|
|
—
|
|
|
—
|
|
|
6,119
|
|
||||
Healthcare
|
47,813
|
|
|
699
|
|
|
1,258
|
|
|
49,770
|
|
||||
Independent Pharmacies
|
1,496
|
|
|
—
|
|
|
—
|
|
|
1,496
|
|
||||
Registered Investment Advisors
|
376
|
|
|
—
|
|
|
—
|
|
|
376
|
|
||||
Veterinary Industry
|
13,184
|
|
|
—
|
|
|
—
|
|
|
13,184
|
|
||||
Other Industries
|
58,120
|
|
|
—
|
|
|
—
|
|
|
58,120
|
|
||||
Total
|
158,846
|
|
|
3,149
|
|
|
1,258
|
|
|
163,253
|
|
||||
Commercial Real Estate
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
46,717
|
|
|
—
|
|
|
—
|
|
|
46,717
|
|
||||
Death Care Management
|
60,671
|
|
|
3,881
|
|
|
2,829
|
|
|
67,381
|
|
||||
Healthcare
|
112,321
|
|
|
9,992
|
|
|
4,318
|
|
|
126,631
|
|
||||
Independent Pharmacies
|
15,641
|
|
|
1,825
|
|
|
1,562
|
|
|
19,028
|
|
||||
Registered Investment Advisors
|
11,649
|
|
|
140
|
|
|
—
|
|
|
11,789
|
|
||||
Veterinary Industry
|
97,065
|
|
|
2,948
|
|
|
13,919
|
|
|
113,932
|
|
||||
Other Industries
|
133,493
|
|
|
679
|
|
|
—
|
|
|
134,172
|
|
||||
Total
|
477,557
|
|
|
19,465
|
|
|
22,628
|
|
|
519,650
|
|
||||
Commercial Land
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
176,811
|
|
|
2,086
|
|
|
—
|
|
|
178,897
|
|
||||
Total
|
176,811
|
|
|
2,086
|
|
|
—
|
|
|
178,897
|
|
||||
Total
1
|
$
|
1,270,083
|
|
|
$
|
37,027
|
|
|
$
|
39,740
|
|
|
$
|
1,346,850
|
|
|
Risk Grades
1 - 4
|
|
Risk Grade
5
|
|
Risk Grades
6 - 8
|
|
Total
|
||||||||
December 31, 2016
|
|
|
|
|
|
|
|
||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
$
|
1,656
|
|
|
$
|
58
|
|
|
$
|
—
|
|
|
$
|
1,714
|
|
Death Care Management
|
9,452
|
|
|
121
|
|
|
111
|
|
|
9,684
|
|
||||
Healthcare
|
28,723
|
|
|
681
|
|
|
7,866
|
|
|
37,270
|
|
||||
Independent Pharmacies
|
73,948
|
|
|
6,542
|
|
|
3,187
|
|
|
83,677
|
|
||||
Registered Investment Advisors
|
65,297
|
|
|
2,246
|
|
|
792
|
|
|
68,335
|
|
||||
Veterinary Industry
|
34,407
|
|
|
1,967
|
|
|
2,556
|
|
|
38,930
|
|
||||
Other Industries
|
94,736
|
|
|
100
|
|
|
—
|
|
|
94,836
|
|
||||
Total
|
308,219
|
|
|
11,715
|
|
|
14,512
|
|
|
334,446
|
|
||||
Construction & Development
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
32,061
|
|
|
—
|
|
|
311
|
|
|
32,372
|
|
||||
Death Care Management
|
3,956
|
|
|
—
|
|
|
—
|
|
|
3,956
|
|
||||
Healthcare
|
30,467
|
|
|
—
|
|
|
—
|
|
|
30,467
|
|
||||
Independent Pharmacies
|
2,013
|
|
|
—
|
|
|
—
|
|
|
2,013
|
|
||||
Registered Investment Advisors
|
294
|
|
|
—
|
|
|
—
|
|
|
294
|
|
||||
Veterinary Industry
|
9,725
|
|
|
1,789
|
|
|
—
|
|
|
11,514
|
|
||||
Other Industries
|
31,715
|
|
|
—
|
|
|
—
|
|
|
31,715
|
|
||||
Total
|
110,231
|
|
|
1,789
|
|
|
311
|
|
|
112,331
|
|
||||
Commercial Real Estate
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
5,591
|
|
|
—
|
|
|
—
|
|
|
5,591
|
|
||||
Death Care Management
|
46,427
|
|
|
4,314
|
|
|
1,769
|
|
|
52,510
|
|
||||
Healthcare
|
103,097
|
|
|
7,142
|
|
|
4,042
|
|
|
114,281
|
|
||||
Independent Pharmacies
|
12,654
|
|
|
1,968
|
|
|
529
|
|
|
15,151
|
|
||||
Registered Investment Advisors
|
11,462
|
|
|
—
|
|
|
—
|
|
|
11,462
|
|
||||
Veterinary Industry
|
88,168
|
|
|
3,995
|
|
|
10,743
|
|
|
102,906
|
|
||||
Other Industries
|
46,245
|
|
|
—
|
|
|
—
|
|
|
46,245
|
|
||||
Total
|
313,644
|
|
|
17,419
|
|
|
17,083
|
|
|
348,146
|
|
||||
Commercial Land
|
|
|
|
|
|
|
|
||||||||
Agriculture
|
112,333
|
|
|
1,138
|
|
|
98
|
|
|
113,569
|
|
||||
Total
|
112,333
|
|
|
1,138
|
|
|
98
|
|
|
113,569
|
|
||||
Total
1
|
$
|
844,427
|
|
|
$
|
32,061
|
|
|
$
|
32,004
|
|
|
$
|
908,492
|
|
1
|
Total loans and leases include $
99.7 million
of U.S. government guaranteed loans as of
December 31, 2017
, segregated by risk grade as follows: Risk Grades 1 – 4 = $
65.0 million
, Risk Grade 5 = $
6.7 million
, Risk Grades 6 – 8 = $
28.0 million
. As of
December 31, 2016
total loans and leases include $
37.7 million
of U.S. government guaranteed loans, segregated by risk grade as follows: Risk Grades 1 – 4 = $
8.7 million
, Risk Grade 5 = $
7.7 million
, Risk Grades 6 – 8 = $
21.3 million
.
|
|
Less Than
30 Days Past Due & Not Accruing
|
|
30-89 Days
Past Due
& Accruing
|
|
30-89 Days
Past Due &
Not
Accruing
|
|
Greater
Than 90
Days Past
Due
|
|
Total Not
Accruing
& Past Due
|
|
Current
|
|
Total Loans and Leases
|
|
90
Days or More
Past Due &
Still Accruing
|
||||||||||||||||
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Agriculture
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,274
|
|
|
$
|
3,274
|
|
|
$
|
—
|
|
Death Care Management
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,495
|
|
|
13,495
|
|
|
—
|
|
||||||||
Healthcare
|
788
|
|
|
131
|
|
|
14
|
|
|
3,004
|
|
|
3,937
|
|
|
39,364
|
|
|
43,301
|
|
|
—
|
|
||||||||
Independent Pharmacies
|
236
|
|
|
2,930
|
|
|
1,349
|
|
|
3,376
|
|
|
7,891
|
|
|
92,029
|
|
|
99,920
|
|
|
—
|
|
||||||||
Registered Investment Advisors
|
—
|
|
|
321
|
|
|
—
|
|
|
—
|
|
|
321
|
|
|
93,449
|
|
|
93,770
|
|
|
—
|
|
||||||||
Veterinary Industry
|
212
|
|
|
594
|
|
|
508
|
|
|
797
|
|
|
2,111
|
|
|
44,276
|
|
|
46,387
|
|
|
—
|
|
||||||||
Other Industries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
184,903
|
|
|
184,903
|
|
|
—
|
|
||||||||
Total
|
1,236
|
|
|
3,976
|
|
|
1,871
|
|
|
7,177
|
|
|
14,260
|
|
|
470,790
|
|
|
485,050
|
|
|
—
|
|
||||||||
Construction & Development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Agriculture
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
34,188
|
|
|
34,188
|
|
|
—
|
|
||||||||
Death Care Management
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,119
|
|
|
6,119
|
|
|
—
|
|
||||||||
Healthcare
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
49,770
|
|
|
49,770
|
|
|
—
|
|
||||||||
Independent Pharmacies
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,496
|
|
|
1,496
|
|
|
—
|
|
||||||||
Registered Investment Advisors
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
376
|
|
|
376
|
|
|
—
|
|
||||||||
Veterinary Industry
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,184
|
|
|
13,184
|
|
|
—
|
|
||||||||
Other Industries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
58,120
|
|
|
58,120
|
|
|
—
|
|
||||||||
Total
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
163,253
|
|
|
163,253
|
|
|
—
|
|
||||||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Agriculture
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
46,717
|
|
|
46,717
|
|
|
—
|
|
||||||||
Death Care Management
|
—
|
|
|
—
|
|
|
168
|
|
|
1,391
|
|
|
1,559
|
|
|
65,822
|
|
|
67,381
|
|
|
—
|
|
||||||||
Healthcare
|
40
|
|
|
54
|
|
|
1,916
|
|
|
1,550
|
|
|
3,560
|
|
|
123,071
|
|
|
126,631
|
|
|
—
|
|
||||||||
Independent Pharmacies
|
—
|
|
|
—
|
|
|
—
|
|
|
1,562
|
|
|
1,562
|
|
|
17,466
|
|
|
19,028
|
|
|
—
|
|
||||||||
Registered Investment Advisors
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,789
|
|
|
11,789
|
|
|
—
|
|
||||||||
Veterinary Industry
|
1,804
|
|
|
3,226
|
|
|
—
|
|
|
4,765
|
|
|
9,795
|
|
|
104,137
|
|
|
113,932
|
|
|
—
|
|
||||||||
Other Industries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
134,172
|
|
|
134,172
|
|
|
—
|
|
||||||||
Total
|
1,844
|
|
|
3,280
|
|
|
2,084
|
|
|
9,268
|
|
|
16,476
|
|
|
503,174
|
|
|
519,650
|
|
|
—
|
|
||||||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Agriculture
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
178,897
|
|
|
178,897
|
|
|
—
|
|
||||||||
Total
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
178,897
|
|
|
178,897
|
|
|
—
|
|
||||||||
Total
1
|
$
|
3,080
|
|
|
$
|
7,256
|
|
|
$
|
3,955
|
|
|
$
|
16,445
|
|
|
$
|
30,736
|
|
|
$
|
1,316,114
|
|
|
$
|
1,346,850
|
|
|
$
|
—
|
|
|
Less Than 30
Days Past
Due & Not
Accruing
|
|
30-89 Days
Past Due
& Accruing
|
|
30-89 Days
Past Due &
Not Accruing
|
|
Greater
Than 90
Days
Past Due
|
|
Total Not
Accruing
& Past Due
|
|
Current
|
|
Total Loans and Leases
|
|
90
Days or More
Past Due &
Still Accruing
|
||||||||||||||||
December 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Agriculture
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,714
|
|
|
$
|
1,714
|
|
|
$
|
—
|
|
Death Care Management
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,684
|
|
|
9,684
|
|
|
—
|
|
||||||||
Healthcare
|
—
|
|
|
272
|
|
|
496
|
|
|
5,920
|
|
|
6,688
|
|
|
30,582
|
|
|
37,270
|
|
|
—
|
|
||||||||
Independent Pharmacies
|
42
|
|
|
293
|
|
|
408
|
|
|
2,349
|
|
|
3,092
|
|
|
80,585
|
|
|
83,677
|
|
|
—
|
|
||||||||
Registered Investment Advisors
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
68,335
|
|
|
68,335
|
|
|
—
|
|
||||||||
Veterinary Industry
|
32
|
|
|
151
|
|
|
646
|
|
|
1,441
|
|
|
2,270
|
|
|
36,660
|
|
|
38,930
|
|
|
—
|
|
||||||||
Other Industries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
94,836
|
|
|
94,836
|
|
|
—
|
|
||||||||
Total
|
74
|
|
|
716
|
|
|
1,550
|
|
|
9,710
|
|
|
12,050
|
|
|
322,396
|
|
|
334,446
|
|
|
—
|
|
||||||||
Construction & Development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Agriculture
|
231
|
|
|
80
|
|
|
—
|
|
|
—
|
|
|
311
|
|
|
32,061
|
|
|
32,372
|
|
|
—
|
|
||||||||
Death Care Management
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,956
|
|
|
3,956
|
|
|
—
|
|
||||||||
Healthcare
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
30,467
|
|
|
30,467
|
|
|
—
|
|
||||||||
Independent Pharmacies
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,013
|
|
|
2,013
|
|
|
—
|
|
||||||||
Registered Investment Advisors
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
294
|
|
|
294
|
|
|
—
|
|
||||||||
Veterinary Industry
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,514
|
|
|
11,514
|
|
|
—
|
|
||||||||
Other Industries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
31,715
|
|
|
31,715
|
|
|
—
|
|
||||||||
Total
|
231
|
|
|
80
|
|
|
—
|
|
|
—
|
|
|
311
|
|
|
112,020
|
|
|
112,331
|
|
|
—
|
|
||||||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Agriculture
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,591
|
|
|
5,591
|
|
|
—
|
|
||||||||
Death Care Management
|
—
|
|
|
—
|
|
|
188
|
|
|
1,423
|
|
|
1,611
|
|
|
50,899
|
|
|
52,510
|
|
|
—
|
|
||||||||
Healthcare
|
—
|
|
|
—
|
|
|
3,180
|
|
|
45
|
|
|
3,225
|
|
|
111,056
|
|
|
114,281
|
|
|
—
|
|
||||||||
Independent Pharmacies
|
—
|
|
|
—
|
|
|
—
|
|
|
529
|
|
|
529
|
|
|
14,622
|
|
|
15,151
|
|
|
—
|
|
||||||||
Registered Investment Advisors
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,462
|
|
|
11,462
|
|
|
—
|
|
||||||||
Veterinary Industry
|
898
|
|
|
3,981
|
|
|
737
|
|
|
5,158
|
|
|
10,774
|
|
|
92,132
|
|
|
102,906
|
|
|
—
|
|
||||||||
Other Industries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
46,245
|
|
|
46,245
|
|
|
—
|
|
||||||||
Total
|
898
|
|
|
3,981
|
|
|
4,105
|
|
|
7,155
|
|
|
16,139
|
|
|
332,007
|
|
|
348,146
|
|
|
—
|
|
||||||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Agriculture
|
58
|
|
|
40
|
|
|
—
|
|
|
—
|
|
|
98
|
|
|
113,471
|
|
|
113,569
|
|
|
—
|
|
||||||||
Total
|
58
|
|
|
40
|
|
|
—
|
|
|
—
|
|
|
98
|
|
|
113,471
|
|
|
113,569
|
|
|
—
|
|
||||||||
Total
1
|
$
|
1,261
|
|
|
$
|
4,817
|
|
|
$
|
5,655
|
|
|
$
|
16,865
|
|
|
$
|
28,598
|
|
|
$
|
879,894
|
|
|
$
|
908,492
|
|
|
$
|
—
|
|
1
|
Total loans and leases include $
99.7 million
of U.S. government guaranteed loans as of
December 31, 2017
, of which $
15.0 million
is greater than 90 days past due, $
7.4 million
is 30-89 days past due and $
77.3 million
is included in current loans and leases as presented above. As of
December 31, 2016
, total loans and leases include $
37.7 million
of U.S. government guaranteed loans, of which $
13.7 million
is greater than 90 days past due, $
6.8 million
is 30-89 days past due and $
17.2 million
is included in current loans and leases as presented above.
|
December 31, 2017
|
Loan and Lease
Balance
|
|
Guaranteed
Balance
|
|
Unguaranteed
Exposure
|
||||||
Commercial & Industrial
|
|
|
|
|
|
||||||
Healthcare
|
$
|
3,806
|
|
|
$
|
3,235
|
|
|
$
|
571
|
|
Independent Pharmacies
|
4,961
|
|
|
3,906
|
|
|
1,055
|
|
|||
Veterinary Industry
|
1,517
|
|
|
1,478
|
|
|
39
|
|
|||
Total
|
10,284
|
|
|
8,619
|
|
|
1,665
|
|
|||
Commercial Real Estate
|
|
|
|
|
|
||||||
Death Care Management
|
1,559
|
|
|
1,237
|
|
|
322
|
|
|||
Healthcare
|
3,506
|
|
|
2,719
|
|
|
787
|
|
|||
Independent Pharmacies
|
1,562
|
|
|
1,562
|
|
|
—
|
|
|||
Veterinary Industry
|
6,569
|
|
|
5,733
|
|
|
836
|
|
|||
Total
|
13,196
|
|
|
11,251
|
|
|
1,945
|
|
|||
Total
|
$
|
23,480
|
|
|
$
|
19,870
|
|
|
$
|
3,610
|
|
December 31, 2016
|
Loan and Lease
Balance |
|
Guaranteed
Balance |
|
Unguaranteed
Exposure |
||||||
Commercial & Industrial
|
|
|
|
|
|
||||||
Healthcare
|
$
|
6,416
|
|
|
$
|
5,152
|
|
|
$
|
1,264
|
|
Independent Pharmacies
|
2,799
|
|
|
2,204
|
|
|
595
|
|
|||
Veterinary Industry
|
2,119
|
|
|
2,079
|
|
|
40
|
|
|||
Total
|
11,334
|
|
|
9,435
|
|
|
1,899
|
|
|||
Construction & Development
|
|
|
|
|
|
||||||
Agriculture
|
231
|
|
|
173
|
|
|
58
|
|
|||
Total
|
231
|
|
|
173
|
|
|
58
|
|
|||
Commercial Real Estate
|
|
|
|
|
|
||||||
Death Care Management
|
1,611
|
|
|
1,263
|
|
|
348
|
|
|||
Healthcare
|
3,225
|
|
|
2,731
|
|
|
494
|
|
|||
Independent Pharmacies
|
529
|
|
|
—
|
|
|
529
|
|
|||
Veterinary Industry
|
6,793
|
|
|
5,395
|
|
|
1,398
|
|
|||
Total
|
12,158
|
|
|
9,389
|
|
|
2,769
|
|
|||
Commercial Land
|
|
|
|
|
|
||||||
Agriculture
|
58
|
|
|
—
|
|
|
58
|
|
|||
Total
|
58
|
|
|
—
|
|
|
58
|
|
|||
Total
|
$
|
23,781
|
|
|
$
|
18,997
|
|
|
$
|
4,784
|
|
•
|
All commercial loans and leases classified substandard or worse.
|
•
|
Any other delinquent loan or lease that is in a nonaccrual status, or any loan or lease that is delinquent more than 89 days and still accruing interest.
|
•
|
Any loan or lease which has been modified such that it meets the definition of a TDR.
|
•
|
The Fair Market Value of Collateral method utilizes the value at which the collateral could be sold considering the appraised value, appraisal discount rate, prior liens and selling costs. The amount of the reserve is the deficit of the estimated collateral value compared to the loan or lease balance.
|
•
|
The Present Value of Future Cash Flows method takes into account the amount and timing of cash flows and the effective interest rate used to discount the cash flows.
|
|
Construction &
Development
|
|
Commercial
Real Estate
|
|
Commercial
& Industrial
|
|
Commercial
Land
|
|
Total
|
||||||||||
December 31, 2017
|
|
|
|
|
|
|
|
|
|
||||||||||
Beginning Balance
|
$
|
1,693
|
|
|
$
|
5,897
|
|
|
$
|
8,413
|
|
|
$
|
2,206
|
|
|
$
|
18,209
|
|
Charge offs
|
—
|
|
|
(1,177
|
)
|
|
(2,617
|
)
|
|
(58
|
)
|
|
(3,852
|
)
|
|||||
Recoveries
|
—
|
|
|
191
|
|
|
101
|
|
|
5
|
|
|
297
|
|
|||||
Provision
|
337
|
|
|
4,269
|
|
|
4,854
|
|
|
76
|
|
|
9,536
|
|
|||||
Ending Balance
|
$
|
2,030
|
|
|
$
|
9,180
|
|
|
$
|
10,751
|
|
|
$
|
2,229
|
|
|
$
|
24,190
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
December 31, 2016
|
|
|
|
|
|
|
|
|
|
||||||||||
Beginning Balance
|
$
|
1,064
|
|
|
$
|
2,486
|
|
|
$
|
2,766
|
|
|
$
|
1,099
|
|
|
$
|
7,415
|
|
Charge offs
|
—
|
|
|
(707
|
)
|
|
(1,464
|
)
|
|
(63
|
)
|
|
(2,234
|
)
|
|||||
Recoveries
|
—
|
|
|
6
|
|
|
486
|
|
|
—
|
|
|
492
|
|
|||||
Provision
|
629
|
|
|
4,112
|
|
|
6,625
|
|
|
1,170
|
|
|
12,536
|
|
|||||
Ending Balance
|
$
|
1,693
|
|
|
$
|
5,897
|
|
|
$
|
8,413
|
|
|
$
|
2,206
|
|
|
$
|
18,209
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
December 31, 2015
|
|
|
|
|
|
|
|
|
|
||||||||||
Beginning Balance
|
$
|
586
|
|
|
$
|
2,291
|
|
|
$
|
1,369
|
|
|
$
|
161
|
|
|
$
|
4,407
|
|
Charge offs
|
—
|
|
|
(164
|
)
|
|
(978
|
)
|
|
—
|
|
|
(1,142
|
)
|
|||||
Recoveries
|
—
|
|
|
131
|
|
|
213
|
|
|
—
|
|
|
344
|
|
|||||
Provision
|
478
|
|
|
228
|
|
|
2,162
|
|
|
938
|
|
|
3,806
|
|
|||||
Ending Balance
|
$
|
1,064
|
|
|
$
|
2,486
|
|
|
$
|
2,766
|
|
|
$
|
1,099
|
|
|
$
|
7,415
|
|
December 31, 2017
|
Construction &
Development
|
|
Commercial
Real Estate
|
|
Commercial
& Industrial
|
|
Commercial
Land
|
|
Total
|
||||||||||
Allowance for Loan and Lease Losses:
|
|
|
|
|
|
|
|
|
|
||||||||||
Loans and leases individually evaluated for impairment
|
$
|
157
|
|
|
$
|
1,502
|
|
|
$
|
1,126
|
|
|
$
|
—
|
|
|
$
|
2,785
|
|
Loans and leases collectively evaluated for impairment
2
|
1,873
|
|
|
7,678
|
|
|
9,625
|
|
|
2,229
|
|
|
21,405
|
|
|||||
Total allowance for loan and lease losses
|
$
|
2,030
|
|
|
$
|
9,180
|
|
|
$
|
10,751
|
|
|
$
|
2,229
|
|
|
$
|
24,190
|
|
Loans and leases receivable
1
:
|
|
|
|
|
|
|
|
|
|
||||||||||
Loans and leases individually evaluated for impairment
|
$
|
1,237
|
|
|
$
|
17,105
|
|
|
$
|
8,672
|
|
|
$
|
—
|
|
|
$
|
27,014
|
|
Loans and leases collectively evaluated for impairment
2
|
162,016
|
|
|
502,545
|
|
|
476,378
|
|
|
178,897
|
|
|
1,319,836
|
|
|||||
Total loans and leases receivable
|
$
|
163,253
|
|
|
$
|
519,650
|
|
|
$
|
485,050
|
|
|
$
|
178,897
|
|
|
$
|
1,346,850
|
|
December 31, 2016
|
Construction
&
Development
|
|
Commercial
Real Estate
|
|
Commercial
& Industrial
|
|
Commercial
Land
|
|
Total
|
||||||||||
Allowance for Loan and Lease Losses:
|
|
|
|
|
|
|
|
|
|
||||||||||
Loans and leases individually evaluated for impairment
|
$
|
—
|
|
|
$
|
1,496
|
|
|
$
|
1,458
|
|
|
$
|
—
|
|
|
$
|
2,954
|
|
Loans and leases collectively evaluated for impairment
2
|
1,693
|
|
|
4,401
|
|
|
6,955
|
|
|
2,206
|
|
|
15,255
|
|
|||||
Total allowance for loan and lease losses
|
$
|
1,693
|
|
|
$
|
5,897
|
|
|
$
|
8,413
|
|
|
$
|
2,206
|
|
|
$
|
18,209
|
|
Loans and Leases Receivable
1
:
|
|
|
|
|
|
|
|
|
|
||||||||||
Loans and leases individually evaluated for impairment
|
$
|
—
|
|
|
$
|
16,359
|
|
|
$
|
6,884
|
|
|
$
|
—
|
|
|
$
|
23,243
|
|
Loans and leases collectively evaluated for impairment
2
|
112,331
|
|
|
331,787
|
|
|
327,562
|
|
|
113,569
|
|
|
885,249
|
|
|||||
Total loans and leases receivable
|
$
|
112,331
|
|
|
$
|
348,146
|
|
|
$
|
334,446
|
|
|
$
|
113,569
|
|
|
$
|
908,492
|
|
1
|
Loans and leases receivable includes $
99.7 million
of U.S. government guaranteed loans as of
December 31, 2017
, of which $
28.1 million
are impaired. As of
December 31, 2016
, loans and leases receivable includes $
37.7 million
of U.S. government guaranteed loans, of which $
22.1 million
are considered impaired.
|
2
|
Included in loans and leases collectively evaluated for impairment are impaired loans and leases with individual unguaranteed exposure of less than $
100 thousand
. As of
December 31, 2017
, these balances totaled $
14.8 million
, of which $
13.2 million
are guaranteed by the U.S. government and $
1.6 million
are unguaranteed. As of
December 31, 2016
, these balances totaled $
12.3 million
, of which $
10.0 million
are guaranteed by the U.S. government and $
2.3 million
are unguaranteed. The allowance for loan and lease losses associated with these loans and leases totaled $
279 thousand
and $
438 thousand
as of
December 31, 2017
and
December 31, 2016
, respectively.
|
December 31, 2017
|
Recorded
Investment
|
|
Guaranteed
Balance
|
|
Unguaranteed
Exposure
|
||||||
Commercial & Industrial
|
|
|
|
|
|
||||||
Death Care Management
|
$
|
7
|
|
|
$
|
—
|
|
|
$
|
7
|
|
Healthcare
|
4,551
|
|
|
3,235
|
|
|
1,316
|
|
|||
Independent Pharmacies
|
8,571
|
|
|
6,356
|
|
|
2,215
|
|
|||
Registered Investment Advisors
|
733
|
|
|
—
|
|
|
733
|
|
|||
Veterinary Industry
|
2,762
|
|
|
2,001
|
|
|
761
|
|
|||
Total
|
16,624
|
|
|
11,592
|
|
|
5,032
|
|
|||
Construction & Development
|
|
|
|
|
|
||||||
Healthcare
|
1,237
|
|
|
944
|
|
|
293
|
|
|||
Total
|
1,237
|
|
|
944
|
|
|
293
|
|
|||
Commercial Real Estate
|
|
|
|
|
|
||||||
Death Care Management
|
2,831
|
|
|
1,237
|
|
|
1,594
|
|
|||
Healthcare
|
4,315
|
|
|
2,967
|
|
|
1,348
|
|
|||
Independent Pharmacies
|
1,562
|
|
|
1,562
|
|
|
—
|
|
|||
Veterinary Industry
|
15,266
|
|
|
9,768
|
|
|
5,498
|
|
|||
Total
|
23,974
|
|
|
15,534
|
|
|
8,440
|
|
|||
Commercial Land
|
|
|
|
|
|
||||||
Agriculture
|
—
|
|
|
—
|
|
|
—
|
|
|||
Total
|
—
|
|
|
—
|
|
|
—
|
|
|||
Total
|
$
|
41,835
|
|
|
$
|
28,070
|
|
|
$
|
13,765
|
|
December 31, 2016
|
Recorded
Investment
|
|
Guaranteed
Balance
|
|
Unguaranteed
Exposure
|
||||||
Commercial & Industrial
|
|
|
|
|
|
||||||
Death Care Management
|
$
|
111
|
|
|
$
|
—
|
|
|
$
|
111
|
|
Healthcare
|
7,923
|
|
|
5,453
|
|
|
2,470
|
|
|||
Independent Pharmacies
|
3,514
|
|
|
2,495
|
|
|
1,019
|
|
|||
Registered Investment Advisors
|
796
|
|
|
—
|
|
|
796
|
|
|||
Veterinary Industry
|
2,882
|
|
|
2,199
|
|
|
683
|
|
|||
Total
|
15,226
|
|
|
10,147
|
|
|
5,079
|
|
|||
Construction & Development
|
|
|
|
|
|
||||||
Agriculture
|
300
|
|
|
233
|
|
|
67
|
|
|||
Total
|
300
|
|
|
233
|
|
|
67
|
|
|||
Commercial Real Estate
|
|
|
|
|
|
||||||
Death Care Management
|
1,768
|
|
|
1,264
|
|
|
504
|
|
|||
Healthcare
|
4,044
|
|
|
2,985
|
|
|
1,059
|
|
|||
Independent Pharmacies
|
528
|
|
|
—
|
|
|
528
|
|
|||
Veterinary Industry
|
13,561
|
|
|
7,518
|
|
|
6,043
|
|
|||
Total
|
19,901
|
|
|
11,767
|
|
|
8,134
|
|
|||
Commercial Land
|
|
|
|
|
|
||||||
Agriculture
|
91
|
|
|
—
|
|
|
91
|
|
|||
Total
|
91
|
|
|
—
|
|
|
91
|
|
|||
Total
|
$
|
35,518
|
|
|
$
|
22,147
|
|
|
$
|
13,371
|
|
|
December 31, 2017
|
||||||||||||||||||
|
Recorded Investment
|
|
|
|
|
||||||||||||||
|
With a
Recorded
Allowance
|
|
With No
Recorded
Allowance
|
|
Total
|
|
Unpaid
Principal
Balance
|
|
Related
Allowance
Recorded
|
||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
||||||||||
Death Care Management
|
$
|
—
|
|
|
$
|
7
|
|
|
$
|
7
|
|
|
$
|
7
|
|
|
$
|
—
|
|
Healthcare
|
3,521
|
|
|
1,030
|
|
|
4,551
|
|
|
5,643
|
|
|
165
|
|
|||||
Independent Pharmacies
|
8,154
|
|
|
417
|
|
|
8,571
|
|
|
9,078
|
|
|
521
|
|
|||||
Registered Investment Advisors
|
662
|
|
|
71
|
|
|
733
|
|
|
725
|
|
|
504
|
|
|||||
Veterinary Industry
|
2,505
|
|
|
257
|
|
|
2,762
|
|
|
3,113
|
|
|
182
|
|
|||||
Total
|
14,842
|
|
|
1,782
|
|
|
16,624
|
|
|
18,566
|
|
|
1,372
|
|
|||||
Construction & Development
|
|
|
|
|
|
|
|
|
|
||||||||||
Healthcare
|
1,237
|
|
|
—
|
|
|
1,237
|
|
|
1,258
|
|
|
157
|
|
|||||
Total
|
1,237
|
|
|
—
|
|
|
1,237
|
|
|
1,258
|
|
|
157
|
|
|||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
||||||||||
Death Care Management
|
2,221
|
|
|
610
|
|
|
2,831
|
|
|
2,964
|
|
|
260
|
|
|||||
Healthcare
|
3,717
|
|
|
598
|
|
|
4,315
|
|
|
4,332
|
|
|
192
|
|
|||||
Independent Pharmacies
|
1,562
|
|
|
—
|
|
|
1,562
|
|
|
1,933
|
|
|
8
|
|
|||||
Veterinary Industry
|
13,711
|
|
|
1,555
|
|
|
15,266
|
|
|
16,584
|
|
|
1,075
|
|
|||||
Total
|
21,211
|
|
|
2,763
|
|
|
23,974
|
|
|
25,813
|
|
|
1,535
|
|
|||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
||||||||||
Agriculture
|
—
|
|
|
—
|
|
|
—
|
|
|
58
|
|
|
—
|
|
|||||
Total
|
—
|
|
|
—
|
|
|
—
|
|
|
58
|
|
|
—
|
|
|||||
Total Impaired Loans and Leases
|
$
|
37,290
|
|
|
$
|
4,545
|
|
|
$
|
41,835
|
|
|
$
|
45,695
|
|
|
$
|
3,064
|
|
|
December 31, 2016
|
||||||||||||||||||
|
Recorded Investment
|
|
|
|
|
||||||||||||||
|
With a
Recorded Allowance |
|
With No
Recorded Allowance |
|
Total
|
|
Unpaid
Principal Balance |
|
Related
Allowance Recorded |
||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
||||||||||
Death Care Management
|
$
|
8
|
|
|
$
|
103
|
|
|
$
|
111
|
|
|
$
|
111
|
|
|
$
|
1
|
|
Healthcare
|
7,259
|
|
|
664
|
|
|
7,923
|
|
|
8,120
|
|
|
778
|
|
|||||
Independent Pharmacies
|
3,184
|
|
|
330
|
|
|
3,514
|
|
|
3,610
|
|
|
327
|
|
|||||
Registered Investment Advisors
|
796
|
|
|
—
|
|
|
796
|
|
|
792
|
|
|
514
|
|
|||||
Veterinary Industry
|
2,754
|
|
|
128
|
|
|
2,882
|
|
|
3,369
|
|
|
106
|
|
|||||
Total
|
14,001
|
|
|
1,225
|
|
|
15,226
|
|
|
16,002
|
|
|
1,726
|
|
|||||
Construction & Development
|
|
|
|
|
|
|
|
|
|
||||||||||
Agriculture
|
300
|
|
|
—
|
|
|
300
|
|
|
311
|
|
|
13
|
|
|||||
Total
|
300
|
|
|
—
|
|
|
300
|
|
|
311
|
|
|
13
|
|
|||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
||||||||||
Death Care Management
|
1,580
|
|
|
188
|
|
|
1,768
|
|
|
1,904
|
|
|
34
|
|
|||||
Healthcare
|
3,514
|
|
|
530
|
|
|
4,044
|
|
|
4,042
|
|
|
47
|
|
|||||
Independent Pharmacies
|
528
|
|
|
—
|
|
|
528
|
|
|
529
|
|
|
284
|
|
|||||
Veterinary Industry
|
11,193
|
|
|
2,368
|
|
|
13,561
|
|
|
14,283
|
|
|
1,273
|
|
|||||
Total
|
16,815
|
|
|
3,086
|
|
|
19,901
|
|
|
20,758
|
|
|
1,638
|
|
|||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
||||||||||
Agriculture
|
91
|
|
|
—
|
|
|
91
|
|
|
161
|
|
|
15
|
|
|||||
Total
|
91
|
|
|
—
|
|
|
91
|
|
|
161
|
|
|
15
|
|
|||||
Total Impaired Loans and Leases
|
$
|
31,207
|
|
|
$
|
4,311
|
|
|
$
|
35,518
|
|
|
$
|
37,232
|
|
|
$
|
3,392
|
|
|
December 31, 2017
|
|
December 31, 2016
|
|
December 31, 2015
|
||||||||||||||||||
|
Average
Balance
|
|
Interest
Income
Recognized
|
|
Average
Balance
|
|
Interest
Income
Recognized
|
|
Average
Balance
|
|
Interest
Income
Recognized
|
||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Death Care Management
|
$
|
8
|
|
|
$
|
—
|
|
|
$
|
112
|
|
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Healthcare
|
6,101
|
|
|
53
|
|
|
7,513
|
|
|
81
|
|
|
3,375
|
|
|
276
|
|
||||||
Independent Pharmacies
|
6,018
|
|
|
100
|
|
|
2,570
|
|
|
76
|
|
|
1,701
|
|
|
148
|
|
||||||
Registered Investment Advisors
|
759
|
|
|
50
|
|
|
817
|
|
|
22
|
|
|
—
|
|
|
—
|
|
||||||
Veterinary Industry
|
2,523
|
|
|
45
|
|
|
2,537
|
|
|
35
|
|
|
2,029
|
|
|
109
|
|
||||||
Total
|
15,409
|
|
|
248
|
|
|
13,549
|
|
|
215
|
|
|
7,105
|
|
|
533
|
|
||||||
Construction & Development
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agriculture
|
—
|
|
|
—
|
|
|
317
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Healthcare
|
1,240
|
|
|
11
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
1,240
|
|
|
11
|
|
|
317
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Death Care Management
|
2,882
|
|
|
50
|
|
|
1,789
|
|
|
7
|
|
|
1,420
|
|
|
—
|
|
||||||
Healthcare
|
4,381
|
|
|
49
|
|
|
4,093
|
|
|
41
|
|
|
1,403
|
|
|
—
|
|
||||||
Independent Pharmacies
|
1,708
|
|
|
—
|
|
|
538
|
|
|
3
|
|
|
—
|
|
|
—
|
|
||||||
Veterinary Industry
|
14,605
|
|
|
536
|
|
|
13,554
|
|
|
336
|
|
|
10,870
|
|
|
556
|
|
||||||
Other Industries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
23,576
|
|
|
635
|
|
|
19,974
|
|
|
387
|
|
|
13,693
|
|
|
556
|
|
||||||
Commercial Land
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agriculture
|
113
|
|
|
—
|
|
|
294
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
113
|
|
|
—
|
|
|
294
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
$
|
40,338
|
|
|
$
|
894
|
|
|
$
|
34,134
|
|
|
$
|
602
|
|
|
$
|
20,798
|
|
|
$
|
1,089
|
|
|
December 31, 2017
|
|
December 31, 2016
|
|
December 31, 2015
|
|||||||||||||||||||||||||||
|
All Restructurings
|
|
All Restructurings
|
|
All Restructurings
|
|||||||||||||||||||||||||||
|
Number of
Loans and Leases
|
|
Pre-
modification
Recorded
Investment
|
|
Post-
modification
Recorded
Investment
|
|
Number of
Loans and Leases
|
|
Pre-
modification
Recorded
Investment
|
|
Post-
modification
Recorded
Investment
|
|
Number of
Loans and Leases
|
|
Pre-
modification
Recorded
Investment
|
|
Post-
modification
Recorded
Investment
|
|||||||||||||||
Interest Only
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Healthcare
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
3
|
|
|
$
|
1,087
|
|
|
$
|
1,087
|
|
Commercial Real Estate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Healthcare
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
94
|
|
|
94
|
|
||||||
Total Interest Only
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4
|
|
|
1,181
|
|
|
1,181
|
|
||||||
Extended Amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Independent Pharmacies
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
322
|
|
|
308
|
|
||||||
Total Extended Amortization
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
322
|
|
|
308
|
|
||||||
Payment Deferral and Extended Amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Independent Pharmacies
|
1
|
|
|
262
|
|
|
262
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total Payment Deferral and Extended Amortization
|
1
|
|
|
262
|
|
|
262
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Payment Deferral
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Commercial & Industrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Veterinary Industry
|
2
|
|
|
559
|
|
|
559
|
|
|
1
|
|
|
420
|
|
|
420
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Healthcare
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
440
|
|
|
440
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total Payment Deferral
|
2
|
|
|
559
|
|
|
559
|
|
|
2
|
|
|
860
|
|
|
860
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total
|
3
|
|
|
$
|
821
|
|
|
$
|
821
|
|
|
2
|
|
|
$
|
860
|
|
|
$
|
860
|
|
|
6
|
|
|
$
|
1,503
|
|
|
$
|
1,489
|
|
|
2017
|
|
2016
|
||||
Balance at beginning of period
|
$
|
51,994
|
|
|
$
|
44,230
|
|
Additions, net
|
14,028
|
|
|
16,584
|
|
||
Fair value changes:
|
|
|
|
||||
Due to changes in valuation inputs or assumptions
|
(2,722
|
)
|
|
(955
|
)
|
||
Decay due to increases in principal paydowns or runoff
|
(11,002
|
)
|
|
(7,865
|
)
|
||
Balance at end of period
|
$
|
52,298
|
|
|
$
|
51,994
|
|
|
2017
|
|
2016
|
||||
Buildings
|
$
|
21,875
|
|
|
$
|
21,713
|
|
Land improvements
|
3,566
|
|
|
3,524
|
|
||
Furniture and equipment
|
10,391
|
|
|
9,735
|
|
||
Computers and software
|
561
|
|
|
444
|
|
||
Leasehold improvements
|
7,539
|
|
|
612
|
|
||
Land
|
8,650
|
|
|
3,749
|
|
||
Transportation
|
44,863
|
|
|
23,470
|
|
||
Solar panels
|
90,640
|
|
|
—
|
|
||
Deposits on fixed assets
|
6,534
|
|
|
10,320
|
|
||
Premises and equipment, total
|
194,619
|
|
|
73,567
|
|
||
Less accumulated depreciation
|
(15,829
|
)
|
|
(8,906
|
)
|
||
Premises and equipment, net of depreciation
|
$
|
178,790
|
|
|
$
|
64,661
|
|
Year
|
Amount
|
||
2018
|
$
|
964
|
|
2019
|
793
|
|
|
2020
|
380
|
|
|
2021
|
232
|
|
|
2022
|
237
|
|
|
Thereafter
|
230
|
|
|
Total
|
$
|
2,836
|
|
|
2017
|
|
2016
|
||||
Noninterest-bearing deposits
|
$
|
57,868
|
|
|
$
|
27,990
|
|
Interest-bearing deposits:
|
|
|
|
||||
Interest-bearing checking
|
36,978
|
|
|
27,402
|
|
||
Money market
|
188,146
|
|
|
489,978
|
|
||
Savings
|
696,989
|
|
|
—
|
|
||
Time deposits
|
1,280,282
|
|
|
939,706
|
|
||
Total
|
2,202,395
|
|
|
1,457,086
|
|
||
Total deposits
|
$
|
2,260,263
|
|
|
$
|
1,485,076
|
|
Year
|
Amount
|
||
2018
|
$
|
892,164
|
|
2019
|
116,615
|
|
|
2020
|
105,746
|
|
|
2021
|
66,420
|
|
|
2022
|
23,263
|
|
|
Thereafter
|
76,074
|
|
|
Total
|
$
|
1,280,282
|
|
|
December 31,
2017 |
|
December 31,
2016 |
||||
Short term borrowings
|
|
|
|
||||
On October 20, 2017, the Company entered into a revolving line of credit of $20 million with an unaffiliated commercial bank. The note is unsecured and accrues interest at LIBOR plus 1.750% for a term of 12 months. Payments are interest only with all principal and accrued interest due on October 19, 2018. The terms of this loan require the Company to maintain minimum capital and debt service coverage ratios. No advances have been made to this line of credit and there is $20 million of available credit remaining at December 31, 2017.
|
$
|
—
|
|
|
$
|
—
|
|
Total short term borrowings
|
$
|
—
|
|
|
$
|
—
|
|
|
December 31,
2017 |
|
December 31,
2016 |
||||
Long term borrowings
|
|
|
|
||||
On September 11, 2014, the Company financed the construction of an additional building located on the Company’s Tiburon Drive main campus for a $24 million construction line of credit with an unaffiliated commercial bank, secured by both properties at its Tiburon Drive main facility location. Payments were interest only through September 11, 2016 at a fixed rate of 3.95% for a term of 84 months. Monthly principal and interest payments of $146 thousand began in October 2016 with all principal and accrued interest due on September 11, 2021. The construction line is fully disbursed and there was no remaining available credit on this construction line at December 31, 2017.
|
$
|
22,990
|
|
|
$
|
23,864
|
|
On February 23, 2015, the Company transferred two related party loans to an unaffiliated commercial bank in exchange for $4.7 million. The exchange price equated to the unpaid principal balance plus accrued but uncollected interest at the time of transfer. The terms of the transfer agreement with the unaffiliated commercial bank identified the transaction as a secured borrowing for accounting purposes. Interest accrues at prime plus 1% with monthly principal and interest payments over a term of 60 months. The interest rate at December 31, 2017 is 5.25%. The maturity date is October 5, 2019. The pledged collateral is classified in other assets with a fair value of $3.6 million at December 31, 2017. Underlying loans carry a risk grade of 3 and are current with no delinquencies.
|
3,574
|
|
|
3,979
|
|
||
On September 18, 2014, the Company entered into a note payable revolving line of credit of $8.1 million with an unaffiliated commercial bank. On April 18, 2017, the Company renewed and increased the revolving line of credit to $25 million. The note is unsecured and accrues interest at Prime minus 0.50% for a term of 24 months. Payments are interest only with all principal and accrued interest due on April 30, 2019. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. This line of credit was paid in full on August 25, 2017, and there is $25 million of available credit remaining at December 31, 2017.
|
—
|
|
|
—
|
|
||
Total long term borrowings
|
$
|
26,564
|
|
|
$
|
27,843
|
|
|
2017
|
|
2016
|
|
2015
|
||||||
Current income tax (benefit) expense:
|
|
|
|
|
|
|
|||||
Federal
|
$
|
(15,424
|
)
|
|
$
|
6,487
|
|
|
$
|
11,387
|
|
State
|
1,162
|
|
|
1,244
|
|
|
1,472
|
|
|||
Total current tax (benefit) expense
|
(14,262
|
)
|
|
7,731
|
|
|
12,859
|
|
|||
Deferred income tax (benefit) expense:
|
|
|
|
|
|
|
|||||
Federal
|
8,389
|
|
|
(3,848
|
)
|
|
992
|
|
|||
State
|
3,628
|
|
|
(440
|
)
|
|
(56
|
)
|
|||
Total deferred tax (benefit) expense
|
12,017
|
|
|
(4,288
|
)
|
|
936
|
|
|||
Income tax (benefit) expense, as reported
|
$
|
(2,245
|
)
|
|
$
|
3,443
|
|
|
$
|
13,795
|
|
|
2017
|
|
2016
|
|
2015
|
||||||
Income tax expense computed at the statutory rate
|
$
|
34,389
|
|
|
$
|
6,023
|
|
|
$
|
12,039
|
|
|
|
|
|
|
|
||||||
State income tax, net of federal benefit
|
3,114
|
|
|
523
|
|
|
920
|
|
|||
Stock-based compensation expense
|
(380
|
)
|
|
768
|
|
|
423
|
|
|||
Change in U.S. tax rate
|
(18,921
|
)
|
|
—
|
|
|
—
|
|
|||
Other
|
62
|
|
|
525
|
|
|
413
|
|
|||
Decrease in taxes due to investment tax credit
|
(20,509
|
)
|
|
(4,396
|
)
|
|
—
|
|
|||
Total income tax expense
|
$
|
(2,245
|
)
|
|
$
|
3,443
|
|
|
$
|
13,795
|
|
|
2017
|
|
2016
|
|
2015
|
||||||
Deferred tax assets:
|
|
|
|
|
|
||||||
Tax credit carryforwards
|
$
|
20,272
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Allowance for loan and lease losses
|
5,806
|
|
|
6,828
|
|
|
2,780
|
|
|||
Mark to market on loans held for sale
|
5,751
|
|
|
—
|
|
|
—
|
|
|||
Stock-based compensation expense
|
1,872
|
|
|
3,877
|
|
|
—
|
|
|||
Goodwill and intangibles
|
1,259
|
|
|
—
|
|
|
—
|
|
|||
Accrued expenses
|
375
|
|
|
725
|
|
|
505
|
|
|||
Other
|
1,062
|
|
|
1,395
|
|
|
734
|
|
|||
Total deferred tax assets
|
36,397
|
|
|
12,825
|
|
|
4,019
|
|
|||
|
|
|
|
|
|
||||||
Deferred tax liabilities:
|
|
|
|
|
|
||||||
Investment in joint venture
|
16,320
|
|
|
—
|
|
|
—
|
|
|||
Unguaranteed loan discount
|
6,615
|
|
|
4,644
|
|
|
4,083
|
|
|||
Premises and equipment
|
24,112
|
|
|
7,193
|
|
|
3,952
|
|
|||
Deferred loan fees and costs, net
|
1,139
|
|
|
1,321
|
|
|
892
|
|
|||
Other
|
323
|
|
|
—
|
|
|
—
|
|
|||
Total deferred tax liabilities
|
48,509
|
|
|
13,158
|
|
|
8,927
|
|
|||
Net deferred tax liability
|
$
|
12,112
|
|
|
$
|
333
|
|
|
$
|
4,908
|
|
December 31, 2017
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Investment securities available-for-sale
|
|
|
|
|
|
|
|
||||||||
US government agencies
|
$
|
22,624
|
|
|
$
|
—
|
|
|
$
|
22,624
|
|
|
$
|
—
|
|
Residential mortgage-backed securities
|
68,696
|
|
|
—
|
|
|
68,696
|
|
|
—
|
|
||||
Mutual fund
|
2,035
|
|
|
—
|
|
|
2,035
|
|
|
—
|
|
||||
Servicing assets
1
|
52,298
|
|
|
—
|
|
|
—
|
|
|
52,298
|
|
||||
Total assets at fair value
|
$
|
145,653
|
|
|
$
|
—
|
|
|
$
|
93,355
|
|
|
$
|
52,298
|
|
|
|
|
|
|
|
|
|
||||||||
Contingent consideration liability
2
|
$
|
1,900
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,900
|
|
Total liabilities at fair value
|
$
|
1,900
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,900
|
|
December 31, 2016
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Investment securities available-for-sale
|
|
|
|
|
|
|
|
||||||||
US government agencies
|
$
|
17,823
|
|
|
$
|
—
|
|
|
$
|
17,823
|
|
|
$
|
—
|
|
Residential mortgage-backed securities
|
51,273
|
|
|
—
|
|
|
51,273
|
|
|
—
|
|
||||
Mutual fund
|
1,960
|
|
|
—
|
|
|
1,960
|
|
|
—
|
|
||||
Servicing assets
1
|
51,994
|
|
|
—
|
|
|
—
|
|
|
51,994
|
|
||||
Total assets at fair value
|
$
|
123,050
|
|
|
$
|
—
|
|
|
$
|
71,056
|
|
|
$
|
51,994
|
|
1
|
See Note 6 for a rollforward of recurring Level 3 fair values for servicing assets.
|
2
|
See Note 2 for activity related to the recurring Level 3 fair value for the contingent consideration liability and various assumptions used in the fair value measurement.
|
December 31, 2017
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Impaired loans
|
$
|
34,493
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
34,493
|
|
Foreclosed assets
|
1,281
|
|
|
—
|
|
|
—
|
|
|
1,281
|
|
||||
Total assets at fair value
|
$
|
35,774
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
35,774
|
|
December 31, 2016
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Impaired loans
|
$
|
27,815
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
27,815
|
|
Foreclosed assets
|
1,648
|
|
|
—
|
|
|
—
|
|
|
1,648
|
|
||||
Total assets at fair value
|
$
|
29,463
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
29,463
|
|
Level 3 Assets with Significant Unobservable Inputs
|
|
Fair Value
|
|
Valuation Technique
|
|
Significant Unobservable Inputs
|
|
Range
|
||
Impaired Loans
|
|
$
|
34,493
|
|
|
Discounted appraisals
Discounted expected cash flows |
|
Appraisal adjustments
(1)
Interest rate & repayment term |
|
10% to 25%
Weighted average discount rate 6.26% |
Foreclosed Assets
|
|
$
|
1,281
|
|
|
Discounted appraisals
|
|
Appraisal adjustments
(1)
|
|
10% to 37%
|
Level 3 Assets with Significant Unobservable Inputs
|
|
Fair Value
|
|
Valuation Technique
|
|
Significant Unobservable Inputs
|
|
Range
|
||
Impaired Loans
|
|
$
|
27,815
|
|
|
Discounted appraisals
Discounted expected cash flows |
|
Appraisal adjustments
(1)
Interest rate & repayment term |
|
0% to 25%
Weighted average discount rate 5.28% |
Foreclosed Assets
|
|
$
|
1,648
|
|
|
Discounted appraisals
|
|
Appraisal adjustments
(1)
|
|
10% to 35%
|
(1)
|
Appraisals may be adjusted by management for customized discounting criteria, estimated sales costs, and proprietary qualitative adjustments.
|
December 31, 2017
|
Carrying Amount
|
|
Quoted Price In Active Markets for Identical Assets/Liabilities (Level 1)
|
|
Significant Other Observable Inputs (Level 2)
|
|
Significant Unobservable Inputs (Level 3)
|
|
Total Fair Value
|
||||||||||
Financial assets
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and due from banks
|
$
|
295,271
|
|
|
$
|
295,271
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
295,271
|
|
Certificates of deposit with other banks
|
3,000
|
|
|
2,993
|
|
|
—
|
|
|
—
|
|
|
2,993
|
|
|||||
Investment securities, available-for-sale
|
93,355
|
|
|
—
|
|
|
93,355
|
|
|
—
|
|
|
93,355
|
|
|||||
Loans held for sale
|
680,454
|
|
|
—
|
|
|
—
|
|
|
706,972
|
|
|
706,972
|
|
|||||
Loans and leases, net of allowance for loan and lease losses
|
1,319,783
|
|
|
—
|
|
|
—
|
|
|
1,319,615
|
|
|
1,319,615
|
|
|||||
Servicing assets
|
52,298
|
|
|
—
|
|
|
—
|
|
|
52,298
|
|
|
52,298
|
|
|||||
Accrued interest receivable
|
10,160
|
|
|
10,160
|
|
|
—
|
|
|
—
|
|
|
10,160
|
|
|||||
Financial liabilities
|
|
|
|
|
|
|
|
|
|
||||||||||
Deposits
|
2,260,263
|
|
|
—
|
|
|
2,232,370
|
|
|
—
|
|
|
2,232,370
|
|
|||||
Accrued interest payable
|
367
|
|
|
367
|
|
|
—
|
|
|
—
|
|
|
367
|
|
|||||
Long term borrowings
|
26,564
|
|
|
—
|
|
|
—
|
|
|
27,390
|
|
|
27,390
|
|
December 31, 2016
|
Carrying Amount
|
|
Quoted Price In Active Markets for Identical Assets/Liabilities (Level 1)
|
|
Significant Other Observable Inputs (Level 2)
|
|
Significant Unobservable Inputs (Level 3)
|
|
Total Fair Value
|
||||||||||
Financial assets
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and due from banks
|
$
|
238,008
|
|
|
$
|
238,008
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
238,008
|
|
Certificates of deposit with other banks
|
7,250
|
|
|
7,236
|
|
|
—
|
|
|
—
|
|
|
7,236
|
|
|||||
Investment securities, available-for-sale
|
71,056
|
|
|
—
|
|
|
71,056
|
|
|
—
|
|
|
71,056
|
|
|||||
Loans held for sale
|
394,278
|
|
|
—
|
|
|
—
|
|
|
397,391
|
|
|
397,391
|
|
|||||
Loans and leases, net of allowance for loan and lease losses
|
889,357
|
|
|
—
|
|
|
—
|
|
|
873,158
|
|
|
873,158
|
|
|||||
Servicing assets
|
51,994
|
|
|
—
|
|
|
—
|
|
|
51,994
|
|
|
51,994
|
|
|||||
Accrued interest receivable
|
7,520
|
|
|
7,520
|
|
|
—
|
|
|
—
|
|
|
7,520
|
|
|||||
Financial liabilities
|
|
|
|
|
|
|
|
|
|
||||||||||
Deposits
|
1,485,076
|
|
|
—
|
|
|
1,469,173
|
|
|
—
|
|
|
1,469,173
|
|
|||||
Accrued interest payable
|
319
|
|
|
319
|
|
|
—
|
|
|
—
|
|
|
319
|
|
|||||
Long term borrowings
|
27,843
|
|
|
—
|
|
|
—
|
|
|
29,559
|
|
|
29,559
|
|
|
December 31,
2017 |
|
December 31,
2016 |
||||
Commitments to extend credit
|
$
|
1,701,137
|
|
|
$
|
1,342,271
|
|
Standby letters of credit
|
2,298
|
|
|
343
|
|
||
Solar purchase commitments
|
106,921
|
|
|
—
|
|
||
Airplane purchase agreement commitments
|
25,450
|
|
|
21,500
|
|
||
Total unfunded off-balance sheet credit risk
|
$
|
1,835,806
|
|
|
$
|
1,364,114
|
|
|
Shares
|
|
Weighted Average Exercise Price
|
|
Weighted Average Remaining Contractual Term
|
|
Aggregate Intrinsic Value
|
|||||
Outstanding at December 31, 2016
|
3,478,208
|
|
|
$
|
11.51
|
|
|
|
|
|
||
Exercised
|
109,010
|
|
|
9.41
|
|
|
|
|
|
|||
Forfeited
|
310,739
|
|
|
14.37
|
|
|
|
|
|
|||
Granted
|
—
|
|
|
—
|
|
|
|
|
|
|||
Outstanding at December 31, 2017
|
3,058,459
|
|
|
$
|
11.30
|
|
|
7.04 years
|
|
$
|
38,398,463
|
|
Exercisable at December 31, 2017
|
693,460
|
|
|
$
|
10.43
|
|
|
6.83 years
|
|
$
|
9,308,406
|
|
|
Shares
|
|
Weighted Average Grant Date Fair Value
|
|||
Non-vested at December 31, 2014
|
1,704,230
|
|
|
$
|
1.18
|
|
Granted
|
2,088,316
|
|
|
6.81
|
|
|
Vested
|
173,180
|
|
|
0.88
|
|
|
Forfeited
|
225,925
|
|
|
2.66
|
|
|
Non-vested at December 31, 2015
|
3,393,441
|
|
|
4.56
|
|
|
Granted
|
169,987
|
|
|
6.58
|
|
|
Vested
|
372,515
|
|
|
4.41
|
|
|
Forfeited
|
174,813
|
|
|
3.06
|
|
|
Non-vested at December 31, 2016
|
3,016,100
|
|
|
4.78
|
|
|
Granted
|
—
|
|
|
—
|
|
|
Vested
|
340,362
|
|
|
4.36
|
|
|
Forfeited
|
310,739
|
|
|
6.25
|
|
|
Non-vested at December 31, 2017
|
2,364,999
|
|
|
$
|
4.65
|
|
|
2016
|
|
2015
|
||
Risk free rate
|
1.56
|
%
|
|
1.95
|
%
|
Dividend yield
|
0.05
|
%
|
|
1.00
|
%
|
Volatility
|
44.20
|
%
|
|
43.53
|
%
|
Average life (in years)
|
7
|
|
|
4-7
|
|
|
Shares
|
|
Weighted Average Grant Date Fair Value
|
|||
Non-vested at December 31, 2016
|
2,364,500
|
|
|
$
|
8.28
|
|
Granted
|
233,791
|
|
|
13.94
|
|
|
Vested
|
—
|
|
|
—
|
|
|
Forfeited
|
65,483
|
|
|
9.17
|
|
|
Non-vested at December 31, 2017
|
2,532,808
|
|
|
$
|
8.78
|
|
|
Actual
|
|
Minimum Capital Requirement
|
|
Minimum To Be Well Capitalized
|
|||||||||||||||
|
Amount
|
|
Ratio
|
|
Amount
|
|
Ratio
|
|
Amount
|
|
Ratio
|
|||||||||
Consolidated - December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Common Equity Tier 1
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
390,816
|
|
|
17.81
|
%
|
|
$
|
98,764
|
|
|
4.50
|
%
|
|
$
|
142,659
|
|
|
6.50
|
%
|
Total Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
415,006
|
|
|
18.91
|
%
|
|
$
|
175,580
|
|
|
8.00
|
%
|
|
$
|
219,475
|
|
|
10.00
|
%
|
Tier 1 Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
390,816
|
|
|
17.81
|
%
|
|
$
|
131,685
|
|
|
6.00
|
%
|
|
$
|
175,580
|
|
|
8.00
|
%
|
Tier 1 Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Average Assets)
|
$
|
390,816
|
|
|
15.50
|
%
|
|
$
|
100,828
|
|
|
4.00
|
%
|
|
$
|
126,036
|
|
|
5.00
|
%
|
Bank - December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Common Equity Tier 1
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
277,943
|
|
|
12.89
|
%
|
|
$
|
97,060
|
|
|
4.50
|
%
|
|
$
|
140,197
|
|
|
6.50
|
%
|
Total Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
302,385
|
|
|
14.02
|
%
|
|
$
|
172,551
|
|
|
8.00
|
%
|
|
$
|
215,688
|
|
|
10.00
|
%
|
Tier 1 Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
277,943
|
|
|
12.89
|
%
|
|
$
|
129,413
|
|
|
6.00
|
%
|
|
$
|
172,551
|
|
|
8.00
|
%
|
Tier 1 Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Average Assets)
|
$
|
277,943
|
|
|
11.36
|
%
|
|
$
|
97,864
|
|
|
4.00
|
%
|
|
$
|
122,330
|
|
|
5.00
|
%
|
Consolidated - December 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Common Equity Tier 1
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
206,670
|
|
|
15.31
|
%
|
|
$
|
60,732
|
|
|
4.50
|
%
|
|
$
|
87,724
|
|
|
6.50
|
%
|
Total Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
223,559
|
|
|
16.56
|
%
|
|
$
|
107,968
|
|
|
8.00
|
%
|
|
$
|
134,960
|
|
|
10.00
|
%
|
Tier 1 Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
206,670
|
|
|
15.31
|
%
|
|
$
|
80,976
|
|
|
6.00
|
%
|
|
$
|
107,968
|
|
|
8.00
|
%
|
Tier 1 Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Average Assets)
|
$
|
206,670
|
|
|
12.00
|
%
|
|
$
|
68,919
|
|
|
4.00
|
%
|
|
$
|
86,149
|
|
|
5.00
|
%
|
Bank - December 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Common Equity Tier 1
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
139,078
|
|
|
10.68
|
%
|
|
$
|
58,579
|
|
|
4.50
|
%
|
|
$
|
84,615
|
|
|
6.50
|
%
|
Total Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
155,423
|
|
|
11.94
|
%
|
|
$
|
104,141
|
|
|
8.00
|
%
|
|
$
|
130,177
|
|
|
10.00
|
%
|
Tier 1 Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Risk-Weighted Assets)
|
$
|
139,078
|
|
|
10.68
|
%
|
|
$
|
78,106
|
|
|
6.00
|
%
|
|
$
|
104,141
|
|
|
8.00
|
%
|
Tier 1 Capital
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(to Average Assets)
|
$
|
139,078
|
|
|
8.41
|
%
|
|
$
|
66,142
|
|
|
4.00
|
%
|
|
$
|
82,678
|
|
|
5.00
|
%
|
|
2017
|
|
2016
|
||||
Assets
|
|
|
|
||||
Cash and cash equivalents
|
$
|
54,502
|
|
|
$
|
14,029
|
|
Investment in subsidiaries
|
351,647
|
|
|
174,957
|
|
||
Premises & equipment, net
|
33,948
|
|
|
30,290
|
|
||
Other assets
|
25,457
|
|
|
32,391
|
|
||
Total assets
|
$
|
465,554
|
|
|
$
|
251,667
|
|
|
|
|
|
||||
Liabilities and Shareholders' Equity
|
|
|
|
||||
Long term borrowings
|
$
|
26,564
|
|
|
$
|
27,843
|
|
Other liabilities
|
2,057
|
|
|
977
|
|
||
Total liabilities
|
28,621
|
|
|
28,820
|
|
||
|
|
|
|
||||
Shareholders' equity:
|
|
|
|
||||
Common stock
|
317,725
|
|
|
199,981
|
|
||
Retained earnings
|
120,241
|
|
|
23,518
|
|
||
Accumulated other comprehensive loss
|
(1,033
|
)
|
|
(652
|
)
|
||
Total equity
|
436,933
|
|
|
222,847
|
|
||
Total liabilities & shareholders' equity
|
$
|
465,554
|
|
|
$
|
251,667
|
|
|
2017
|
|
2016
|
|
2015
|
||||||
Interest income
|
$
|
5
|
|
|
$
|
50
|
|
|
$
|
70
|
|
Interest expense
|
1,210
|
|
|
964
|
|
|
1,156
|
|
|||
Net interest loss
|
(1,205
|
)
|
|
(914
|
)
|
|
(1,086
|
)
|
|||
Noninterest income:
|
|
|
|
|
|
||||||
Dividends from banking subsidiary
|
—
|
|
|
—
|
|
|
4,205
|
|
|||
Gain on sale of investment in non-consolidated affiliate
|
—
|
|
|
—
|
|
|
3,782
|
|
|||
Other noninterest income
|
2,114
|
|
|
2,041
|
|
|
1,360
|
|
|||
Total noninterest income
|
2,114
|
|
|
2,041
|
|
|
9,347
|
|
|||
Noninterest expense:
|
|
|
|
|
|
||||||
Salaries and employee benefits
|
10,531
|
|
|
12,785
|
|
|
2,592
|
|
|||
Professional services expense
|
1,192
|
|
|
675
|
|
|
812
|
|
|||
Renewable energy tax credit investment impairment
|
690
|
|
|
3,197
|
|
|
—
|
|
|||
Contingent consideration fair value adjustment
|
(4,350
|
)
|
|
—
|
|
|
—
|
|
|||
Other expense
|
2,588
|
|
|
2,076
|
|
|
1,719
|
|
|||
Total noninterest expense
|
10,651
|
|
|
18,733
|
|
|
5,123
|
|
|||
Net (loss) income before equity in undistributed income of subsidiaries
|
(9,742
|
)
|
|
(17,606
|
)
|
|
3,138
|
|
|||
Income tax benefit
|
(320
|
)
|
|
(10,065
|
)
|
|
(41
|
)
|
|||
Net (loss) income
|
(9,422
|
)
|
|
(7,541
|
)
|
|
3,179
|
|
|||
Equity in undistributed income of subsidiaries in excess of dividends from subsidiaries
|
109,921
|
|
|
21,305
|
|
|
17,422
|
|
|||
Net income
|
100,499
|
|
|
13,764
|
|
|
20,601
|
|
|||
Net loss attributable to noncontrolling interest
|
—
|
|
|
9
|
|
|
24
|
|
|||
Net income attributable to Live Oak Bancshares, Inc.
|
$
|
100,499
|
|
|
$
|
13,773
|
|
|
$
|
20,625
|
|
|
2017
|
|
2016
|
|
2015
|
||||||
Cash flows from operating activities
|
|
|
|
|
|
||||||
Net income
|
$
|
100,499
|
|
|
$
|
13,764
|
|
|
$
|
20,601
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
|
|
|
|
|
||||||
Equity in undistributed net income of subsidiaries in excess of dividends of subsidiaries
|
(109,921
|
)
|
|
(21,305
|
)
|
|
(17,422
|
)
|
|||
Depreciation
|
1,188
|
|
|
1,173
|
|
|
739
|
|
|||
Impairment on contingent consideration
|
(4,350
|
)
|
|
—
|
|
|
—
|
|
|||
Deferred income tax
|
(5,376
|
)
|
|
(2,695
|
)
|
|
582
|
|
|||
Renewable energy tax credit investment impairment
|
690
|
|
|
3,197
|
|
|
—
|
|
|||
Stock option based compensation expense
|
1,786
|
|
|
2,349
|
|
|
1,277
|
|
|||
Restricted stock expense
|
5,717
|
|
|
9,724
|
|
|
148
|
|
|||
Gain on sale of investment in non-consolidated affiliate
|
—
|
|
|
—
|
|
|
(3,782
|
)
|
|||
Business combination contingent consideration fair value adjustment
|
1,950
|
|
|
—
|
|
|
—
|
|
|||
Net change in other assets
|
11,649
|
|
|
(17,930
|
)
|
|
(8,785
|
)
|
|||
Net change in other liabilities
|
(820
|
)
|
|
(358
|
)
|
|
1,422
|
|
|||
Net cash provided by (used in) operating activities
|
3,012
|
|
|
(12,081
|
)
|
|
(5,220
|
)
|
|||
Cash flows from investing activities
|
|
|
|
|
|
||||||
Capital investment in subsidiaries
|
(55,240
|
)
|
|
(45,870
|
)
|
|
(28,250
|
)
|
|||
Net change in advances to subsidiaries
|
640
|
|
|
—
|
|
|
—
|
|
|||
Business combination, net of cash acquired
|
(7,696
|
)
|
|
—
|
|
|
—
|
|
|||
Proceeds from sale of investment in non-consolidated affiliate
|
—
|
|
|
—
|
|
|
9,896
|
|
|||
Capital contribution from non-controlling interest
|
—
|
|
|
—
|
|
|
22
|
|
|||
Purchases of premises and equipment
|
(4,864
|
)
|
|
(143
|
)
|
|
(11,397
|
)
|
|||
Net cash used in investing activities
|
(67,160
|
)
|
|
(46,013
|
)
|
|
(29,729
|
)
|
|||
Cash flows from financing activities
|
|
|
|
|
|
||||||
Proceeds from long term borrowings
|
16,900
|
|
|
—
|
|
|
12,960
|
|
|||
Repayments of long term borrowings
|
(26,279
|
)
|
|
(532
|
)
|
|
(26,609
|
)
|
|||
Proceeds from short term borrowings
|
8,100
|
|
|
—
|
|
|
—
|
|
|||
Stock option exercises
|
1,026
|
|
|
401
|
|
|
239
|
|
|||
Employee stock purchase program
|
445
|
|
|
—
|
|
|
—
|
|
|||
Withholding cash issued in lieu of restricted stock
|
(4,891
|
)
|
|
—
|
|
|
—
|
|
|||
Sale of common stock, net
|
113,096
|
|
|
—
|
|
|
87,171
|
|
|||
Shareholder dividend distributions
|
(3,776
|
)
|
|
(2,737
|
)
|
|
(2,732
|
)
|
|||
Net cash provided by (used in) financing activities
|
104,621
|
|
|
(2,868
|
)
|
|
71,029
|
|
|||
Net change in cash and cash equivalents
|
40,473
|
|
|
(60,962
|
)
|
|
36,080
|
|
|||
Cash and cash equivalents at beginning of year
|
14,029
|
|
|
74,991
|
|
|
38,911
|
|
|||
Cash and cash equivalents at end of year
|
$
|
54,502
|
|
|
$
|
14,029
|
|
|
$
|
74,991
|
|
Item 9.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
Item 9A.
|
CONTROLS AND PROCEDURES
|
Item 9B.
|
OTHER INFORMATION
|
Item 10.
|
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
Item 11.
|
EXECUTIVE COMPENSATION
|
Item 12.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS
|
Item 13.
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
|
Item 14.
|
PRINCIPAL ACCOUNTING FEES AND SERVICES
|
Item 15.
|
EXHIBITS, FINANCIAL STATEMENT SCHEDULES
|
(a)(1)
Financial Statements.
The following financial statements and supplementary data are included in Item 8 of this report.
|
Financial Statements
|
Quarterly Financial Information
|
Reports of Independent Registered Public Accounting Firm
|
Consolidated Balance Sheets as of December 31, 2017 and 2016
|
Consolidated Statements of Income for the Years Ended December 31, 2017, 2016 and 2015
|
Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2017, 2016 and 2015
|
Consolidated Statements of Changes in Shareholders’ Equity for the Years Ended December 31, 2017, 2016 and 2015
|
Consolidated Statements of Cash Flows for the Years Ended December 31, 2017, 2016 and 2015
|
(a)(2)
Financial Statement Schedules.
All applicable financial statement schedules required under Regulation S-X have been included in the Notes to the Consolidated Financial Statements
|
(a)(3)
Exhibits.
The exhibits listed in the accompanying Exhibit Index are filed as a part of this Annual Report on Form 10-K
|
|
Live Oak Bancshares, Inc.
|
|
|
(
Registrant
)
|
|
|
|
|
Date: March 8, 2018
|
By:
|
/
s
/ James S. Mahan III
|
|
|
James S. Mahan III
|
|
|
Chairman and Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
|
|
Date
|
|
/s/ James S. Mahan III
|
|
|
|
James S. Mahan III
|
|
March 8, 2018
|
|
Chairman and Chief Executive Officer (Principal Executive Officer)
|
|
|
|
|
|
|
|
/s/ S. Brett Caines
|
|
|
|
S. Brett Caines
|
|
March 8, 2018
|
|
Chief Financial Officer
|
|
|
|
(Principal Financial Officer)
|
|
|
|
|
|
|
|
/s/ J. Wesley Sutherland
|
|
|
|
J. Wesley Sutherland
|
|
March 8, 2018
|
|
Chief Accounting Officer
|
|
|
|
(Principal Accounting Officer)
|
|
|
|
|
|
|
|
/s/ William L. Williams III
|
|
|
|
William L. Williams III
|
|
March 8, 2018
|
|
Vice Chairman of the Board of Directors
|
|
|
|
|
|
|
|
/s/ William H. Cameron
|
|
|
|
William H. Cameron
|
|
March 8, 2018
|
|
Director
|
|
|
|
|
|
|
|
/s/ Diane B. Glossman
|
|
|
|
Diane B. Glossman
|
|
March 8, 2018
|
|
Director
|
|
|
|
|
|
|
|
/s/ Glen F. Hoffsis
|
|
|
|
Glen F. Hoffsis
|
|
March 8, 2018
|
|
Director
|
|
|
|
|
|
|
|
/s/ Howard K. Landis
|
|
|
|
Howard K. Landis
|
|
March 8, 2018
|
|
Director
|
|
|
|
|
|
|
|
/s/ Miltom E. Petty
|
|
|
|
Miltom E. Petty
|
|
March 8, 2018
|
|
Director
|
|
|
|
|
|
|
|
/s/ Jerald L. Pullins
|
|
|
|
Jerald L. Pullins
|
|
March 8, 2018
|
|
Director
|
|
|
|
|
|
|
|
/s/ Neil L. Underwood
|
|
|
|
Neil L. Underwood
|
|
March 8, 2018
|
|
Director
|
|
|
|
Exhibit No.
|
|
Description of Exhibit
|
|
|
|
|
|
2.1
|
|
|
Contribution Agreement dated as of May 9, 2017 (incorporated by reference to Exhibit 2.1 of the current report on Form 8-K filed on May 5, 2017)
|
3.1
|
|
|
Amended and Restated Articles of Incorporation of Live Oak Bancshares, Inc. (incorporated by reference to Exhibit 3.1 of the registration statement on Form S-1, filed on June 19, 2015)
|
3.2
|
|
|
Amended Bylaws of Live Oak Bancshares, Inc. (incorporated by reference to Exhibit 3.2 of the registration statement on Form S-1, filed on June 19, 2015)
|
4.1
|
|
|
Form of Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the registration statement on Form S-1, filed on June 19, 2015)
|
4.2
|
|
|
Registration and Other Rights Agreement between Live Oak Bancshares, Inc. and Wellington purchasers (incorporated by reference to Exhibit 4.2 of the registration statement on Form S-1, filed on June 19, 2015)
|
10.1
|
|
|
2008 Incentive Stock Option Plan, as amended (incorporated by reference to Exhibit 10.1 of the registration statement on Form S-1, filed on June 19, 2015)
|
10.2
|
|
|
2008 Nonstatutory Stock Option Plan, as amended (incorporated by reference to Exhibit 10.2 of the registration statement on Form S-1, filed on June 19, 2015)
|
10.3
|
|
|
Amended and Restated Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.4 of the quarterly report on Form 10-Q filed on August 8, 2016)
|
10.4.1
|
|
|
2015 Omnibus Stock Incentive Plan (incorporated by reference to Exhibit 10.4 of the registration statement on Form S-1 filed on June 19, 2015)
|
10.4.2
|
|
|
Amendment to 2015 Omnibus Stock Incentive Plan dated December 17, 2015 (incorporated by reference to Exhibit 10.4.2 of the 2015 10-K)
|
10.4.3
|
|
|
2015 Omnibus Stock Incentive Plan as Amended and Restated effective May 24, 2016 (incorporated by reference to Exhibit 10.1 of the current report on Form 8-K filed on May 27, 2016)
|
10.5.1
|
|
|
Securities Purchase Agreement, dated May 28, 2014 between Live Oak Bancshares, Inc. and Wellington purchasers (incorporated by reference to Exhibit 10.7 of the registration statement on Form S-1 filed on June 19, 2015)
|
10.5.2
|
|
|
First Amendment to Securities Purchase Agreement, dated July 31, 2014 between Live Oak Bancshares, Inc. and Wellington purchasers (incorporated by reference to Exhibit 10.8 of the registration statement on Form S-1 filed on June 19, 2015)
|
10.5.3
|
|
|
Second Amendment to Securities Purchase Agreement, dated August 1, 2014 between Live Oak Bancshares, Inc. and Wellington purchasers (incorporated by reference to Exhibit 10.9 of the registration statement on Form S-1 filed on June 19, 2015)
|
10.6.1
|
|
|
Software Service Agreement between Live Oak Banking Company and nCino, LLC, dated November 1, 2012 (incorporated by reference to Exhibit 10.10 of the registration statement on Form S-1 filed on June 19, 2015)
|
10.6.2
|
|
|
Amendment to Software Service Agreement dated October 9, 2015, between Live Oak Banking Company and nCino, Inc. (incorporated by reference to Exhibit 10.7.2 of the 2015 10-K)
|
10.7.1
|
|
|
Form of Stock Option Award Agreement for executive officers under the 2015 Omnibus Stock Incentive Plan (incorporated by reference to Exhibit 10.8 of the 2015 10-K)
|
10.7.2
|
|
|
Performance RSU Award Agreement for Neil L. Underwood (incorporated by reference to Exhibit 99.1 of the current report on Form 8-K filed on March 25, 2016)
|
10.7.3
|
|
|
Performance RSU Award Agreement with Stock Price Condition for Neil L. Underwood (incorporated by reference to Exhibit 99.2 of the current report on Form 8-K filed on March 25, 2016)
|
10.7.4
|
|
|
Form of Performance RSU Award Agreement with Stock Price Condition for certain executive officers (incorporated by reference to Exhibit 99.1 of the current report on Form 8-K filed on December 2, 2016)
|
10.7.5
|
|
|
Form of Performance RSU Award Agreement with Stock Price Condition for certain executive officers (incorporated by reference to Exhibit 99.1 of the current report on Form 8-K filed on February 2, 2017)
|
10.7.6
|
|
|
|
10.7.7
|
|
|
|
10.7.8
|
|
|
Exhibit No.
|
|
Description of Exhibit
|
|
21.1
|
|
|
|
23.1
|
|
|
|
31.1
|
|
|
|
31.2
|
|
|
|
32
|
|
|
|
101
|
|
|
Interactive data files pursuant to Rule 405 of Regulation S-T: (i) Consolidated Balance Sheets as of December 31, 2017 and 2016; (ii) Consolidated Statements of Income for the Years Ended December 31, 2017, 2016 and 2015; (iii) Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2017, 2016 and 2015; (iv) Consolidated Statements of Changes in Shareholders’ Equity for the Years Ended December 31, 2017, 2016 and 2015; (v) Consolidated Statements of Cash Flows for the Years Ended December 31, 2017, 2016 and 2015; and (vi) Notes to Consolidated Financial Statements.*
|
*
|
Indicates a document being filed with this Form 10-K.
|
**
|
Furnished herewith. This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that Section. Such exhibit shall not be deemed incorporated into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.
|
Grantee:
|
[NAME]
|
Date of Grant:
|
August 7, 2017
|
Expiration Date:
|
August 7, 2024
|
Number of Units subject to Vesting Conditions:
|
[#######]
|
Performance Period
|
July 1, 2017, through June 30, 2018
|
Date of Triggering Event
|
Target Stock Price
|
% of Units Vested
|
January 1, 2018 through December 31, 2018
|
$24.00/share
|
14.3%
|
January 1, 2019 through December 31, 2019
|
$26.00/share
|
28.6%
|
January 1, 2020 through December 31, 2020
|
$28.00/share
|
42.9%
|
January 1, 2021 through December 31, 2021
|
$30.00/share
|
57.2%
|
January 1, 2022 through December 31, 2022
|
$32.00/share
|
71.4%
|
On or after January 1, 2023 but before Expiration Date
|
$36.00/share
|
85.7%
|
•
|
If Grantee’s Continuous Service terminates as a result of his Disability on July 1, 2020, and the Units were not previously forfeited, the Target Stock Price for determining whether the Modified Stock Price Condition has been met will be $28.00/share, and if the Modified Stock Price Condition is met, Grantee would vest in 42.9% of the total Units awarded hereunder as of the date of the termination due to Disability.
|
•
|
If a Corporate Transaction occurs on October 31, 2022, and the Units were not previously forfeited, the Target Stock Price for determining whether the Modified Stock Price Condition has been met will be $32.00/share, and if the Modified Stock Price Condition is met, Grantee would vest in 71.4% of the total Units awarded hereunder as of the date of the Corporate Transaction.
|
(a)
|
Separation Pay. If you sign and do not revoke this Agreement, the Bank will pay you Thirty-Three Thousand Three Hundred Thirty-Four Dollars ($33,334.00) a month (minus applicable federal, state and local payroll taxes, and other withholdings required by law or authorized by you) for a period of twelve months (collectively, the “Separation Pay”). You will receive the Separation Pay in accordance with the Bank’s payroll procedures beginning on the Bank’s first regular payday after the expiration of the Revocation Period (as that term is defined in Section 9 herein).
|
(b)
|
Health Benefits. If you sign and do not revoke this Agreement, and if you properly and timely elect to continue your health insurance benefits under the Consolidated Omnibus Budget Reconciliation Act of 1986 (“COBRA”) after the Termination Date, the Bank will directly pay the cost of your applicable COBRA premiums through and including January 31, 2019. Provided, however, the Bank has the right to discontinue the payment of these premiums and pay you a lump sum amount equal to the current monthly COBRA premium times the number of months remaining in the specified period if the Bank determines that continued payment of the COBRA premiums is discriminatory under Section 105(h) of the Internal Revenue Code. After January 31, 2019, you may continue your health insurance at your own expense in accordance with applicable provisions of COBRA.
|
(c)
|
Stock Grant. The Compensation Committee of the Board of Directors of Live Oak Bancshares (“Bancshares”) has approved a grant of Twenty-Five Thousand (25,000) Restricted Stock Units (“RSUs”) under the Bancshares 2015 Omnibus Stock Incentive Plan, conditioned upon your execution and delivery of this Agreement, such RSUs to vest one business day after the expiration of the Revocation Period (as defined below).
|
1.
|
I have reviewed this Annual Report on Form 10-K of Live Oak Bancshares, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: March 8, 2018
|
/s/ James S. Mahan III
|
|
James S. Mahan III
|
|
Chief Executive Officer
|
|
(principal executive officer)
|
1.
|
I have reviewed this Annual Report on Form 10-K of Live Oak Bancshares, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: March 8, 2018
|
/s/ S. Brett Caines
|
|
S. Brett Caines
|
|
Chief Financial Officer
|
|
(principal financial officer)
|
Date: March 8, 2018
|
/s/ James S. Mahan III
|
|
James S. Mahan III
|
|
Chief Executive Officer
|
|
(principal executive officer)
|
Date: March 8, 2018
|
/s/ S. Brett Caines
|
|
S. Brett Caines
|
|
Chief Financial Officer
|
|
(principal financial officer)
|